data_1ut3_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ut3 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.05 -34.95 89.84 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.564 -0.351 . . . . 0.0 113.062 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 92.0 mt -73.61 -2.38 22.73 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.6 t -137.58 -157.67 0.8 Allowed 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.419 ' HG2' ' O ' ' A' ' 6' ' ' ARG . 40.9 ttm180 56.01 30.2 15.75 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.802 0.81 . . . . 0.0 109.819 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.9 mt -74.86 -52.76 10.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.701 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 39.3 mtp85 -95.93 -55.38 3.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.383 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 45.3 ttt-85 -174.19 39.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.494 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.71 121.16 5.34 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.177 -1.011 . . . . 0.0 110.908 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.657 ' HE2' ' HG2' ' A' ' 36' ' ' ARG . 35.2 p90 -104.11 139.2 39.52 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.246 0.546 . . . . 0.0 110.746 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 61.1 m -76.12 126.4 30.92 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.646 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.532 ' HB1' ' SG ' ' A' ' 34' ' ' CYS . . . -123.76 136.75 54.61 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.093 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -70.1 120.44 15.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.247 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.84 -130.07 16.75 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.945 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 78.2 mtt-85 -76.8 146.96 37.5 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.899 0.38 . . . . 0.0 111.83 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 82.7 m -67.19 150.25 49.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.358 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.423 ' HD2' ' N ' ' A' ' 18' ' ' ARG . 1.1 mpt_? -68.49 163.51 23.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.241 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.76 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 30.4 t80 -46.86 -59.12 5.66 Favored Pre-proline 0 CA--C 1.543 0.674 0 O-C-N 123.648 0.592 . . . . 0.0 112.521 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.76 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 4.1 Cg_endo -86.53 46.87 1.61 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.36 2.04 . . . . 0.0 112.142 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.405 ' HG ' ' C ' ' A' ' 20' ' ' PRO . 14.9 m -151.32 130.47 12.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.551 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.3 pt -104.65 139.16 19.83 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-O 120.983 0.42 . . . . 0.0 111.118 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.54 75.54 5.0 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 123.08 2.52 . . . . 0.0 112.798 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.677 HD12 ' HB2' ' A' ' 35' ' ' ARG . 45.9 pt -63.75 -30.13 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.103 0.478 . . . . 0.0 111.008 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -162.91 -172.99 31.08 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.6 mtm-85 -111.96 132.4 54.79 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.917 0.359 . . . . 0.0 110.507 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.582 ' HB3' HG13 ' A' ' 31' ' ' VAL . 35.0 t -77.77 -34.6 52.27 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.5 t -146.61 -141.85 0.12 Allowed 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -83.67 -57.52 3.19 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.638 -0.425 . . . . 0.0 109.973 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -93.29 -38.53 11.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.773 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.582 HG13 ' HB3' ' A' ' 27' ' ' CYS . 84.5 t -68.64 117.06 10.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.155 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -89.0 160.46 17.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.829 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 30.5 t -103.98 69.14 0.93 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.532 ' SG ' ' HB1' ' A' ' 13' ' ' ALA . 13.3 m -63.73 131.05 46.67 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.44 -1.255 . . . . 0.0 112.509 -177.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.677 ' HB2' HD12 ' A' ' 24' ' ' ILE . 15.2 tpt180 -107.68 138.55 43.71 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.264 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.657 ' HG2' ' HE2' ' A' ' 11' ' ' PHE . 22.5 mmt85 -62.02 150.24 38.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.993 0.425 . . . . 0.0 110.449 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.1 p -139.23 37.82 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 122.478 1.132 . . . . 0.0 109.57 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 12.3 m0 . . . . . 0 C--O 1.249 1.062 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.503 179.872 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.688 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 40.7 p90 . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 110.612 -0.144 . . . . 0.0 110.612 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -55.39 -49.6 63.63 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.538 -0.363 . . . . 0.0 113.19 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.28 -40.59 96.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.244 0.545 . . . . 0.0 110.19 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.609 ' SG ' ' HA2' ' A' ' 10' ' ' GLY . 47.7 t -62.96 -40.93 99.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.262 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.688 ' HG2' ' O ' ' A' ' 2' ' ' PHE . 20.9 mmt85 -59.91 -41.72 92.3 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.949 0.404 . . . . 0.0 110.565 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.3 mt -63.18 -34.82 78.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.18 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.2 ttm180 -86.64 10.69 14.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.04 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? 62.68 41.69 8.99 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.762 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.609 ' HA2' ' SG ' ' A' ' 5' ' ' CYS . . . -94.95 136.16 12.79 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 178.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -94.6 133.1 38.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.098 0.475 . . . . 0.0 110.862 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 85.4 m -78.45 108.84 12.11 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.836 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -103.44 128.59 50.57 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.967 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.426 ' HG2' HG23 ' A' ' 31' ' ' VAL . 73.3 mtm180 -72.28 111.88 7.87 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.0 0.428 . . . . 0.0 111.382 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.45 -58.86 3.72 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.76 -0.655 . . . . 0.0 113.659 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.5 mmm-85 -145.71 146.68 31.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.928 0.394 . . . . 0.0 111.663 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.7 m -76.25 125.68 29.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.993 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -90.45 45.88 1.3 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.712 0.768 . . . . 0.0 109.567 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -171.47 146.62 1.97 Allowed Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 114.35 -1.296 . . . . 0.0 107.908 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -63.24 60.44 0.17 Allowed 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.67 2.913 . . . . 0.0 113.944 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 57.8 m -127.02 129.73 48.62 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.7 pt -81.09 138.79 49.16 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 121.136 0.493 . . . . 0.0 111.691 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.653 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 65.8 Cg_endo -81.0 116.3 3.1 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.657 2.238 . . . . 0.0 111.427 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 25.5 pt -78.85 -30.31 14.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.988 0.423 . . . . 0.0 111.303 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -164.46 153.89 24.42 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -70.13 135.98 49.7 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.055 0.455 . . . . 0.0 110.975 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.4 ' HB3' HG13 ' A' ' 31' ' ' VAL . 34.9 t -80.96 -31.02 35.03 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.7 t -147.55 -140.44 0.1 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.315 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -86.44 -49.69 7.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.938 0.399 . . . . 0.0 110.298 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -103.15 -35.29 8.54 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.426 HG23 ' HG2' ' A' ' 14' ' ' ARG . 57.9 t -70.42 123.63 24.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.3 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -95.22 -177.56 4.16 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.481 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.5 t -139.92 107.73 5.67 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.653 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 0.7 OUTLIER -94.75 128.88 41.77 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.554 -176.266 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 61.7 ttt-85 -97.65 134.34 40.97 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.235 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.2 tpp85 -65.23 132.4 49.0 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.03 44.13 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 121.84 0.828 . . . . 0.0 111.32 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.931 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.126 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 15.8 p90 . . . . . 0 CA--C 1.526 0.035 0 CA-C-O 120.575 0.226 . . . . 0.0 111.57 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -60.29 -52.89 49.9 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.893 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.428 HD11 ' N ' ' A' ' 5' ' ' CYS . 4.0 pp -71.47 -35.02 70.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.723 0.296 . . . . 0.0 111.127 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.521 ' SG ' ' HA2' ' A' ' 10' ' ' GLY . 26.7 t -66.65 -32.78 74.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.104 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -57.85 -38.43 75.65 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.136 0.494 . . . . 0.0 110.26 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.7 mt -67.64 -37.62 82.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.089 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -76.91 -5.71 49.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.591 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 69.02 29.56 4.76 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.726 0.81 . . . . 0.0 112.171 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.521 ' HA2' ' SG ' ' A' ' 5' ' ' CYS . . . -76.19 137.93 21.93 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -96.41 142.08 28.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 117.471 0.635 . . . . 0.0 111.222 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 75.7 m -80.73 124.7 29.25 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.326 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.565 ' HB1' ' SG ' ' A' ' 17' ' ' CYS . . . -130.83 111.78 12.43 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.28 0.562 . . . . 0.0 110.05 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.49 ' HG3' HG23 ' A' ' 31' ' ' VAL . 16.9 ttm180 -74.61 134.67 42.06 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.342 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.12 42.27 51.58 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.167 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 69.61 149.22 0.07 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.563 0.697 . . . . 0.0 111.595 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.565 ' SG ' ' HB1' ' A' ' 13' ' ' ALA . 3.2 m -90.11 -172.48 3.5 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.917 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 68.2 mtm-85 -80.48 -178.84 6.88 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.925 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.459 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 85.6 t80 -65.79 -55.34 23.41 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.459 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 72.2 Cg_endo -75.06 46.12 1.49 Allowed 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.179 1.92 . . . . 0.0 113.464 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.5 p -158.98 116.29 2.77 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.928 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.0 pt -96.02 138.49 21.65 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 120.92 0.391 . . . . 0.0 111.121 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -74.91 77.71 3.03 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.843 2.362 . . . . 0.0 112.676 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.8 pt -62.94 -27.41 43.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.392 0.615 . . . . 0.0 110.27 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -156.28 -167.82 18.18 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.568 ' HD2' ' O ' ' A' ' 29' ' ' ARG . 83.7 mtm180 -141.33 135.57 30.66 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 47.7 m -68.2 -51.41 45.93 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.794 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.6 m -115.65 -62.94 1.52 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.934 0.397 . . . . 0.0 110.678 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.568 ' O ' ' HD2' ' A' ' 26' ' ' ARG . 8.1 tpp180 -172.83 -60.91 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.436 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -80.14 -40.32 27.63 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.49 HG23 ' HG3' ' A' ' 14' ' ' ARG . 61.3 t -70.16 114.73 8.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.282 178.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -77.06 154.48 33.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.324 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 12.8 t -122.3 69.46 0.96 Allowed 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 56.1 m -74.63 137.61 42.38 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.781 -1.099 . . . . 0.0 113.214 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.3 ttm-85 -88.09 138.01 31.83 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.385 177.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -65.95 131.58 46.57 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.122 0.487 . . . . 0.0 110.502 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.1 t -108.36 60.25 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.325 0.583 . . . . 0.0 110.052 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.518 -0.753 . . . . 0.0 111.032 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.698 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 16.5 t80 . . . . . 0 C--O 1.227 -0.093 0 N-CA-C 111.381 0.141 . . . . 0.0 111.381 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -56.55 -52.37 50.68 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.424 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.476 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 3.1 tm? -60.68 -43.01 98.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.027 0.442 . . . . 0.0 109.843 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 53.3 t -61.75 -46.41 89.72 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.382 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 62.7 ttt-85 -65.39 -44.03 88.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.778 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 4' ' ' LEU . 4.2 pp -66.26 -32.83 74.49 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.253 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -85.51 -2.37 58.07 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.609 0.242 . . . . 0.0 110.649 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 70.0 mtm180 61.91 42.89 9.77 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.488 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.71 147.1 19.21 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -81.88 134.11 35.38 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 117.211 0.506 . . . . 0.0 109.771 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.62 ' SG ' HG11 ' A' ' 31' ' ' VAL . 9.4 t -107.91 132.59 53.31 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -125.37 142.31 51.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.016 0.436 . . . . 0.0 111.805 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.549 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 15.1 ptp180 -70.2 126.2 28.97 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.19 129.22 4.34 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.736 ' HG2' ' HG3' ' A' ' 32' ' ' GLN . 73.5 mtt180 -60.75 114.78 3.21 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.983 0.42 . . . . 0.0 111.918 -178.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.7 m -72.03 150.53 43.9 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -154.93 56.83 0.67 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.021 -0.672 . . . . 0.0 111.736 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.873 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 36.2 t80 -166.39 -66.9 0.01 OUTLIER Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.144 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.873 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 94.3 Cg_endo -90.26 -20.84 0.98 Allowed 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.974 1.783 . . . . 0.0 112.267 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.3 m -154.27 148.41 25.83 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.493 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.535 HG12 HG22 ' A' ' 37' ' ' VAL . 36.6 pt -117.23 144.4 33.74 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 120.572 0.225 . . . . 0.0 110.916 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.768 ' HB3' ' HB3' ' A' ' 32' ' ' GLN . 11.5 Cg_exo -68.99 104.15 1.15 Allowed 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.675 2.25 . . . . 0.0 112.013 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.5 pt -88.6 -32.98 6.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.065 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -137.93 144.85 16.27 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.066 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 28' ' ' SER . 17.1 ttm105 -88.41 122.18 31.62 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.707 0.289 . . . . 0.0 111.563 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.698 ' HA ' ' HB2' ' A' ' 2' ' ' PHE . 26.9 m -88.89 -38.97 14.13 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.518 ' HB3' HG22 ' A' ' 31' ' ' VAL . 17.1 t -154.59 -161.34 1.2 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.045 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 43.7 ttt-85 -65.14 -53.18 49.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.088 0.47 . . . . 0.0 111.051 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -98.47 -35.6 10.21 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.686 -178.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.62 HG11 ' SG ' ' A' ' 12' ' ' CYS . 1.8 t -71.12 116.64 13.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.138 -178.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.768 ' HB3' ' HB3' ' A' ' 23' ' ' PRO . 15.0 mm100 -116.38 139.99 49.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.808 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 47.9 t -85.3 93.97 8.82 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 23.2 m -84.3 109.65 17.97 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.683 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.455 ' O ' HG21 ' A' ' 37' ' ' VAL . 46.6 ttp180 -76.26 138.55 40.65 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.265 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -56.5 125.51 22.4 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 123.438 0.461 . . . . 0.0 111.583 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.535 HG22 HG12 ' A' ' 22' ' ' ILE . 29.4 t -126.31 77.96 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.851 0.834 . . . . 0.0 109.23 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 14.3 t-105 . . . . . 0 C--O 1.251 1.153 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.226 179.945 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.708 ' CE1' ' HA2' ' A' ' 25' ' ' GLY . 60.4 m-85 . . . . . 0 N--CA 1.454 -0.225 0 CA-C-O 120.514 0.197 . . . . 0.0 110.678 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -56.49 -26.75 52.71 Favored Glycine 0 C--N 1.336 0.531 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 42.0 tp -160.07 75.66 0.61 Allowed 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.49 142.47 48.73 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.676 -178.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.43 ' O ' ' HB2' ' A' ' 7' ' ' LEU . 69.8 mtt85 -41.65 -31.23 0.27 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -176.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 73.0 mt 72.25 -45.12 0.61 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.137 0.575 . . . . 0.0 110.636 -178.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.429 ' H ' ' C ' ' A' ' 6' ' ' ARG . 3.5 tpp180 -68.45 -41.74 79.79 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.2 ttt-85 -91.33 -65.44 1.01 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.801 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.734 ' HA3' ' HA ' ' A' ' 35' ' ' ARG . . . -123.96 123.53 5.22 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 178.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -109.04 131.23 55.27 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.016 0.436 . . . . 0.0 110.806 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.609 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -85.17 126.02 33.3 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.959 0.409 . . . . 0.0 110.545 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.472 ' HB1' ' SG ' ' A' ' 17' ' ' CYS . . . -129.34 143.21 50.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.821 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.425 ' HA ' HG23 ' A' ' 31' ' ' VAL . 28.6 ttp-105 -62.62 126.95 29.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.046 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.15 -129.98 13.26 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.122 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -100.52 132.62 45.8 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.472 ' SG ' ' HB1' ' A' ' 13' ' ' ALA . 58.1 m -71.25 118.07 13.58 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.168 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -83.58 58.62 4.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.643 0.735 . . . . 0.0 109.949 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.58 ' CD1' ' HD2' ' A' ' 20' ' ' PRO . 37.3 t80 -167.94 138.58 2.26 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.809 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.58 ' HD2' ' CD1' ' A' ' 19' ' ' PHE . 10.0 Cg_endo -53.99 83.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 124.067 3.178 . . . . 0.0 112.96 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.853 ' HA ' HG13 ' A' ' 37' ' ' VAL . 57.4 m -158.62 121.39 3.71 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.101 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.1 pt -82.99 138.52 42.84 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-O 121.131 0.491 . . . . 0.0 111.558 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.784 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 46.6 Cg_endo -76.04 111.66 3.32 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.384 2.056 . . . . 0.0 112.196 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.426 HD12 ' HB2' ' A' ' 35' ' ' ARG . 16.8 pt -79.01 -24.06 12.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.512 0.672 . . . . 0.0 110.264 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.708 ' HA2' ' CE1' ' A' ' 2' ' ' PHE . . . -158.03 -165.82 16.2 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.111 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.448 ' HA ' ' HA ' ' A' ' 32' ' ' GLN . 44.3 ttp180 -148.58 124.19 10.44 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.876 0.338 . . . . 0.0 110.123 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 40.2 m -74.66 -52.23 12.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.871 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.9 m -114.55 -147.98 0.42 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.411 ' O ' ' HD2' ' A' ' 26' ' ' ARG . 14.7 tpp180 -84.82 -46.03 11.75 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -95.69 -42.99 8.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.826 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.551 HG13 ' SG ' ' A' ' 12' ' ' CYS . 28.7 t -64.04 109.35 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.777 -178.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.609 ' O ' ' HA ' ' A' ' 12' ' ' CYS . 51.5 mt-30 -104.5 147.31 27.73 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.601 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 52.5 t -92.34 84.95 5.25 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.784 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 59.3 m -77.49 116.08 17.77 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.212 -178.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.734 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 59.3 ttp85 -80.19 135.42 36.27 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.73 178.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 18.1 tpp85 -60.65 125.48 23.87 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.228 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.853 HG13 ' HA ' ' A' ' 21' ' ' SER . 11.8 p -132.73 39.35 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 122.652 1.215 . . . . 0.0 108.721 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 2.3 t90 . . . . . 0 C--O 1.243 0.752 0 CA-C-N 114.495 -1.229 . . . . 0.0 108.943 179.791 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.42 ' CG ' ' HA ' ' A' ' 27' ' ' CYS . 88.3 m-85 . . . . . 0 N--CA 1.466 0.349 0 CA-C-O 121.039 0.447 . . . . 0.0 111.969 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.18 -42.49 3.48 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 80.1 mt -108.24 41.4 1.56 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.6 ' HA ' ' HG2' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -64.02 -29.49 70.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.592 -178.44 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.543 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 72.3 mtp85 -66.66 -47.81 71.33 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.5 pp -77.81 -32.53 52.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.6 ' HG2' ' HA ' ' A' ' 5' ' ' CYS . 6.5 ptm85 -63.61 -50.62 68.67 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.159 -0.616 . . . . 0.0 109.504 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.542 ' HB2' ' O ' ' A' ' 8' ' ' ARG . 36.0 ttm180 163.51 97.16 0.0 OUTLIER 'General case' 0 C--O 1.235 0.306 0 O-C-N 124.01 0.819 . . . . 0.0 109.978 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.543 ' O ' ' HA ' ' A' ' 6' ' ' ARG . . . 127.74 -143.16 14.14 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.596 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -175.39 138.59 0.42 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 33' ' ' CYS . 45.6 t -89.38 123.61 33.7 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.492 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.44 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . . . -122.97 135.43 54.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.821 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.591 ' HA ' HG12 ' A' ' 31' ' ' VAL . 54.6 ttm-85 -75.53 133.2 41.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.026 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.24 -60.03 4.85 Favored Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.292 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.418 ' CZ ' ' HB2' ' A' ' 16' ' ' ARG . 2.3 ptm85 -173.79 173.19 3.35 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.44 ' SG ' ' HB2' ' A' ' 13' ' ' ALA . 6.7 m -112.29 -171.07 1.78 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.958 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -91.27 178.42 5.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.913 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.581 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 36.2 t80 -59.66 -52.85 71.01 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.581 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 10.1 Cg_exo -72.49 40.88 0.49 Allowed 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.39 2.06 . . . . 0.0 113.671 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.7 p -161.83 123.42 2.79 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.206 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.405 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 45.9 pt -102.84 141.67 22.97 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 120.79 0.328 . . . . 0.0 111.115 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 22' ' ' ILE . 18.9 Cg_exo -64.11 118.69 5.63 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.675 2.25 . . . . 0.0 111.714 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 33' ' ' CYS . 15.8 pt -101.85 -23.83 4.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.529 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 177.25 143.79 5.06 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.892 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 66.0 mtt85 -74.4 135.05 42.4 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.42 ' HA ' ' CG ' ' A' ' 2' ' ' PHE . 8.4 m -72.22 -34.53 68.41 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.1 m -141.15 -57.02 0.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.617 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 34.9 ttm105 -172.24 -66.47 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.01 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -76.6 -41.26 46.79 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.591 HG12 ' HA ' ' A' ' 14' ' ' ARG . 2.5 t -71.23 126.58 31.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.142 178.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -117.39 151.72 36.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.758 0.313 . . . . 0.0 111.514 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.494 ' O ' HG12 ' A' ' 24' ' ' ILE . 42.4 t -107.63 120.47 42.32 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 176.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.8 m -118.97 118.62 32.0 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.888 -0.725 . . . . 0.0 112.021 -177.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.414 ' HB2' HG22 ' A' ' 24' ' ' ILE . 28.3 ttm180 -70.91 130.71 42.33 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.932 178.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.541 ' HB2' ' CE3' ' A' ' 38' ' ' TRP . 25.6 mtp-105 -63.71 138.68 58.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.278 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 t -80.55 53.43 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.549 0.69 . . . . 0.0 110.243 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.541 ' CE3' ' HB2' ' A' ' 36' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.583 -0.723 . . . . 0.0 110.559 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 37.3 p90 . . . . . 0 C--O 1.225 -0.228 0 CA-C-O 120.33 0.109 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -52.1 -43.13 55.99 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 116.392 -0.367 . . . . 0.0 113.791 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.465 HD11 ' HA ' ' A' ' 4' ' ' LEU . 3.4 mm? -65.87 -48.08 72.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.017 0.436 . . . . 0.0 111.287 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -69.91 -32.78 71.27 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.583 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.555 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 62.4 ttt-85 -54.84 -37.67 66.46 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -178.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.433 HD21 ' N ' ' A' ' 7' ' ' LEU . 1.9 pt? -151.23 -33.09 0.15 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 119.769 -0.772 . . . . 0.0 112.859 -178.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 4' ' ' LEU . 26.1 mmm180 -62.15 -28.39 69.62 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 121.233 -0.187 . . . . 0.0 111.169 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 41.6 mtm105 -141.66 35.41 1.62 Allowed 'General case' 0 C--O 1.233 0.198 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 7' ' ' LEU . . . 150.83 -144.52 11.89 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.057 -1.068 . . . . 0.0 112.969 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.555 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 22.8 p90 -159.62 148.65 17.93 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.535 ' SG ' ' HA ' ' A' ' 6' ' ' ARG . 62.7 m -87.97 142.06 28.09 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.083 0.468 . . . . 0.0 111.871 -178.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -134.6 133.34 40.07 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.569 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 57.3 ttt85 -82.78 116.32 22.08 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.98 -67.4 1.12 Allowed Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.561 -0.745 . . . . 0.0 113.919 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.403 ' N ' ' HD3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -113.65 134.42 54.74 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.607 0.241 . . . . 0.0 110.69 -179.198 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.5 m -81.36 164.31 22.23 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 -69.07 167.6 15.67 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.606 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 41.6 t80 -50.88 -55.47 27.23 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.606 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 57.2 Cg_endo -88.57 51.98 1.8 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.169 1.912 . . . . 0.0 113.509 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.5 p -156.67 144.7 19.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.923 0.392 . . . . 0.0 111.629 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.559 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 25.8 pt -124.51 142.73 41.23 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.309 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.94 70.94 3.53 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 123.253 2.635 . . . . 0.0 113.153 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.457 HD12 ' HD3' ' A' ' 35' ' ' ARG . 40.7 pt -63.66 -35.36 72.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.9 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -139.69 -148.98 5.3 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.936 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.475 ' HA ' ' HA ' ' A' ' 32' ' ' GLN . 19.1 ttp-105 -155.26 136.43 13.9 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.97 0.385 . . . . 0.0 110.765 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.6 m -97.35 -35.02 10.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.896 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.6 t -138.77 -146.61 0.21 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -81.18 -52.66 7.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.072 0.463 . . . . 0.0 110.033 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -98.27 -33.24 11.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.672 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.569 ' HA ' ' HA ' ' A' ' 14' ' ' ARG . 41.6 t -70.9 114.47 8.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.194 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 26' ' ' ARG . 55.0 mt-30 -96.35 161.51 13.9 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.398 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.6 t -94.76 100.77 12.62 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 176.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.559 ' HA ' ' O ' ' A' ' 22' ' ' ILE . 6.8 m -108.36 94.39 5.04 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.313 -177.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.457 ' HD3' HD12 ' A' ' 24' ' ' ILE . 29.9 ptt180 -69.58 144.75 52.95 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.881 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.46 ' C ' ' H ' ' A' ' 38' ' ' TRP . 57.6 ttt180 -69.69 129.77 40.53 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.405 HG23 ' C ' ' A' ' 20' ' ' PRO . 27.4 m -75.89 37.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 122.545 0.338 . . . . 0.0 111.691 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.46 ' H ' ' C ' ' A' ' 36' ' ' ARG . 30.2 t-105 . . . . . 0 C--O 1.251 1.154 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.228 178.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.624 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 4.9 m-30 . . . . . 0 CA--C 1.522 -0.115 0 CA-C-O 121.055 0.455 . . . . 0.0 109.945 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.17 39.75 31.15 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.441 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 30.4 tp 60.77 28.62 18.36 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.756 0.789 . . . . 0.0 109.918 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.597 ' HA ' ' HG3' ' A' ' 9' ' ' ARG . 4.0 t -97.78 -177.2 3.69 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.355 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.404 ' HD2' ' O ' ' A' ' 6' ' ' ARG . 0.3 OUTLIER 68.96 -37.16 0.36 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.812 0.845 . . . . 0.0 113.043 178.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.8 mt -53.47 -63.97 0.98 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.034 0.445 . . . . 0.0 110.683 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -137.79 29.12 2.61 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.597 ' HG3' ' HA ' ' A' ' 5' ' ' CYS . 29.6 mmm180 -108.46 -53.97 2.57 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.684 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.83 -144.28 5.19 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.049 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -133.55 142.24 48.09 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.005 0.431 . . . . 0.0 110.606 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.426 ' HB3' HG13 ' A' ' 31' ' ' VAL . 75.4 m -78.05 121.34 24.13 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.195 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.49 138.72 52.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.489 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -80.06 52.84 1.6 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.406 0.622 . . . . 0.0 110.415 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -174.83 148.54 9.75 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.394 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.576 ' HA ' ' HG3' ' A' ' 32' ' ' GLN . 89.2 mtm180 -75.41 87.73 2.59 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.06 0.457 . . . . 0.0 110.642 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.6 m -61.96 135.56 57.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.197 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -163.08 46.32 0.13 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.829 0.823 . . . . 0.0 109.996 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.814 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 31.8 t80 -172.84 -61.89 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.111 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.814 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 75.5 Cg_endo -91.79 8.69 2.99 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.042 1.828 . . . . 0.0 112.383 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.3 t 179.52 148.72 0.27 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.5 pt -106.68 137.87 19.6 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.165 0.507 . . . . 0.0 111.273 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.75 72.58 6.44 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 123.174 2.583 . . . . 0.0 112.319 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.522 HG22 ' HD2' ' A' ' 35' ' ' ARG . 40.3 pt -65.37 -23.22 32.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.435 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -146.13 -166.01 11.81 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.803 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 23.5 ttp-105 -142.97 123.79 14.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.825 0.345 . . . . 0.0 111.041 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 2' ' ' PHE . 36.3 m -87.22 -40.57 14.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.49 0.662 . . . . 0.0 109.368 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.487 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 35.3 m -153.25 165.38 35.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.652 -1.158 . . . . 0.0 107.99 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.0 tpp180 -51.44 -48.08 62.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.712 0.233 . . . . 0.0 111.528 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -99.39 20.87 12.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.815 0.341 . . . . 0.0 111.582 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.524 HG13 ' HB2' ' A' ' 27' ' ' CYS . 57.3 t -138.07 101.65 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.015 0.436 . . . . 0.0 110.586 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.576 ' HG3' ' HA ' ' A' ' 16' ' ' ARG . 15.0 mm100 -80.36 146.47 31.52 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.814 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 49.4 t -93.06 73.91 4.72 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.7 m -70.75 120.23 16.05 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.43 -1.259 . . . . 0.0 113.184 -176.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.522 ' HD2' HG22 ' A' ' 24' ' ' ILE . 16.4 ttm180 -95.82 132.4 41.11 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.539 177.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -64.15 130.54 44.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.943 0.401 . . . . 0.0 110.89 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.63 52.37 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 1.6 t90 . . . . . 0 C--O 1.246 0.907 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.322 -178.735 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.433 ' CD2' ' HB3' ' A' ' 27' ' ' CYS . 2.5 m-85 . . . . . 0 C--O 1.233 0.206 0 CA-C-O 121.096 0.474 . . . . 0.0 110.328 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -63.12 -30.34 77.18 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.805 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.4 mp -114.1 52.66 0.82 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.822 0.344 . . . . 0.0 110.213 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.506 ' C ' ' H ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -56.42 145.92 26.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.618 -179.628 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.544 ' HD2' HD11 ' A' ' 24' ' ' ILE . 47.6 ttt85 71.11 -19.19 0.25 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.435 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.506 ' H ' ' C ' ' A' ' 5' ' ' CYS . 69.6 mt 72.26 -28.62 0.19 Allowed 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.305 1.042 . . . . 0.0 113.108 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -78.47 53.59 1.31 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.285 0.564 . . . . 0.0 110.493 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 69.0 mtt85 60.76 45.5 9.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.036 -0.984 . . . . 0.0 112.002 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.12 154.81 16.35 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.435 ' HZ ' ' HG ' ' A' ' 21' ' ' SER . 18.7 p90 -145.93 139.73 26.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 118.097 0.948 . . . . 0.0 112.195 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.499 ' SG ' ' HB2' ' A' ' 33' ' ' CYS . 12.3 m -91.16 128.63 37.06 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.216 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.82 140.61 50.51 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.292 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.8 mtm-85 -72.77 142.7 48.11 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.414 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.58 -100.2 2.64 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.039 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -163.54 154.92 16.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.997 0.427 . . . . 0.0 111.484 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.25 129.67 33.99 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -162.56 57.03 0.22 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.203 0.525 . . . . 0.0 110.996 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.908 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 69.5 t80 -159.79 -63.01 0.02 OUTLIER Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.881 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.908 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 3.7 Cg_endo -84.92 -36.04 0.15 Allowed 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.136 1.891 . . . . 0.0 111.272 178.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.459 ' H ' ' HD2' ' A' ' 20' ' ' PRO . 22.6 m -139.27 144.15 38.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.294 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.677 HG12 HG22 ' A' ' 37' ' ' VAL . 38.5 pt -95.07 146.05 30.64 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.518 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -69.39 101.32 0.85 Allowed 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.49 2.127 . . . . 0.0 112.487 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.544 HD11 ' HD2' ' A' ' 6' ' ' ARG . 45.1 pt -84.23 -29.07 7.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.457 0.646 . . . . 0.0 110.054 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -166.68 -145.73 4.58 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -170.99 140.79 1.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 117.869 0.834 . . . . 0.0 112.273 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.433 ' HB3' ' CD2' ' A' ' 2' ' ' PHE . 87.8 m -81.11 -32.75 33.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.507 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.6 m -145.81 171.75 14.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.262 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -50.91 -51.48 51.52 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.35 0.406 . . . . 0.0 112.034 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -105.63 29.8 6.27 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.9 0.381 . . . . 0.0 110.93 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.486 ' CG1' ' HB3' ' A' ' 12' ' ' CYS . 31.9 t -136.59 80.51 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -71.67 142.83 49.87 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.183 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.499 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 41.9 t -94.29 106.23 18.21 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 177.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 83.9 m -115.88 92.24 3.84 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.174 0.512 . . . . 0.0 110.575 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 73.7 ttt-85 -66.35 139.56 58.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.04 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -64.17 124.76 22.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.257 0.551 . . . . 0.0 110.596 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.677 HG22 HG12 ' A' ' 22' ' ' ILE . 16.9 t -114.87 65.96 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.513 0.673 . . . . 0.0 109.907 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 63.4 p-90 . . . . . 0 C--O 1.252 1.19 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.322 -179.603 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.437 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 5.1 p90 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.716 0.293 . . . . 0.0 111.419 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -60.34 -39.77 96.59 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.289 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.435 ' O ' HD11 ' A' ' 4' ' ' LEU . 1.1 pp -88.72 38.75 0.89 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.01 0.433 . . . . 0.0 111.113 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.451 ' C ' ' H ' ' A' ' 7' ' ' LEU . 3.0 t -151.35 167.67 27.19 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.238 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 25.3 tpp180 70.24 -35.69 0.33 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.603 0.761 . . . . 0.0 112.22 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.452 ' C ' ' H ' ' A' ' 9' ' ' ARG . 59.5 mt -82.82 62.88 6.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.178 0.513 . . . . 0.0 110.978 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 43.8 mtm-85 72.72 -22.61 0.22 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.585 -1.188 . . . . 0.0 112.429 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.452 ' H ' ' C ' ' A' ' 7' ' ' LEU . 24.1 tpp180 -64.91 -31.34 72.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.358 0.599 . . . . 0.0 110.389 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.11 -147.03 9.69 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -155.43 138.14 15.2 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.163 0.506 . . . . 0.0 110.172 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.674 ' HB3' HG13 ' A' ' 31' ' ' VAL . 81.8 m -77.04 130.16 37.05 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.102 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -138.48 123.68 19.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.659 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.599 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 18.5 ptp180 -74.57 137.47 42.39 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.181 0.515 . . . . 0.0 110.892 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.14 -121.0 5.08 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 -161.31 112.2 1.73 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.507 0.67 . . . . 0.0 110.421 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.463 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 2.5 p -90.9 136.39 33.11 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.472 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -163.38 52.05 0.16 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.551 0.691 . . . . 0.0 110.123 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.939 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 47.0 t80 -167.05 -65.27 0.01 OUTLIER Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.142 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.939 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 2.9 Cg_endo -84.71 -23.73 2.55 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.136 1.891 . . . . 0.0 111.667 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 24.8 m -155.67 150.95 26.85 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.366 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.454 HD11 HG22 ' A' ' 22' ' ' ILE . 28.8 pt -110.3 143.58 28.36 Favored Pre-proline 0 C--N 1.323 -0.554 0 O-C-N 123.124 0.265 . . . . 0.0 110.821 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 17' ' ' CYS . 61.2 Cg_endo -75.22 78.26 3.0 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.862 2.375 . . . . 0.0 112.176 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.402 HD11 ' HD2' ' A' ' 35' ' ' ARG . 36.4 pt -62.37 -37.64 79.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.976 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -131.99 -160.56 9.77 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.853 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -140.28 119.7 13.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.852 0.358 . . . . 0.0 111.002 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.437 ' HB3' ' HB3' ' A' ' 2' ' ' PHE . 56.2 m -83.56 -36.68 23.8 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.4 m -159.9 172.66 17.21 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.165 -1.421 . . . . 0.0 107.165 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.9 tpp85 -56.07 -46.45 78.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 118.326 0.512 . . . . 0.0 111.097 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.5 ' CD2' ' HB2' ' A' ' 14' ' ' ARG . 8.6 t80 -87.61 -35.72 17.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.751 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.674 HG13 ' HB3' ' A' ' 12' ' ' CYS . 16.7 t -85.6 107.27 16.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.325 0.583 . . . . 0.0 111.916 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -85.95 153.73 21.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.96 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 37.6 t -97.16 85.9 3.82 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 20.5 m -82.44 117.63 22.62 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.642 -177.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.402 ' HD2' HD11 ' A' ' 24' ' ' ILE . 51.5 ttt85 -89.11 127.28 35.7 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.544 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -58.9 129.35 41.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.021 0.439 . . . . 0.0 111.017 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.6 p -152.68 42.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 122.504 1.145 . . . . 0.0 109.601 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 4.6 t90 . . . . . 0 C--O 1.247 0.97 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.403 179.612 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.476 0.845 0 CA-C-O 120.408 0.147 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 72.67 -50.62 0.7 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.691 0.796 . . . . 0.0 111.72 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.05 -34.95 89.84 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.564 -0.351 . . . . 0.0 113.062 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 92.0 mt -73.61 -2.38 22.73 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.6 t -137.58 -157.67 0.8 Allowed 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.419 ' HG2' ' O ' ' A' ' 6' ' ' ARG . 40.9 ttm180 56.01 30.2 15.75 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.802 0.81 . . . . 0.0 109.819 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.9 mt -74.86 -52.76 10.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.701 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 39.3 mtp85 -95.93 -55.38 3.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.383 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 45.3 ttt-85 -174.19 39.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.494 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.71 121.16 5.34 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.177 -1.011 . . . . 0.0 110.908 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.657 ' HE2' ' HG2' ' A' ' 36' ' ' ARG . 35.2 p90 -104.11 139.2 39.52 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.246 0.546 . . . . 0.0 110.746 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 61.1 m -76.12 126.4 30.92 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.646 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.532 ' HB1' ' SG ' ' A' ' 34' ' ' CYS . . . -123.76 136.75 54.61 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.093 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -70.1 120.44 15.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.247 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.84 -130.07 16.75 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.945 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 78.2 mtt-85 -76.8 146.96 37.5 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.899 0.38 . . . . 0.0 111.83 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 82.7 m -67.19 150.25 49.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.358 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.423 ' HD2' ' N ' ' A' ' 18' ' ' ARG . 1.1 mpt_? -68.49 163.51 23.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.241 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.76 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 30.4 t80 -46.86 -59.12 5.66 Favored Pre-proline 0 CA--C 1.543 0.674 0 O-C-N 123.648 0.592 . . . . 0.0 112.521 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.76 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 4.1 Cg_endo -86.53 46.87 1.61 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.36 2.04 . . . . 0.0 112.142 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.405 ' HG ' ' C ' ' A' ' 20' ' ' PRO . 14.9 m -151.32 130.47 12.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.551 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.3 pt -104.65 139.16 19.83 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-O 120.983 0.42 . . . . 0.0 111.118 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.54 75.54 5.0 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 123.08 2.52 . . . . 0.0 112.798 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.677 HD12 ' HB2' ' A' ' 35' ' ' ARG . 45.9 pt -63.75 -30.13 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.103 0.478 . . . . 0.0 111.008 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -162.91 -172.99 31.08 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.6 mtm-85 -111.96 132.4 54.79 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.917 0.359 . . . . 0.0 110.507 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.582 ' HB3' HG13 ' A' ' 31' ' ' VAL . 35.0 t -77.77 -34.6 52.27 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.5 t -146.61 -141.85 0.12 Allowed 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -83.67 -57.52 3.19 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.638 -0.425 . . . . 0.0 109.973 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -93.29 -38.53 11.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.773 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.582 HG13 ' HB3' ' A' ' 27' ' ' CYS . 84.5 t -68.64 117.06 10.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.155 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -89.0 160.46 17.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.829 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 30.5 t -103.98 69.14 0.93 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.532 ' SG ' ' HB1' ' A' ' 13' ' ' ALA . 13.3 m -63.73 131.05 46.67 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.44 -1.255 . . . . 0.0 112.509 -177.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.677 ' HB2' HD12 ' A' ' 24' ' ' ILE . 15.2 tpt180 -107.68 138.55 43.71 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.264 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.657 ' HG2' ' HE2' ' A' ' 11' ' ' PHE . 22.5 mmt85 -62.02 150.24 38.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.993 0.425 . . . . 0.0 110.449 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.1 p -139.23 37.82 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 122.478 1.132 . . . . 0.0 109.57 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 12.3 m0 . . . . . 0 C--O 1.249 1.062 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.503 179.872 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 41.9 t . . . . . 0 N--CA 1.478 0.962 0 CA-C-O 120.769 0.319 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.688 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 40.7 p90 -91.98 -37.17 13.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.612 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -55.39 -49.6 63.63 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.538 -0.363 . . . . 0.0 113.19 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.28 -40.59 96.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.244 0.545 . . . . 0.0 110.19 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.609 ' SG ' ' HA2' ' A' ' 10' ' ' GLY . 47.7 t -62.96 -40.93 99.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.262 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.688 ' HG2' ' O ' ' A' ' 2' ' ' PHE . 20.9 mmt85 -59.91 -41.72 92.3 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.949 0.404 . . . . 0.0 110.565 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.3 mt -63.18 -34.82 78.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.18 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.2 ttm180 -86.64 10.69 14.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.04 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? 62.68 41.69 8.99 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.762 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.609 ' HA2' ' SG ' ' A' ' 5' ' ' CYS . . . -94.95 136.16 12.79 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 178.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -94.6 133.1 38.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.098 0.475 . . . . 0.0 110.862 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 85.4 m -78.45 108.84 12.11 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.836 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -103.44 128.59 50.57 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.967 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.426 ' HG2' HG23 ' A' ' 31' ' ' VAL . 73.3 mtm180 -72.28 111.88 7.87 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.0 0.428 . . . . 0.0 111.382 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.45 -58.86 3.72 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.76 -0.655 . . . . 0.0 113.659 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.5 mmm-85 -145.71 146.68 31.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.928 0.394 . . . . 0.0 111.663 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.7 m -76.25 125.68 29.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.993 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -90.45 45.88 1.3 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.712 0.768 . . . . 0.0 109.567 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -171.47 146.62 1.97 Allowed Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 114.35 -1.296 . . . . 0.0 107.908 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -63.24 60.44 0.17 Allowed 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.67 2.913 . . . . 0.0 113.944 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 57.8 m -127.02 129.73 48.62 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.7 pt -81.09 138.79 49.16 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 121.136 0.493 . . . . 0.0 111.691 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.653 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 65.8 Cg_endo -81.0 116.3 3.1 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.657 2.238 . . . . 0.0 111.427 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 25.5 pt -78.85 -30.31 14.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.988 0.423 . . . . 0.0 111.303 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -164.46 153.89 24.42 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -70.13 135.98 49.7 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.055 0.455 . . . . 0.0 110.975 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.4 ' HB3' HG13 ' A' ' 31' ' ' VAL . 34.9 t -80.96 -31.02 35.03 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.7 t -147.55 -140.44 0.1 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.315 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -86.44 -49.69 7.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.938 0.399 . . . . 0.0 110.298 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -103.15 -35.29 8.54 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.426 HG23 ' HG2' ' A' ' 14' ' ' ARG . 57.9 t -70.42 123.63 24.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.3 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -95.22 -177.56 4.16 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.481 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.5 t -139.92 107.73 5.67 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.653 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 0.7 OUTLIER -94.75 128.88 41.77 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.554 -176.266 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 61.7 ttt-85 -97.65 134.34 40.97 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.235 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.2 tpp85 -65.23 132.4 49.0 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.03 44.13 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 121.84 0.828 . . . . 0.0 111.32 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.931 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.126 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.415 ' HB3' HD22 ' A' ' 4' ' ' LEU . 13.6 m . . . . . 0 N--CA 1.478 0.925 0 CA-C-O 121.178 0.513 . . . . 0.0 110.698 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -68.73 -24.39 64.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.57 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -60.29 -52.89 49.9 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.893 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.428 HD11 ' N ' ' A' ' 5' ' ' CYS . 4.0 pp -71.47 -35.02 70.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.723 0.296 . . . . 0.0 111.127 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.521 ' SG ' ' HA2' ' A' ' 10' ' ' GLY . 26.7 t -66.65 -32.78 74.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.104 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -57.85 -38.43 75.65 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.136 0.494 . . . . 0.0 110.26 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.7 mt -67.64 -37.62 82.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.089 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -76.91 -5.71 49.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.591 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 69.02 29.56 4.76 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.726 0.81 . . . . 0.0 112.171 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.521 ' HA2' ' SG ' ' A' ' 5' ' ' CYS . . . -76.19 137.93 21.93 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -96.41 142.08 28.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 117.471 0.635 . . . . 0.0 111.222 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 75.7 m -80.73 124.7 29.25 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.326 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.565 ' HB1' ' SG ' ' A' ' 17' ' ' CYS . . . -130.83 111.78 12.43 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.28 0.562 . . . . 0.0 110.05 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.49 ' HG3' HG23 ' A' ' 31' ' ' VAL . 16.9 ttm180 -74.61 134.67 42.06 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.342 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.12 42.27 51.58 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.167 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 69.61 149.22 0.07 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.563 0.697 . . . . 0.0 111.595 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.565 ' SG ' ' HB1' ' A' ' 13' ' ' ALA . 3.2 m -90.11 -172.48 3.5 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.917 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 68.2 mtm-85 -80.48 -178.84 6.88 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.925 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.459 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 85.6 t80 -65.79 -55.34 23.41 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.459 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 72.2 Cg_endo -75.06 46.12 1.49 Allowed 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.179 1.92 . . . . 0.0 113.464 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.5 p -158.98 116.29 2.77 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.928 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.0 pt -96.02 138.49 21.65 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 120.92 0.391 . . . . 0.0 111.121 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -74.91 77.71 3.03 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.843 2.362 . . . . 0.0 112.676 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.8 pt -62.94 -27.41 43.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.392 0.615 . . . . 0.0 110.27 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -156.28 -167.82 18.18 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.568 ' HD2' ' O ' ' A' ' 29' ' ' ARG . 83.7 mtm180 -141.33 135.57 30.66 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 47.7 m -68.2 -51.41 45.93 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.794 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.6 m -115.65 -62.94 1.52 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.934 0.397 . . . . 0.0 110.678 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.568 ' O ' ' HD2' ' A' ' 26' ' ' ARG . 8.1 tpp180 -172.83 -60.91 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.436 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -80.14 -40.32 27.63 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.49 HG23 ' HG3' ' A' ' 14' ' ' ARG . 61.3 t -70.16 114.73 8.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.282 178.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -77.06 154.48 33.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.324 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 12.8 t -122.3 69.46 0.96 Allowed 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 56.1 m -74.63 137.61 42.38 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.781 -1.099 . . . . 0.0 113.214 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.3 ttm-85 -88.09 138.01 31.83 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.385 177.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -65.95 131.58 46.57 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.122 0.487 . . . . 0.0 110.502 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.1 t -108.36 60.25 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.325 0.583 . . . . 0.0 110.052 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.518 -0.753 . . . . 0.0 111.032 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 N--CA 1.478 0.94 0 N-CA-C 110.804 -0.073 . . . . 0.0 110.804 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.698 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 16.5 t80 -62.69 -38.69 91.39 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 111.381 0.141 . . . . 0.0 111.381 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -56.55 -52.37 50.68 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.424 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.476 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 3.1 tm? -60.68 -43.01 98.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.027 0.442 . . . . 0.0 109.843 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 53.3 t -61.75 -46.41 89.72 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.382 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 62.7 ttt-85 -65.39 -44.03 88.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.778 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 4' ' ' LEU . 4.2 pp -66.26 -32.83 74.49 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.253 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -85.51 -2.37 58.07 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.609 0.242 . . . . 0.0 110.649 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 70.0 mtm180 61.91 42.89 9.77 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.488 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.71 147.1 19.21 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -81.88 134.11 35.38 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 117.211 0.506 . . . . 0.0 109.771 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.62 ' SG ' HG11 ' A' ' 31' ' ' VAL . 9.4 t -107.91 132.59 53.31 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -125.37 142.31 51.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.016 0.436 . . . . 0.0 111.805 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.549 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 15.1 ptp180 -70.2 126.2 28.97 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.19 129.22 4.34 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.736 ' HG2' ' HG3' ' A' ' 32' ' ' GLN . 73.5 mtt180 -60.75 114.78 3.21 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.983 0.42 . . . . 0.0 111.918 -178.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.7 m -72.03 150.53 43.9 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -154.93 56.83 0.67 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.021 -0.672 . . . . 0.0 111.736 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.873 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 36.2 t80 -166.39 -66.9 0.01 OUTLIER Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.144 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.873 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 94.3 Cg_endo -90.26 -20.84 0.98 Allowed 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.974 1.783 . . . . 0.0 112.267 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.3 m -154.27 148.41 25.83 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.493 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.535 HG12 HG22 ' A' ' 37' ' ' VAL . 36.6 pt -117.23 144.4 33.74 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 120.572 0.225 . . . . 0.0 110.916 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.768 ' HB3' ' HB3' ' A' ' 32' ' ' GLN . 11.5 Cg_exo -68.99 104.15 1.15 Allowed 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.675 2.25 . . . . 0.0 112.013 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.5 pt -88.6 -32.98 6.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.065 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -137.93 144.85 16.27 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.066 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 28' ' ' SER . 17.1 ttm105 -88.41 122.18 31.62 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.707 0.289 . . . . 0.0 111.563 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.698 ' HA ' ' HB2' ' A' ' 2' ' ' PHE . 26.9 m -88.89 -38.97 14.13 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.518 ' HB3' HG22 ' A' ' 31' ' ' VAL . 17.1 t -154.59 -161.34 1.2 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.045 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 43.7 ttt-85 -65.14 -53.18 49.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.088 0.47 . . . . 0.0 111.051 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -98.47 -35.6 10.21 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.686 -178.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.62 HG11 ' SG ' ' A' ' 12' ' ' CYS . 1.8 t -71.12 116.64 13.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.138 -178.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.768 ' HB3' ' HB3' ' A' ' 23' ' ' PRO . 15.0 mm100 -116.38 139.99 49.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.808 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 47.9 t -85.3 93.97 8.82 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 23.2 m -84.3 109.65 17.97 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.683 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.455 ' O ' HG21 ' A' ' 37' ' ' VAL . 46.6 ttp180 -76.26 138.55 40.65 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.265 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -56.5 125.51 22.4 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 123.438 0.461 . . . . 0.0 111.583 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.535 HG22 HG12 ' A' ' 22' ' ' ILE . 29.4 t -126.31 77.96 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.851 0.834 . . . . 0.0 109.23 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 14.3 t-105 . . . . . 0 C--O 1.251 1.153 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.226 179.945 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 36.1 t . . . . . 0 N--CA 1.479 0.975 0 CA-C-O 120.735 0.302 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.708 ' CE1' ' HA2' ' A' ' 25' ' ' GLY . 60.4 m-85 -89.68 -19.02 25.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.678 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -56.49 -26.75 52.71 Favored Glycine 0 C--N 1.336 0.531 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 42.0 tp -160.07 75.66 0.61 Allowed 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.49 142.47 48.73 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.676 -178.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.43 ' O ' ' HB2' ' A' ' 7' ' ' LEU . 69.8 mtt85 -41.65 -31.23 0.27 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -176.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 73.0 mt 72.25 -45.12 0.61 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.137 0.575 . . . . 0.0 110.636 -178.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.429 ' H ' ' C ' ' A' ' 6' ' ' ARG . 3.5 tpp180 -68.45 -41.74 79.79 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.2 ttt-85 -91.33 -65.44 1.01 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.801 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.734 ' HA3' ' HA ' ' A' ' 35' ' ' ARG . . . -123.96 123.53 5.22 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 178.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -109.04 131.23 55.27 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.016 0.436 . . . . 0.0 110.806 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.609 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -85.17 126.02 33.3 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.959 0.409 . . . . 0.0 110.545 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.472 ' HB1' ' SG ' ' A' ' 17' ' ' CYS . . . -129.34 143.21 50.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.821 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.425 ' HA ' HG23 ' A' ' 31' ' ' VAL . 28.6 ttp-105 -62.62 126.95 29.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.046 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.15 -129.98 13.26 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.122 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -100.52 132.62 45.8 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.472 ' SG ' ' HB1' ' A' ' 13' ' ' ALA . 58.1 m -71.25 118.07 13.58 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.168 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -83.58 58.62 4.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.643 0.735 . . . . 0.0 109.949 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.58 ' CD1' ' HD2' ' A' ' 20' ' ' PRO . 37.3 t80 -167.94 138.58 2.26 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.809 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.58 ' HD2' ' CD1' ' A' ' 19' ' ' PHE . 10.0 Cg_endo -53.99 83.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 124.067 3.178 . . . . 0.0 112.96 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.853 ' HA ' HG13 ' A' ' 37' ' ' VAL . 57.4 m -158.62 121.39 3.71 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.101 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.1 pt -82.99 138.52 42.84 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-O 121.131 0.491 . . . . 0.0 111.558 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.784 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 46.6 Cg_endo -76.04 111.66 3.32 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.384 2.056 . . . . 0.0 112.196 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.426 HD12 ' HB2' ' A' ' 35' ' ' ARG . 16.8 pt -79.01 -24.06 12.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.512 0.672 . . . . 0.0 110.264 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.708 ' HA2' ' CE1' ' A' ' 2' ' ' PHE . . . -158.03 -165.82 16.2 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.111 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.448 ' HA ' ' HA ' ' A' ' 32' ' ' GLN . 44.3 ttp180 -148.58 124.19 10.44 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.876 0.338 . . . . 0.0 110.123 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 40.2 m -74.66 -52.23 12.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.871 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.9 m -114.55 -147.98 0.42 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.411 ' O ' ' HD2' ' A' ' 26' ' ' ARG . 14.7 tpp180 -84.82 -46.03 11.75 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -95.69 -42.99 8.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.826 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.551 HG13 ' SG ' ' A' ' 12' ' ' CYS . 28.7 t -64.04 109.35 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.777 -178.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.609 ' O ' ' HA ' ' A' ' 12' ' ' CYS . 51.5 mt-30 -104.5 147.31 27.73 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.601 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 52.5 t -92.34 84.95 5.25 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.784 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 59.3 m -77.49 116.08 17.77 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.212 -178.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.734 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 59.3 ttp85 -80.19 135.42 36.27 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.73 178.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 18.1 tpp85 -60.65 125.48 23.87 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.228 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.853 HG13 ' HA ' ' A' ' 21' ' ' SER . 11.8 p -132.73 39.35 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 122.652 1.215 . . . . 0.0 108.721 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 2.3 t90 . . . . . 0 C--O 1.243 0.752 0 CA-C-N 114.495 -1.229 . . . . 0.0 108.943 179.791 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.473 0.706 0 N-CA-C 110.572 -0.158 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.42 ' CG ' ' HA ' ' A' ' 27' ' ' CYS . 88.3 m-85 58.69 26.55 14.73 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 122.982 0.513 . . . . 0.0 111.969 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.18 -42.49 3.48 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 80.1 mt -108.24 41.4 1.56 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.6 ' HA ' ' HG2' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -64.02 -29.49 70.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.592 -178.44 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.543 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 72.3 mtp85 -66.66 -47.81 71.33 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.5 pp -77.81 -32.53 52.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.6 ' HG2' ' HA ' ' A' ' 5' ' ' CYS . 6.5 ptm85 -63.61 -50.62 68.67 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.159 -0.616 . . . . 0.0 109.504 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.542 ' HB2' ' O ' ' A' ' 8' ' ' ARG . 36.0 ttm180 163.51 97.16 0.0 OUTLIER 'General case' 0 C--O 1.235 0.306 0 O-C-N 124.01 0.819 . . . . 0.0 109.978 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.543 ' O ' ' HA ' ' A' ' 6' ' ' ARG . . . 127.74 -143.16 14.14 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.596 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -175.39 138.59 0.42 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 33' ' ' CYS . 45.6 t -89.38 123.61 33.7 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.492 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.44 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . . . -122.97 135.43 54.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.821 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.591 ' HA ' HG12 ' A' ' 31' ' ' VAL . 54.6 ttm-85 -75.53 133.2 41.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.026 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.24 -60.03 4.85 Favored Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.292 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.418 ' CZ ' ' HB2' ' A' ' 16' ' ' ARG . 2.3 ptm85 -173.79 173.19 3.35 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.44 ' SG ' ' HB2' ' A' ' 13' ' ' ALA . 6.7 m -112.29 -171.07 1.78 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.958 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -91.27 178.42 5.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.913 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.581 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 36.2 t80 -59.66 -52.85 71.01 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.581 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 10.1 Cg_exo -72.49 40.88 0.49 Allowed 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.39 2.06 . . . . 0.0 113.671 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.7 p -161.83 123.42 2.79 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.206 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.405 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 45.9 pt -102.84 141.67 22.97 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 120.79 0.328 . . . . 0.0 111.115 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 22' ' ' ILE . 18.9 Cg_exo -64.11 118.69 5.63 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.675 2.25 . . . . 0.0 111.714 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 33' ' ' CYS . 15.8 pt -101.85 -23.83 4.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.529 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 177.25 143.79 5.06 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.892 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 66.0 mtt85 -74.4 135.05 42.4 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.42 ' HA ' ' CG ' ' A' ' 2' ' ' PHE . 8.4 m -72.22 -34.53 68.41 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.1 m -141.15 -57.02 0.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.617 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 34.9 ttm105 -172.24 -66.47 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.01 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -76.6 -41.26 46.79 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.591 HG12 ' HA ' ' A' ' 14' ' ' ARG . 2.5 t -71.23 126.58 31.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.142 178.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -117.39 151.72 36.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.758 0.313 . . . . 0.0 111.514 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.494 ' O ' HG12 ' A' ' 24' ' ' ILE . 42.4 t -107.63 120.47 42.32 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 176.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.8 m -118.97 118.62 32.0 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.888 -0.725 . . . . 0.0 112.021 -177.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.414 ' HB2' HG22 ' A' ' 24' ' ' ILE . 28.3 ttm180 -70.91 130.71 42.33 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.932 178.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.541 ' HB2' ' CE3' ' A' ' 38' ' ' TRP . 25.6 mtp-105 -63.71 138.68 58.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.278 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 t -80.55 53.43 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.549 0.69 . . . . 0.0 110.243 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.541 ' CE3' ' HB2' ' A' ' 36' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.583 -0.723 . . . . 0.0 110.559 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.6 t . . . . . 0 N--CA 1.476 0.827 0 CA-C-O 120.879 0.371 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -68.73 -25.13 64.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.259 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -52.1 -43.13 55.99 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 116.392 -0.367 . . . . 0.0 113.791 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.465 HD11 ' HA ' ' A' ' 4' ' ' LEU . 3.4 mm? -65.87 -48.08 72.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.017 0.436 . . . . 0.0 111.287 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -69.91 -32.78 71.27 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.583 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.555 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 62.4 ttt-85 -54.84 -37.67 66.46 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -178.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.433 HD21 ' N ' ' A' ' 7' ' ' LEU . 1.9 pt? -151.23 -33.09 0.15 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 119.769 -0.772 . . . . 0.0 112.859 -178.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 4' ' ' LEU . 26.1 mmm180 -62.15 -28.39 69.62 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 121.233 -0.187 . . . . 0.0 111.169 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 41.6 mtm105 -141.66 35.41 1.62 Allowed 'General case' 0 C--O 1.233 0.198 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 7' ' ' LEU . . . 150.83 -144.52 11.89 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.057 -1.068 . . . . 0.0 112.969 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.555 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 22.8 p90 -159.62 148.65 17.93 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.535 ' SG ' ' HA ' ' A' ' 6' ' ' ARG . 62.7 m -87.97 142.06 28.09 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.083 0.468 . . . . 0.0 111.871 -178.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -134.6 133.34 40.07 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.569 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 57.3 ttt85 -82.78 116.32 22.08 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.98 -67.4 1.12 Allowed Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.561 -0.745 . . . . 0.0 113.919 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.403 ' N ' ' HD3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -113.65 134.42 54.74 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.607 0.241 . . . . 0.0 110.69 -179.198 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.5 m -81.36 164.31 22.23 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 -69.07 167.6 15.67 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.606 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 41.6 t80 -50.88 -55.47 27.23 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.606 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 57.2 Cg_endo -88.57 51.98 1.8 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.169 1.912 . . . . 0.0 113.509 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.5 p -156.67 144.7 19.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.923 0.392 . . . . 0.0 111.629 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.559 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 25.8 pt -124.51 142.73 41.23 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.309 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.94 70.94 3.53 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 123.253 2.635 . . . . 0.0 113.153 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.457 HD12 ' HD3' ' A' ' 35' ' ' ARG . 40.7 pt -63.66 -35.36 72.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.9 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -139.69 -148.98 5.3 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.936 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.475 ' HA ' ' HA ' ' A' ' 32' ' ' GLN . 19.1 ttp-105 -155.26 136.43 13.9 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.97 0.385 . . . . 0.0 110.765 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.6 m -97.35 -35.02 10.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.896 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.6 t -138.77 -146.61 0.21 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -81.18 -52.66 7.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.072 0.463 . . . . 0.0 110.033 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -98.27 -33.24 11.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.672 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.569 ' HA ' ' HA ' ' A' ' 14' ' ' ARG . 41.6 t -70.9 114.47 8.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.194 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 26' ' ' ARG . 55.0 mt-30 -96.35 161.51 13.9 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.398 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.6 t -94.76 100.77 12.62 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 176.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.559 ' HA ' ' O ' ' A' ' 22' ' ' ILE . 6.8 m -108.36 94.39 5.04 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.313 -177.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.457 ' HD3' HD12 ' A' ' 24' ' ' ILE . 29.9 ptt180 -69.58 144.75 52.95 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.881 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.46 ' C ' ' H ' ' A' ' 38' ' ' TRP . 57.6 ttt180 -69.69 129.77 40.53 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.405 HG23 ' C ' ' A' ' 20' ' ' PRO . 27.4 m -75.89 37.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 122.545 0.338 . . . . 0.0 111.691 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.46 ' H ' ' C ' ' A' ' 36' ' ' ARG . 30.2 t-105 . . . . . 0 C--O 1.251 1.154 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.228 178.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 53.3 m . . . . . 0 N--CA 1.476 0.848 0 CA-C-O 120.892 0.377 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.624 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 4.9 m-30 -74.49 -21.16 59.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.945 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.17 39.75 31.15 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.441 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 30.4 tp 60.77 28.62 18.36 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.756 0.789 . . . . 0.0 109.918 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.597 ' HA ' ' HG3' ' A' ' 9' ' ' ARG . 4.0 t -97.78 -177.2 3.69 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.355 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.404 ' HD2' ' O ' ' A' ' 6' ' ' ARG . 0.3 OUTLIER 68.96 -37.16 0.36 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.812 0.845 . . . . 0.0 113.043 178.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.8 mt -53.47 -63.97 0.98 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.034 0.445 . . . . 0.0 110.683 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -137.79 29.12 2.61 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.597 ' HG3' ' HA ' ' A' ' 5' ' ' CYS . 29.6 mmm180 -108.46 -53.97 2.57 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.684 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.83 -144.28 5.19 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.049 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -133.55 142.24 48.09 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.005 0.431 . . . . 0.0 110.606 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.426 ' HB3' HG13 ' A' ' 31' ' ' VAL . 75.4 m -78.05 121.34 24.13 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.195 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.49 138.72 52.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.489 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -80.06 52.84 1.6 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.406 0.622 . . . . 0.0 110.415 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -174.83 148.54 9.75 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.394 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.576 ' HA ' ' HG3' ' A' ' 32' ' ' GLN . 89.2 mtm180 -75.41 87.73 2.59 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.06 0.457 . . . . 0.0 110.642 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.6 m -61.96 135.56 57.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.197 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -163.08 46.32 0.13 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.829 0.823 . . . . 0.0 109.996 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.814 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 31.8 t80 -172.84 -61.89 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.111 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.814 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 75.5 Cg_endo -91.79 8.69 2.99 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.042 1.828 . . . . 0.0 112.383 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.3 t 179.52 148.72 0.27 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.5 pt -106.68 137.87 19.6 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.165 0.507 . . . . 0.0 111.273 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.75 72.58 6.44 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 123.174 2.583 . . . . 0.0 112.319 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.522 HG22 ' HD2' ' A' ' 35' ' ' ARG . 40.3 pt -65.37 -23.22 32.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.435 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -146.13 -166.01 11.81 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.803 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 23.5 ttp-105 -142.97 123.79 14.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.825 0.345 . . . . 0.0 111.041 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 2' ' ' PHE . 36.3 m -87.22 -40.57 14.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.49 0.662 . . . . 0.0 109.368 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.487 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 35.3 m -153.25 165.38 35.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.652 -1.158 . . . . 0.0 107.99 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.0 tpp180 -51.44 -48.08 62.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.712 0.233 . . . . 0.0 111.528 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -99.39 20.87 12.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.815 0.341 . . . . 0.0 111.582 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.524 HG13 ' HB2' ' A' ' 27' ' ' CYS . 57.3 t -138.07 101.65 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.015 0.436 . . . . 0.0 110.586 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.576 ' HG3' ' HA ' ' A' ' 16' ' ' ARG . 15.0 mm100 -80.36 146.47 31.52 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.814 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 49.4 t -93.06 73.91 4.72 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.7 m -70.75 120.23 16.05 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.43 -1.259 . . . . 0.0 113.184 -176.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.522 ' HD2' HG22 ' A' ' 24' ' ' ILE . 16.4 ttm180 -95.82 132.4 41.11 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.539 177.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -64.15 130.54 44.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.943 0.401 . . . . 0.0 110.89 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.63 52.37 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 1.6 t90 . . . . . 0 C--O 1.246 0.907 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.322 -178.735 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 45.1 m . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 120.595 0.236 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.433 ' CD2' ' HB3' ' A' ' 27' ' ' CYS . 2.5 m-85 -66.49 -38.29 86.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.096 0.474 . . . . 0.0 110.328 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -63.12 -30.34 77.18 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.805 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.4 mp -114.1 52.66 0.82 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.822 0.344 . . . . 0.0 110.213 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.506 ' C ' ' H ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -56.42 145.92 26.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.618 -179.628 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.544 ' HD2' HD11 ' A' ' 24' ' ' ILE . 47.6 ttt85 71.11 -19.19 0.25 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.435 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.506 ' H ' ' C ' ' A' ' 5' ' ' CYS . 69.6 mt 72.26 -28.62 0.19 Allowed 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.305 1.042 . . . . 0.0 113.108 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -78.47 53.59 1.31 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.285 0.564 . . . . 0.0 110.493 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 69.0 mtt85 60.76 45.5 9.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.036 -0.984 . . . . 0.0 112.002 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.12 154.81 16.35 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.435 ' HZ ' ' HG ' ' A' ' 21' ' ' SER . 18.7 p90 -145.93 139.73 26.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 118.097 0.948 . . . . 0.0 112.195 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.499 ' SG ' ' HB2' ' A' ' 33' ' ' CYS . 12.3 m -91.16 128.63 37.06 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.216 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.82 140.61 50.51 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.292 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.8 mtm-85 -72.77 142.7 48.11 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.414 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.58 -100.2 2.64 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.039 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -163.54 154.92 16.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.997 0.427 . . . . 0.0 111.484 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.25 129.67 33.99 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -162.56 57.03 0.22 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.203 0.525 . . . . 0.0 110.996 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.908 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 69.5 t80 -159.79 -63.01 0.02 OUTLIER Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.881 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.908 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 3.7 Cg_endo -84.92 -36.04 0.15 Allowed 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.136 1.891 . . . . 0.0 111.272 178.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.459 ' H ' ' HD2' ' A' ' 20' ' ' PRO . 22.6 m -139.27 144.15 38.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.294 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.677 HG12 HG22 ' A' ' 37' ' ' VAL . 38.5 pt -95.07 146.05 30.64 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.518 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -69.39 101.32 0.85 Allowed 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.49 2.127 . . . . 0.0 112.487 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.544 HD11 ' HD2' ' A' ' 6' ' ' ARG . 45.1 pt -84.23 -29.07 7.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.457 0.646 . . . . 0.0 110.054 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -166.68 -145.73 4.58 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -170.99 140.79 1.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 117.869 0.834 . . . . 0.0 112.273 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.433 ' HB3' ' CD2' ' A' ' 2' ' ' PHE . 87.8 m -81.11 -32.75 33.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.507 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.6 m -145.81 171.75 14.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.262 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -50.91 -51.48 51.52 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.35 0.406 . . . . 0.0 112.034 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -105.63 29.8 6.27 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.9 0.381 . . . . 0.0 110.93 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.486 ' CG1' ' HB3' ' A' ' 12' ' ' CYS . 31.9 t -136.59 80.51 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -71.67 142.83 49.87 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.183 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.499 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 41.9 t -94.29 106.23 18.21 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 177.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 83.9 m -115.88 92.24 3.84 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.174 0.512 . . . . 0.0 110.575 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 73.7 ttt-85 -66.35 139.56 58.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.04 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -64.17 124.76 22.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.257 0.551 . . . . 0.0 110.596 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.677 HG22 HG12 ' A' ' 22' ' ' ILE . 16.9 t -114.87 65.96 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.513 0.673 . . . . 0.0 109.907 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 63.4 p-90 . . . . . 0 C--O 1.252 1.19 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.322 -179.603 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 17.3 p . . . . . 0 N--CA 1.479 0.987 0 CA-C-O 120.637 0.256 . . . . 0.0 111.468 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.437 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 5.1 p90 -88.94 -4.86 58.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.716 0.293 . . . . 0.0 111.419 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -60.34 -39.77 96.59 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.289 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.435 ' O ' HD11 ' A' ' 4' ' ' LEU . 1.1 pp -88.72 38.75 0.89 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.01 0.433 . . . . 0.0 111.113 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.451 ' C ' ' H ' ' A' ' 7' ' ' LEU . 3.0 t -151.35 167.67 27.19 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.238 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 25.3 tpp180 70.24 -35.69 0.33 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.603 0.761 . . . . 0.0 112.22 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.452 ' C ' ' H ' ' A' ' 9' ' ' ARG . 59.5 mt -82.82 62.88 6.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.178 0.513 . . . . 0.0 110.978 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 43.8 mtm-85 72.72 -22.61 0.22 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.585 -1.188 . . . . 0.0 112.429 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.452 ' H ' ' C ' ' A' ' 7' ' ' LEU . 24.1 tpp180 -64.91 -31.34 72.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.358 0.599 . . . . 0.0 110.389 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.11 -147.03 9.69 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -155.43 138.14 15.2 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.163 0.506 . . . . 0.0 110.172 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.674 ' HB3' HG13 ' A' ' 31' ' ' VAL . 81.8 m -77.04 130.16 37.05 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.102 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -138.48 123.68 19.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.659 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.599 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 18.5 ptp180 -74.57 137.47 42.39 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.181 0.515 . . . . 0.0 110.892 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.14 -121.0 5.08 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 -161.31 112.2 1.73 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.507 0.67 . . . . 0.0 110.421 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.463 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 2.5 p -90.9 136.39 33.11 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.472 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -163.38 52.05 0.16 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.551 0.691 . . . . 0.0 110.123 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.939 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 47.0 t80 -167.05 -65.27 0.01 OUTLIER Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.142 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.939 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 2.9 Cg_endo -84.71 -23.73 2.55 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.136 1.891 . . . . 0.0 111.667 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 24.8 m -155.67 150.95 26.85 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.366 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.454 HD11 HG22 ' A' ' 22' ' ' ILE . 28.8 pt -110.3 143.58 28.36 Favored Pre-proline 0 C--N 1.323 -0.554 0 O-C-N 123.124 0.265 . . . . 0.0 110.821 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 17' ' ' CYS . 61.2 Cg_endo -75.22 78.26 3.0 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.862 2.375 . . . . 0.0 112.176 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.402 HD11 ' HD2' ' A' ' 35' ' ' ARG . 36.4 pt -62.37 -37.64 79.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.976 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -131.99 -160.56 9.77 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.853 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -140.28 119.7 13.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.852 0.358 . . . . 0.0 111.002 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.437 ' HB3' ' HB3' ' A' ' 2' ' ' PHE . 56.2 m -83.56 -36.68 23.8 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.4 m -159.9 172.66 17.21 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.165 -1.421 . . . . 0.0 107.165 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.9 tpp85 -56.07 -46.45 78.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 118.326 0.512 . . . . 0.0 111.097 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.5 ' CD2' ' HB2' ' A' ' 14' ' ' ARG . 8.6 t80 -87.61 -35.72 17.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.751 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.674 HG13 ' HB3' ' A' ' 12' ' ' CYS . 16.7 t -85.6 107.27 16.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.325 0.583 . . . . 0.0 111.916 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -85.95 153.73 21.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.96 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 37.6 t -97.16 85.9 3.82 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 20.5 m -82.44 117.63 22.62 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.642 -177.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.402 ' HD2' HD11 ' A' ' 24' ' ' ILE . 51.5 ttt85 -89.11 127.28 35.7 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.544 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -58.9 129.35 41.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.021 0.439 . . . . 0.0 111.017 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.6 p -152.68 42.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 122.504 1.145 . . . . 0.0 109.601 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 4.6 t90 . . . . . 0 C--O 1.247 0.97 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.403 179.612 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.05 -34.95 89.84 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.564 -0.351 . . . . 0.0 113.062 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 92.0 mt -73.61 -2.38 22.73 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.6 t -137.58 -157.67 0.8 Allowed 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 6' ' ' ARG . 40.9 ttm180 56.01 30.2 15.75 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.802 0.81 . . . . 0.0 109.819 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.9 mt -74.86 -52.76 10.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.701 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 39.3 mtp85 -95.93 -55.38 3.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.383 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 45.3 ttt-85 -174.19 39.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.494 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.71 121.16 5.34 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.177 -1.011 . . . . 0.0 110.908 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.656 ' HE2' ' HG2' ' A' ' 36' ' ' ARG . 35.2 p90 -104.11 139.2 39.52 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.246 0.546 . . . . 0.0 110.746 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 61.1 m -76.12 126.4 30.92 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.646 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.489 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -123.76 136.75 54.61 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.093 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -70.1 120.44 15.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.247 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.84 -130.07 16.75 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.945 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 78.2 mtt-85 -76.8 146.96 37.5 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.899 0.38 . . . . 0.0 111.83 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 82.7 m -67.19 150.25 49.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.358 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.432 ' H ' ' HD2' ' A' ' 18' ' ' ARG . 1.1 mpt_? -68.49 163.51 23.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.241 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.753 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 30.4 t80 -46.86 -59.12 5.66 Favored Pre-proline 0 CA--C 1.543 0.674 0 O-C-N 123.648 0.592 . . . . 0.0 112.521 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.753 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 4.1 Cg_endo -86.53 46.87 1.61 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.36 2.04 . . . . 0.0 112.142 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.9 m -151.32 130.47 12.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.551 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.3 pt -104.65 139.16 19.83 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-O 120.983 0.42 . . . . 0.0 111.118 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.54 75.54 5.0 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 123.08 2.52 . . . . 0.0 112.798 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.9 pt -63.75 -30.13 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.103 0.478 . . . . 0.0 111.008 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -162.91 -172.99 31.08 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.6 mtm-85 -111.96 132.4 54.79 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.917 0.359 . . . . 0.0 110.507 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.503 ' HB3' HG12 ' A' ' 31' ' ' VAL . 35.0 t -77.77 -34.6 52.27 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.5 t -146.61 -141.85 0.12 Allowed 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.406 ' HA ' ' HD2' ' A' ' 29' ' ' ARG . 9.0 tpt180 -83.67 -57.52 3.19 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.638 -0.425 . . . . 0.0 109.973 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -93.29 -38.53 11.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.773 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.503 HG12 ' HB3' ' A' ' 27' ' ' CYS . 84.5 t -68.64 117.06 10.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.155 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -89.0 160.46 17.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.829 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 30.5 t -103.98 69.14 0.93 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.489 ' SG ' ' HB3' ' A' ' 13' ' ' ALA . 13.3 m -63.73 131.05 46.67 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.44 -1.255 . . . . 0.0 112.509 -177.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -107.68 138.55 43.71 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.264 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.656 ' HG2' ' HE2' ' A' ' 11' ' ' PHE . 22.5 mmt85 -62.02 150.24 38.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.993 0.425 . . . . 0.0 110.449 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.1 p -139.23 37.82 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 122.478 1.132 . . . . 0.0 109.57 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 12.3 m0 . . . . . 0 C--O 1.249 1.062 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.503 179.872 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.698 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 40.7 p90 . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 110.612 -0.144 . . . . 0.0 110.612 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -55.39 -49.6 63.63 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.538 -0.363 . . . . 0.0 113.19 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.28 -40.59 96.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.244 0.545 . . . . 0.0 110.19 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.608 ' SG ' ' HA3' ' A' ' 10' ' ' GLY . 47.7 t -62.96 -40.93 99.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.262 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.698 ' HG2' ' O ' ' A' ' 2' ' ' PHE . 20.9 mmt85 -59.91 -41.72 92.3 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.949 0.404 . . . . 0.0 110.565 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.3 mt -63.18 -34.82 78.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.18 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.2 ttm180 -86.64 10.69 14.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.04 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? 62.68 41.69 8.99 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.762 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.608 ' HA3' ' SG ' ' A' ' 5' ' ' CYS . . . -94.95 136.16 12.79 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 178.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -94.6 133.1 38.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.098 0.475 . . . . 0.0 110.862 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 85.4 m -78.45 108.84 12.11 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.836 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -103.44 128.59 50.57 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.967 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -72.28 111.88 7.87 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.0 0.428 . . . . 0.0 111.382 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.45 -58.86 3.72 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.76 -0.655 . . . . 0.0 113.659 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.5 mmm-85 -145.71 146.68 31.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.928 0.394 . . . . 0.0 111.663 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.7 m -76.25 125.68 29.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.993 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -90.45 45.88 1.3 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.712 0.768 . . . . 0.0 109.567 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -171.47 146.62 1.97 Allowed Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 114.35 -1.296 . . . . 0.0 107.908 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -63.24 60.44 0.17 Allowed 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.67 2.913 . . . . 0.0 113.944 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 57.8 m -127.02 129.73 48.62 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.7 pt -81.09 138.79 49.16 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 121.136 0.493 . . . . 0.0 111.691 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.64 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 65.8 Cg_endo -81.0 116.3 3.1 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.657 2.238 . . . . 0.0 111.427 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 25.5 pt -78.85 -30.31 14.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.988 0.423 . . . . 0.0 111.303 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -164.46 153.89 24.42 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -70.13 135.98 49.7 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.055 0.455 . . . . 0.0 110.975 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 34.9 t -80.96 -31.02 35.03 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.7 t -147.55 -140.44 0.1 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.315 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -86.44 -49.69 7.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.938 0.399 . . . . 0.0 110.298 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -103.15 -35.29 8.54 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 57.9 t -70.42 123.63 24.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.3 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -95.22 -177.56 4.16 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.481 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.5 t -139.92 107.73 5.67 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.64 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 0.7 OUTLIER -94.75 128.88 41.77 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.554 -176.266 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 61.7 ttt-85 -97.65 134.34 40.97 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.235 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.2 tpp85 -65.23 132.4 49.0 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.03 44.13 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 121.84 0.828 . . . . 0.0 111.32 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.931 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.126 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.434 ' HB3' ' HA ' ' A' ' 27' ' ' CYS . 15.8 p90 . . . . . 0 CA--C 1.526 0.035 0 CA-C-O 120.575 0.226 . . . . 0.0 111.57 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -60.29 -52.89 49.9 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.893 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.466 HD12 ' N ' ' A' ' 5' ' ' CYS . 4.0 pp -71.47 -35.02 70.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.723 0.296 . . . . 0.0 111.127 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.517 ' SG ' ' HA3' ' A' ' 10' ' ' GLY . 26.7 t -66.65 -32.78 74.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.104 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -57.85 -38.43 75.65 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.136 0.494 . . . . 0.0 110.26 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.7 mt -67.64 -37.62 82.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.089 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -76.91 -5.71 49.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.591 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 69.02 29.56 4.76 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.726 0.81 . . . . 0.0 112.171 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.517 ' HA3' ' SG ' ' A' ' 5' ' ' CYS . . . -76.19 137.93 21.93 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -96.41 142.08 28.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 117.471 0.635 . . . . 0.0 111.222 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 75.7 m -80.73 124.7 29.25 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.326 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.629 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . . . -130.83 111.78 12.43 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.28 0.562 . . . . 0.0 110.05 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.488 ' HG3' HG22 ' A' ' 31' ' ' VAL . 16.9 ttm180 -74.61 134.67 42.06 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.342 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.12 42.27 51.58 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.167 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 69.61 149.22 0.07 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.563 0.697 . . . . 0.0 111.595 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.629 ' SG ' ' HB3' ' A' ' 13' ' ' ALA . 3.2 m -90.11 -172.48 3.5 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.917 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 68.2 mtm-85 -80.48 -178.84 6.88 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.925 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.477 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 85.6 t80 -65.79 -55.34 23.41 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.477 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 72.2 Cg_endo -75.06 46.12 1.49 Allowed 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.179 1.92 . . . . 0.0 113.464 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.469 ' HA ' HG23 ' A' ' 37' ' ' VAL . 24.5 p -158.98 116.29 2.77 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.928 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.0 pt -96.02 138.49 21.65 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 120.92 0.391 . . . . 0.0 111.121 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 37.5 Cg_endo -74.91 77.71 3.03 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.843 2.362 . . . . 0.0 112.676 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.611 HD13 ' HB2' ' A' ' 35' ' ' ARG . 47.8 pt -62.94 -27.41 43.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.392 0.615 . . . . 0.0 110.27 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -156.28 -167.82 18.18 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.574 ' HD2' ' O ' ' A' ' 29' ' ' ARG . 83.7 mtm180 -141.33 135.57 30.66 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.434 ' HA ' ' HB3' ' A' ' 2' ' ' PHE . 47.7 m -68.2 -51.41 45.93 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.794 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.6 m -115.65 -62.94 1.52 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.934 0.397 . . . . 0.0 110.678 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.574 ' O ' ' HD2' ' A' ' 26' ' ' ARG . 8.1 tpp180 -172.83 -60.91 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.436 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -80.14 -40.32 27.63 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.488 HG22 ' HG3' ' A' ' 14' ' ' ARG . 61.3 t -70.16 114.73 8.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.282 178.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -77.06 154.48 33.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.324 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 12.8 t -122.3 69.46 0.96 Allowed 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 56.1 m -74.63 137.61 42.38 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.781 -1.099 . . . . 0.0 113.214 -176.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.611 ' HB2' HD13 ' A' ' 24' ' ' ILE . 25.3 ttm-85 -88.09 138.01 31.83 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.385 177.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -65.95 131.58 46.57 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.122 0.487 . . . . 0.0 110.502 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.469 HG23 ' HA ' ' A' ' 21' ' ' SER . 12.1 t -108.36 60.25 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.325 0.583 . . . . 0.0 110.052 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.518 -0.753 . . . . 0.0 111.032 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.704 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 16.5 t80 . . . . . 0 C--O 1.227 -0.093 0 N-CA-C 111.381 0.141 . . . . 0.0 111.381 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -56.55 -52.37 50.68 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.424 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.485 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 3.1 tm? -60.68 -43.01 98.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.027 0.442 . . . . 0.0 109.843 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 53.3 t -61.75 -46.41 89.72 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.382 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 62.7 ttt-85 -65.39 -44.03 88.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.778 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 4' ' ' LEU . 4.2 pp -66.26 -32.83 74.49 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.253 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -85.51 -2.37 58.07 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.609 0.242 . . . . 0.0 110.649 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 70.0 mtm180 61.91 42.89 9.77 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.488 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.71 147.1 19.21 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -81.88 134.11 35.38 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 117.211 0.506 . . . . 0.0 109.771 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.785 ' SG ' HG12 ' A' ' 31' ' ' VAL . 9.4 t -107.91 132.59 53.31 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -125.37 142.31 51.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.016 0.436 . . . . 0.0 111.805 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.557 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 15.1 ptp180 -70.2 126.2 28.97 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.19 129.22 4.34 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.757 ' HG2' ' HG3' ' A' ' 32' ' ' GLN . 73.5 mtt180 -60.75 114.78 3.21 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.983 0.42 . . . . 0.0 111.918 -178.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 21' ' ' SER . 3.7 m -72.03 150.53 43.9 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -154.93 56.83 0.67 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.021 -0.672 . . . . 0.0 111.736 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.889 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 36.2 t80 -166.39 -66.9 0.01 OUTLIER Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.144 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.889 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 94.3 Cg_endo -90.26 -20.84 0.98 Allowed 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.974 1.783 . . . . 0.0 112.267 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 38.3 m -154.27 148.41 25.83 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.493 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.543 HG12 HG21 ' A' ' 37' ' ' VAL . 36.6 pt -117.23 144.4 33.74 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 120.572 0.225 . . . . 0.0 110.916 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.771 ' HB3' ' HB3' ' A' ' 32' ' ' GLN . 11.5 Cg_exo -68.99 104.15 1.15 Allowed 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.675 2.25 . . . . 0.0 112.013 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.553 HD13 ' HD3' ' A' ' 35' ' ' ARG . 36.5 pt -88.6 -32.98 6.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.065 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -137.93 144.85 16.27 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.066 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 28' ' ' SER . 17.1 ttm105 -88.41 122.18 31.62 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.707 0.289 . . . . 0.0 111.563 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.704 ' HA ' ' HB2' ' A' ' 2' ' ' PHE . 26.9 m -88.89 -38.97 14.13 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.42 ' O ' ' HG3' ' A' ' 26' ' ' ARG . 17.1 t -154.59 -161.34 1.2 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.045 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 43.7 ttt-85 -65.14 -53.18 49.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.088 0.47 . . . . 0.0 111.051 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -98.47 -35.6 10.21 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.686 -178.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.785 HG12 ' SG ' ' A' ' 12' ' ' CYS . 1.8 t -71.12 116.64 13.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.138 -178.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.771 ' HB3' ' HB3' ' A' ' 23' ' ' PRO . 15.0 mm100 -116.38 139.99 49.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.808 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 47.9 t -85.3 93.97 8.82 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 23.2 m -84.3 109.65 17.97 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.683 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.553 ' HD3' HD13 ' A' ' 24' ' ' ILE . 46.6 ttp180 -76.26 138.55 40.65 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.265 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -56.5 125.51 22.4 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 123.438 0.461 . . . . 0.0 111.583 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.543 HG21 HG12 ' A' ' 22' ' ' ILE . 29.4 t -126.31 77.96 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.851 0.834 . . . . 0.0 109.23 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 14.3 t-105 . . . . . 0 C--O 1.251 1.153 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.226 179.945 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.712 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 60.4 m-85 . . . . . 0 N--CA 1.454 -0.225 0 CA-C-O 120.514 0.197 . . . . 0.0 110.678 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -56.49 -26.75 52.71 Favored Glycine 0 C--N 1.336 0.531 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 42.0 tp -160.07 75.66 0.61 Allowed 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 10' ' ' GLY . 0.1 OUTLIER -58.49 142.47 48.73 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.676 -178.641 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.425 ' O ' ' HB2' ' A' ' 7' ' ' LEU . 69.8 mtt85 -41.65 -31.23 0.27 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -176.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 73.0 mt 72.25 -45.12 0.61 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.137 0.575 . . . . 0.0 110.636 -178.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -68.45 -41.74 79.79 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.2 ttt-85 -91.33 -65.44 1.01 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.801 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.765 ' HA2' ' HA ' ' A' ' 35' ' ' ARG . . . -123.96 123.53 5.22 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 178.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -109.04 131.23 55.27 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.016 0.436 . . . . 0.0 110.806 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.623 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -85.17 126.02 33.3 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.959 0.409 . . . . 0.0 110.545 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.475 ' O ' ' HA ' ' A' ' 31' ' ' VAL . . . -129.34 143.21 50.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.821 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.523 ' HA ' HG22 ' A' ' 31' ' ' VAL . 28.6 ttp-105 -62.62 126.95 29.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.046 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.15 -129.98 13.26 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.122 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -100.52 132.62 45.8 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.451 ' SG ' ' HB3' ' A' ' 13' ' ' ALA . 58.1 m -71.25 118.07 13.58 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.168 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -83.58 58.62 4.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.643 0.735 . . . . 0.0 109.949 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.584 ' CD1' ' HD2' ' A' ' 20' ' ' PRO . 37.3 t80 -167.94 138.58 2.26 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.809 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.584 ' HD2' ' CD1' ' A' ' 19' ' ' PHE . 10.0 Cg_endo -53.99 83.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 124.067 3.178 . . . . 0.0 112.96 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.85 ' HA ' HG12 ' A' ' 37' ' ' VAL . 57.4 m -158.62 121.39 3.71 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.101 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.1 pt -82.99 138.52 42.84 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-O 121.131 0.491 . . . . 0.0 111.558 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.769 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 46.6 Cg_endo -76.04 111.66 3.32 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.384 2.056 . . . . 0.0 112.196 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.405 HD13 ' HB2' ' A' ' 35' ' ' ARG . 16.8 pt -79.01 -24.06 12.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.512 0.672 . . . . 0.0 110.264 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.712 ' HA3' ' CE1' ' A' ' 2' ' ' PHE . . . -158.03 -165.82 16.2 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.111 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 32' ' ' GLN . 44.3 ttp180 -148.58 124.19 10.44 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.876 0.338 . . . . 0.0 110.123 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 40.2 m -74.66 -52.23 12.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.871 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.9 m -114.55 -147.98 0.42 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.413 ' O ' ' HD2' ' A' ' 26' ' ' ARG . 14.7 tpp180 -84.82 -46.03 11.75 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -95.69 -42.99 8.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.826 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.533 HG12 ' SG ' ' A' ' 12' ' ' CYS . 28.7 t -64.04 109.35 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.777 -178.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.623 ' O ' ' HA ' ' A' ' 12' ' ' CYS . 51.5 mt-30 -104.5 147.31 27.73 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.601 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 52.5 t -92.34 84.95 5.25 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.769 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 59.3 m -77.49 116.08 17.77 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.212 -178.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.765 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 59.3 ttp85 -80.19 135.42 36.27 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.73 178.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 18.1 tpp85 -60.65 125.48 23.87 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.228 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.85 HG12 ' HA ' ' A' ' 21' ' ' SER . 11.8 p -132.73 39.35 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 122.652 1.215 . . . . 0.0 108.721 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 2.3 t90 . . . . . 0 C--O 1.243 0.752 0 CA-C-N 114.495 -1.229 . . . . 0.0 108.943 179.791 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.43 ' CG ' ' HA ' ' A' ' 27' ' ' CYS . 88.3 m-85 . . . . . 0 N--CA 1.466 0.349 0 CA-C-O 121.039 0.447 . . . . 0.0 111.969 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.18 -42.49 3.48 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 80.1 mt -108.24 41.4 1.56 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.614 ' HA ' ' HG2' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -64.02 -29.49 70.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.592 -178.44 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 72.3 mtp85 -66.66 -47.81 71.33 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.425 HD12 ' N ' ' A' ' 8' ' ' ARG . 4.5 pp -77.81 -32.53 52.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.614 ' HG2' ' HA ' ' A' ' 5' ' ' CYS . 6.5 ptm85 -63.61 -50.62 68.67 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.159 -0.616 . . . . 0.0 109.504 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.556 ' HB2' ' O ' ' A' ' 8' ' ' ARG . 36.0 ttm180 163.51 97.16 0.0 OUTLIER 'General case' 0 C--O 1.235 0.306 0 O-C-N 124.01 0.819 . . . . 0.0 109.978 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.545 ' O ' ' HA ' ' A' ' 6' ' ' ARG . . . 127.74 -143.16 14.14 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.596 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.405 ' HE2' ' HG2' ' A' ' 36' ' ' ARG . 53.7 p90 -175.39 138.59 0.42 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.499 ' SG ' HG12 ' A' ' 31' ' ' VAL . 45.6 t -89.38 123.61 33.7 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.492 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -122.97 135.43 54.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.821 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.639 ' HA ' HG13 ' A' ' 31' ' ' VAL . 54.6 ttm-85 -75.53 133.2 41.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.026 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.24 -60.03 4.85 Favored Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.292 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.419 ' CZ ' ' HB2' ' A' ' 16' ' ' ARG . 2.3 ptm85 -173.79 173.19 3.35 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.7 m -112.29 -171.07 1.78 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.958 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -91.27 178.42 5.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.913 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.576 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 36.2 t80 -59.66 -52.85 71.01 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.576 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 10.1 Cg_exo -72.49 40.88 0.49 Allowed 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.39 2.06 . . . . 0.0 113.671 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.7 p -161.83 123.42 2.79 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.206 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.404 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 45.9 pt -102.84 141.67 22.97 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 120.79 0.328 . . . . 0.0 111.115 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 22' ' ' ILE . 18.9 Cg_exo -64.11 118.69 5.63 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.675 2.25 . . . . 0.0 111.714 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.515 HG12 ' O ' ' A' ' 33' ' ' CYS . 15.8 pt -101.85 -23.83 4.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.529 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 177.25 143.79 5.06 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.892 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.409 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 66.0 mtt85 -74.4 135.05 42.4 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.43 ' HA ' ' CG ' ' A' ' 2' ' ' PHE . 8.4 m -72.22 -34.53 68.41 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.1 m -141.15 -57.02 0.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.617 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.409 ' HA ' ' HD3' ' A' ' 26' ' ' ARG . 34.9 ttm105 -172.24 -66.47 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.01 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -76.6 -41.26 46.79 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.639 HG13 ' HA ' ' A' ' 14' ' ' ARG . 2.5 t -71.23 126.58 31.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.142 178.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -117.39 151.72 36.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.758 0.313 . . . . 0.0 111.514 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.515 ' O ' HG12 ' A' ' 24' ' ' ILE . 42.4 t -107.63 120.47 42.32 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 176.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.8 m -118.97 118.62 32.0 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.888 -0.725 . . . . 0.0 112.021 -177.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.437 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 28.3 ttm180 -70.91 130.71 42.33 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.932 178.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.554 ' HB2' ' CE3' ' A' ' 38' ' ' TRP . 25.6 mtp-105 -63.71 138.68 58.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.278 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 t -80.55 53.43 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.549 0.69 . . . . 0.0 110.243 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.554 ' CE3' ' HB2' ' A' ' 36' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.583 -0.723 . . . . 0.0 110.559 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 37.3 p90 . . . . . 0 C--O 1.225 -0.228 0 CA-C-O 120.33 0.109 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -52.1 -43.13 55.99 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 116.392 -0.367 . . . . 0.0 113.791 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.437 ' O ' ' HB2' ' A' ' 8' ' ' ARG . 3.4 mm? -65.87 -48.08 72.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.017 0.436 . . . . 0.0 111.287 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -69.91 -32.78 71.27 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.583 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.557 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 62.4 ttt-85 -54.84 -37.67 66.46 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -178.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.545 HD22 HH11 ' A' ' 6' ' ' ARG . 1.9 pt? -151.23 -33.09 0.15 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 119.769 -0.772 . . . . 0.0 112.859 -178.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 4' ' ' LEU . 26.1 mmm180 -62.15 -28.39 69.62 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 121.233 -0.187 . . . . 0.0 111.169 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 41.6 mtm105 -141.66 35.41 1.62 Allowed 'General case' 0 C--O 1.233 0.198 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 7' ' ' LEU . . . 150.83 -144.52 11.89 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.057 -1.068 . . . . 0.0 112.969 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.557 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 22.8 p90 -159.62 148.65 17.93 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.517 ' SG ' ' HA ' ' A' ' 6' ' ' ARG . 62.7 m -87.97 142.06 28.09 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.083 0.468 . . . . 0.0 111.871 -178.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.458 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -134.6 133.34 40.07 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.593 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 57.3 ttt85 -82.78 116.32 22.08 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.98 -67.4 1.12 Allowed Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.561 -0.745 . . . . 0.0 113.919 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.65 134.42 54.74 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.607 0.241 . . . . 0.0 110.69 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.5 m -81.36 164.31 22.23 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 -69.07 167.6 15.67 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.62 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 41.6 t80 -50.88 -55.47 27.23 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.62 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 57.2 Cg_endo -88.57 51.98 1.8 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.169 1.912 . . . . 0.0 113.509 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.5 p -156.67 144.7 19.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.923 0.392 . . . . 0.0 111.629 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.575 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 25.8 pt -124.51 142.73 41.23 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.309 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.94 70.94 3.53 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 123.253 2.635 . . . . 0.0 113.153 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.542 HD13 ' HD3' ' A' ' 35' ' ' ARG . 40.7 pt -63.66 -35.36 72.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.9 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.403 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -139.69 -148.98 5.3 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.936 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.493 ' HA ' ' HA ' ' A' ' 32' ' ' GLN . 19.1 ttp-105 -155.26 136.43 13.9 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.97 0.385 . . . . 0.0 110.765 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.6 m -97.35 -35.02 10.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.896 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.6 t -138.77 -146.61 0.21 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -81.18 -52.66 7.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.072 0.463 . . . . 0.0 110.033 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -98.27 -33.24 11.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.672 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 14' ' ' ARG . 41.6 t -70.9 114.47 8.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.194 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 26' ' ' ARG . 55.0 mt-30 -96.35 161.51 13.9 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.398 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.6 t -94.76 100.77 12.62 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 176.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 22' ' ' ILE . 6.8 m -108.36 94.39 5.04 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.313 -177.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.542 ' HD3' HD13 ' A' ' 24' ' ' ILE . 29.9 ptt180 -69.58 144.75 52.95 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.881 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.426 ' C ' ' H ' ' A' ' 38' ' ' TRP . 57.6 ttt180 -69.69 129.77 40.53 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.4 m -75.89 37.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 122.545 0.338 . . . . 0.0 111.691 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.426 ' H ' ' C ' ' A' ' 36' ' ' ARG . 30.2 t-105 . . . . . 0 C--O 1.251 1.154 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.228 178.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.646 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 4.9 m-30 . . . . . 0 CA--C 1.522 -0.115 0 CA-C-O 121.055 0.455 . . . . 0.0 109.945 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.17 39.75 31.15 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.455 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 30.4 tp 60.77 28.62 18.36 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.756 0.789 . . . . 0.0 109.918 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.62 ' HA ' ' HG3' ' A' ' 9' ' ' ARG . 4.0 t -97.78 -177.2 3.69 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.355 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 68.96 -37.16 0.36 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.812 0.845 . . . . 0.0 113.043 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.8 mt -53.47 -63.97 0.98 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.034 0.445 . . . . 0.0 110.683 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -137.79 29.12 2.61 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.657 ' HB3' HD11 ' A' ' 24' ' ' ILE . 29.6 mmm180 -108.46 -53.97 2.57 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.684 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.83 -144.28 5.19 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.049 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -133.55 142.24 48.09 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.005 0.431 . . . . 0.0 110.606 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.424 ' HB3' ' CG1' ' A' ' 31' ' ' VAL . 75.4 m -78.05 121.34 24.13 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.195 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.49 138.72 52.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.489 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -80.06 52.84 1.6 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.406 0.622 . . . . 0.0 110.415 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -174.83 148.54 9.75 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.394 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.61 ' HA ' ' HG3' ' A' ' 32' ' ' GLN . 89.2 mtm180 -75.41 87.73 2.59 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.06 0.457 . . . . 0.0 110.642 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.6 m -61.96 135.56 57.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.197 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -163.08 46.32 0.13 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.829 0.823 . . . . 0.0 109.996 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.825 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 31.8 t80 -172.84 -61.89 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.111 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.825 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 75.5 Cg_endo -91.79 8.69 2.99 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.042 1.828 . . . . 0.0 112.383 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.3 t 179.52 148.72 0.27 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 18.5 pt -106.68 137.87 19.6 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.165 0.507 . . . . 0.0 111.273 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.75 72.58 6.44 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 123.174 2.583 . . . . 0.0 112.319 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.657 HD11 ' HB3' ' A' ' 9' ' ' ARG . 40.3 pt -65.37 -23.22 32.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.435 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -146.13 -166.01 11.81 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.803 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 23.5 ttp-105 -142.97 123.79 14.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.825 0.345 . . . . 0.0 111.041 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.646 ' HA ' ' HA ' ' A' ' 2' ' ' PHE . 36.3 m -87.22 -40.57 14.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.49 0.662 . . . . 0.0 109.368 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.489 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 35.3 m -153.25 165.38 35.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.652 -1.158 . . . . 0.0 107.99 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.0 tpp180 -51.44 -48.08 62.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.712 0.233 . . . . 0.0 111.528 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -99.39 20.87 12.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.815 0.341 . . . . 0.0 111.582 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.489 ' HB ' ' HB2' ' A' ' 28' ' ' SER . 57.3 t -138.07 101.65 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.015 0.436 . . . . 0.0 110.586 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.61 ' HG3' ' HA ' ' A' ' 16' ' ' ARG . 15.0 mm100 -80.36 146.47 31.52 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.814 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 49.4 t -93.06 73.91 4.72 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 22' ' ' ILE . 7.7 m -70.75 120.23 16.05 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.43 -1.259 . . . . 0.0 113.184 -176.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.56 ' HD2' HG21 ' A' ' 24' ' ' ILE . 16.4 ttm180 -95.82 132.4 41.11 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.539 177.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -64.15 130.54 44.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.943 0.401 . . . . 0.0 110.89 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.63 52.37 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 1.6 t90 . . . . . 0 C--O 1.246 0.907 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.322 -178.735 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.44 ' CD2' ' HB3' ' A' ' 27' ' ' CYS . 2.5 m-85 . . . . . 0 C--O 1.233 0.206 0 CA-C-O 121.096 0.474 . . . . 0.0 110.328 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -63.12 -30.34 77.18 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.805 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.4 mp -114.1 52.66 0.82 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.822 0.344 . . . . 0.0 110.213 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.497 ' C ' ' H ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -56.42 145.92 26.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.618 -179.628 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.595 ' HD2' HD12 ' A' ' 24' ' ' ILE . 47.6 ttt85 71.11 -19.19 0.25 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.435 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.497 ' H ' ' C ' ' A' ' 5' ' ' CYS . 69.6 mt 72.26 -28.62 0.19 Allowed 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.305 1.042 . . . . 0.0 113.108 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -78.47 53.59 1.31 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.285 0.564 . . . . 0.0 110.493 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 69.0 mtt85 60.76 45.5 9.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.036 -0.984 . . . . 0.0 112.002 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.12 154.81 16.35 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -145.93 139.73 26.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 118.097 0.948 . . . . 0.0 112.195 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.783 ' HB3' HG12 ' A' ' 31' ' ' VAL . 12.3 m -91.16 128.63 37.06 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.216 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.82 140.61 50.51 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.292 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.8 mtm-85 -72.77 142.7 48.11 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.414 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.58 -100.2 2.64 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.039 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -163.54 154.92 16.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.997 0.427 . . . . 0.0 111.484 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.25 129.67 33.99 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -162.56 57.03 0.22 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.203 0.525 . . . . 0.0 110.996 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.905 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 69.5 t80 -159.79 -63.01 0.02 OUTLIER Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.881 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.905 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 3.7 Cg_endo -84.92 -36.04 0.15 Allowed 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.136 1.891 . . . . 0.0 111.272 178.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.438 ' H ' ' HD2' ' A' ' 20' ' ' PRO . 22.6 m -139.27 144.15 38.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.294 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.468 HG12 HG21 ' A' ' 37' ' ' VAL . 38.5 pt -95.07 146.05 30.64 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.518 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -69.39 101.32 0.85 Allowed 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.49 2.127 . . . . 0.0 112.487 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.595 HD12 ' HD2' ' A' ' 6' ' ' ARG . 45.1 pt -84.23 -29.07 7.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.457 0.646 . . . . 0.0 110.054 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -166.68 -145.73 4.58 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.419 ' CB ' ' HA ' ' A' ' 32' ' ' GLN . 40.4 ptt180 -170.99 140.79 1.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 117.869 0.834 . . . . 0.0 112.273 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.44 ' HB3' ' CD2' ' A' ' 2' ' ' PHE . 87.8 m -81.11 -32.75 33.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.507 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.6 m -145.81 171.75 14.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.262 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -50.91 -51.48 51.52 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.35 0.406 . . . . 0.0 112.034 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -105.63 29.8 6.27 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.9 0.381 . . . . 0.0 110.93 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.783 HG12 ' HB3' ' A' ' 12' ' ' CYS . 31.9 t -136.59 80.51 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.419 ' HA ' ' CB ' ' A' ' 26' ' ' ARG . 85.5 mt-30 -71.67 142.83 49.87 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.183 -178.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.497 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 41.9 t -94.29 106.23 18.21 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 177.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 83.9 m -115.88 92.24 3.84 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.174 0.512 . . . . 0.0 110.575 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 73.7 ttt-85 -66.35 139.56 58.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.04 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -64.17 124.76 22.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.257 0.551 . . . . 0.0 110.596 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.468 HG21 HG12 ' A' ' 22' ' ' ILE . 16.9 t -114.87 65.96 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.513 0.673 . . . . 0.0 109.907 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 63.4 p-90 . . . . . 0 C--O 1.252 1.19 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.322 -179.603 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.448 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 5.1 p90 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.716 0.293 . . . . 0.0 111.419 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -60.34 -39.77 96.59 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.289 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 pp -88.72 38.75 0.89 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.01 0.433 . . . . 0.0 111.113 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.417 ' C ' ' H ' ' A' ' 7' ' ' LEU . 3.0 t -151.35 167.67 27.19 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.238 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 25.3 tpp180 70.24 -35.69 0.33 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.603 0.761 . . . . 0.0 112.22 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.417 ' H ' ' C ' ' A' ' 5' ' ' CYS . 59.5 mt -82.82 62.88 6.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.178 0.513 . . . . 0.0 110.978 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 43.8 mtm-85 72.72 -22.61 0.22 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.585 -1.188 . . . . 0.0 112.429 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.405 ' H ' ' C ' ' A' ' 7' ' ' LEU . 24.1 tpp180 -64.91 -31.34 72.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.358 0.599 . . . . 0.0 110.389 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.11 -147.03 9.69 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -155.43 138.14 15.2 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.163 0.506 . . . . 0.0 110.172 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.61 ' HB3' ' CG1' ' A' ' 31' ' ' VAL . 81.8 m -77.04 130.16 37.05 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.102 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -138.48 123.68 19.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.659 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.619 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 18.5 ptp180 -74.57 137.47 42.39 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.181 0.515 . . . . 0.0 110.892 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.14 -121.0 5.08 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 -161.31 112.2 1.73 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.507 0.67 . . . . 0.0 110.421 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.481 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 2.5 p -90.9 136.39 33.11 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.472 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -163.38 52.05 0.16 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.551 0.691 . . . . 0.0 110.123 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.939 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 47.0 t80 -167.05 -65.27 0.01 OUTLIER Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.142 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.939 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 2.9 Cg_endo -84.71 -23.73 2.55 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.136 1.891 . . . . 0.0 111.667 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.53 ' HA ' HG12 ' A' ' 37' ' ' VAL . 24.8 m -155.67 150.95 26.85 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.366 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.8 pt -110.3 143.58 28.36 Favored Pre-proline 0 C--N 1.323 -0.554 0 O-C-N 123.124 0.265 . . . . 0.0 110.821 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 17' ' ' CYS . 61.2 Cg_endo -75.22 78.26 3.0 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.862 2.375 . . . . 0.0 112.176 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.549 HD13 ' HD2' ' A' ' 35' ' ' ARG . 36.4 pt -62.37 -37.64 79.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.976 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.404 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -131.99 -160.56 9.77 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.853 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 28' ' ' SER . 37.5 ttm180 -140.28 119.7 13.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.852 0.358 . . . . 0.0 111.002 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 2' ' ' PHE . 56.2 m -83.56 -36.68 23.8 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.413 ' O ' ' HG3' ' A' ' 26' ' ' ARG . 47.4 m -159.9 172.66 17.21 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.165 -1.421 . . . . 0.0 107.165 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.9 tpp85 -56.07 -46.45 78.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 118.326 0.512 . . . . 0.0 111.097 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.512 ' CD2' ' HB2' ' A' ' 14' ' ' ARG . 8.6 t80 -87.61 -35.72 17.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.751 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.619 ' HA ' ' HA ' ' A' ' 14' ' ' ARG . 16.7 t -85.6 107.27 16.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.325 0.583 . . . . 0.0 111.916 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -85.95 153.73 21.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.96 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 37.6 t -97.16 85.9 3.82 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 20.5 m -82.44 117.63 22.62 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.642 -177.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.549 ' HD2' HD13 ' A' ' 24' ' ' ILE . 51.5 ttt85 -89.11 127.28 35.7 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.544 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -58.9 129.35 41.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.021 0.439 . . . . 0.0 111.017 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.53 HG12 ' HA ' ' A' ' 21' ' ' SER . 13.6 p -152.68 42.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 122.504 1.145 . . . . 0.0 109.601 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 4.6 t90 . . . . . 0 C--O 1.247 0.97 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.403 179.612 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.476 0.845 0 CA-C-O 120.408 0.147 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 72.67 -50.62 0.7 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.691 0.796 . . . . 0.0 111.72 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.05 -34.95 89.84 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.564 -0.351 . . . . 0.0 113.062 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 92.0 mt -73.61 -2.38 22.73 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.6 t -137.58 -157.67 0.8 Allowed 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 6' ' ' ARG . 40.9 ttm180 56.01 30.2 15.75 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.802 0.81 . . . . 0.0 109.819 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.9 mt -74.86 -52.76 10.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.701 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 39.3 mtp85 -95.93 -55.38 3.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.383 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 45.3 ttt-85 -174.19 39.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.494 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.71 121.16 5.34 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.177 -1.011 . . . . 0.0 110.908 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.656 ' HE2' ' HG2' ' A' ' 36' ' ' ARG . 35.2 p90 -104.11 139.2 39.52 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.246 0.546 . . . . 0.0 110.746 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 61.1 m -76.12 126.4 30.92 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.646 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.489 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -123.76 136.75 54.61 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.093 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -70.1 120.44 15.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.247 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.84 -130.07 16.75 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.945 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 78.2 mtt-85 -76.8 146.96 37.5 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.899 0.38 . . . . 0.0 111.83 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 82.7 m -67.19 150.25 49.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.358 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.432 ' H ' ' HD2' ' A' ' 18' ' ' ARG . 1.1 mpt_? -68.49 163.51 23.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.241 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.753 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 30.4 t80 -46.86 -59.12 5.66 Favored Pre-proline 0 CA--C 1.543 0.674 0 O-C-N 123.648 0.592 . . . . 0.0 112.521 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.753 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 4.1 Cg_endo -86.53 46.87 1.61 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.36 2.04 . . . . 0.0 112.142 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.9 m -151.32 130.47 12.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.551 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.3 pt -104.65 139.16 19.83 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-O 120.983 0.42 . . . . 0.0 111.118 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.54 75.54 5.0 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 123.08 2.52 . . . . 0.0 112.798 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.9 pt -63.75 -30.13 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.103 0.478 . . . . 0.0 111.008 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -162.91 -172.99 31.08 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.6 mtm-85 -111.96 132.4 54.79 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.917 0.359 . . . . 0.0 110.507 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.503 ' HB3' HG12 ' A' ' 31' ' ' VAL . 35.0 t -77.77 -34.6 52.27 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.5 t -146.61 -141.85 0.12 Allowed 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.406 ' HA ' ' HD2' ' A' ' 29' ' ' ARG . 9.0 tpt180 -83.67 -57.52 3.19 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.638 -0.425 . . . . 0.0 109.973 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -93.29 -38.53 11.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.773 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.503 HG12 ' HB3' ' A' ' 27' ' ' CYS . 84.5 t -68.64 117.06 10.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.155 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -89.0 160.46 17.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.829 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 30.5 t -103.98 69.14 0.93 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.489 ' SG ' ' HB3' ' A' ' 13' ' ' ALA . 13.3 m -63.73 131.05 46.67 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.44 -1.255 . . . . 0.0 112.509 -177.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -107.68 138.55 43.71 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.264 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.656 ' HG2' ' HE2' ' A' ' 11' ' ' PHE . 22.5 mmt85 -62.02 150.24 38.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.993 0.425 . . . . 0.0 110.449 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.1 p -139.23 37.82 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 122.478 1.132 . . . . 0.0 109.57 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 12.3 m0 . . . . . 0 C--O 1.249 1.062 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.503 179.872 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 41.9 t . . . . . 0 N--CA 1.478 0.962 0 CA-C-O 120.769 0.319 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.698 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 40.7 p90 -91.98 -37.17 13.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.612 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -55.39 -49.6 63.63 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.538 -0.363 . . . . 0.0 113.19 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.28 -40.59 96.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.244 0.545 . . . . 0.0 110.19 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.608 ' SG ' ' HA3' ' A' ' 10' ' ' GLY . 47.7 t -62.96 -40.93 99.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.262 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.698 ' HG2' ' O ' ' A' ' 2' ' ' PHE . 20.9 mmt85 -59.91 -41.72 92.3 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.949 0.404 . . . . 0.0 110.565 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.3 mt -63.18 -34.82 78.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.18 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.2 ttm180 -86.64 10.69 14.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.04 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? 62.68 41.69 8.99 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.762 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.608 ' HA3' ' SG ' ' A' ' 5' ' ' CYS . . . -94.95 136.16 12.79 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 178.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -94.6 133.1 38.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.098 0.475 . . . . 0.0 110.862 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 85.4 m -78.45 108.84 12.11 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.836 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -103.44 128.59 50.57 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.967 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -72.28 111.88 7.87 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.0 0.428 . . . . 0.0 111.382 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.45 -58.86 3.72 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.76 -0.655 . . . . 0.0 113.659 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.5 mmm-85 -145.71 146.68 31.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.928 0.394 . . . . 0.0 111.663 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.7 m -76.25 125.68 29.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.993 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -90.45 45.88 1.3 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.712 0.768 . . . . 0.0 109.567 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -171.47 146.62 1.97 Allowed Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 114.35 -1.296 . . . . 0.0 107.908 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -63.24 60.44 0.17 Allowed 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.67 2.913 . . . . 0.0 113.944 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 57.8 m -127.02 129.73 48.62 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.7 pt -81.09 138.79 49.16 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 121.136 0.493 . . . . 0.0 111.691 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.64 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 65.8 Cg_endo -81.0 116.3 3.1 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.657 2.238 . . . . 0.0 111.427 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 25.5 pt -78.85 -30.31 14.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.988 0.423 . . . . 0.0 111.303 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -164.46 153.89 24.42 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -70.13 135.98 49.7 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.055 0.455 . . . . 0.0 110.975 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 34.9 t -80.96 -31.02 35.03 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.7 t -147.55 -140.44 0.1 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.315 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -86.44 -49.69 7.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.938 0.399 . . . . 0.0 110.298 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -103.15 -35.29 8.54 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 57.9 t -70.42 123.63 24.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.3 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -95.22 -177.56 4.16 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.481 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.5 t -139.92 107.73 5.67 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.64 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 0.7 OUTLIER -94.75 128.88 41.77 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.554 -176.266 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 61.7 ttt-85 -97.65 134.34 40.97 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.235 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.2 tpp85 -65.23 132.4 49.0 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.03 44.13 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 121.84 0.828 . . . . 0.0 111.32 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.931 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.126 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.6 m . . . . . 0 N--CA 1.478 0.925 0 CA-C-O 121.178 0.513 . . . . 0.0 110.698 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.434 ' HB3' ' HA ' ' A' ' 27' ' ' CYS . 15.8 p90 -68.73 -24.39 64.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.57 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -60.29 -52.89 49.9 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.893 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.466 HD12 ' N ' ' A' ' 5' ' ' CYS . 4.0 pp -71.47 -35.02 70.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.723 0.296 . . . . 0.0 111.127 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.517 ' SG ' ' HA3' ' A' ' 10' ' ' GLY . 26.7 t -66.65 -32.78 74.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.104 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -57.85 -38.43 75.65 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.136 0.494 . . . . 0.0 110.26 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.7 mt -67.64 -37.62 82.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.089 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -76.91 -5.71 49.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.591 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 69.02 29.56 4.76 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.726 0.81 . . . . 0.0 112.171 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.517 ' HA3' ' SG ' ' A' ' 5' ' ' CYS . . . -76.19 137.93 21.93 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -96.41 142.08 28.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 117.471 0.635 . . . . 0.0 111.222 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 75.7 m -80.73 124.7 29.25 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.326 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.629 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . . . -130.83 111.78 12.43 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.28 0.562 . . . . 0.0 110.05 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.488 ' HG3' HG22 ' A' ' 31' ' ' VAL . 16.9 ttm180 -74.61 134.67 42.06 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.342 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.12 42.27 51.58 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.167 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 69.61 149.22 0.07 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.563 0.697 . . . . 0.0 111.595 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.629 ' SG ' ' HB3' ' A' ' 13' ' ' ALA . 3.2 m -90.11 -172.48 3.5 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.917 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 68.2 mtm-85 -80.48 -178.84 6.88 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.925 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.477 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 85.6 t80 -65.79 -55.34 23.41 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.477 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 72.2 Cg_endo -75.06 46.12 1.49 Allowed 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.179 1.92 . . . . 0.0 113.464 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.469 ' HA ' HG23 ' A' ' 37' ' ' VAL . 24.5 p -158.98 116.29 2.77 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.928 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.0 pt -96.02 138.49 21.65 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 120.92 0.391 . . . . 0.0 111.121 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 37.5 Cg_endo -74.91 77.71 3.03 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.843 2.362 . . . . 0.0 112.676 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.611 HD13 ' HB2' ' A' ' 35' ' ' ARG . 47.8 pt -62.94 -27.41 43.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.392 0.615 . . . . 0.0 110.27 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -156.28 -167.82 18.18 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.574 ' HD2' ' O ' ' A' ' 29' ' ' ARG . 83.7 mtm180 -141.33 135.57 30.66 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.434 ' HA ' ' HB3' ' A' ' 2' ' ' PHE . 47.7 m -68.2 -51.41 45.93 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.794 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.6 m -115.65 -62.94 1.52 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.934 0.397 . . . . 0.0 110.678 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.574 ' O ' ' HD2' ' A' ' 26' ' ' ARG . 8.1 tpp180 -172.83 -60.91 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.436 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -80.14 -40.32 27.63 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.488 HG22 ' HG3' ' A' ' 14' ' ' ARG . 61.3 t -70.16 114.73 8.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.282 178.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -77.06 154.48 33.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.324 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 12.8 t -122.3 69.46 0.96 Allowed 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 56.1 m -74.63 137.61 42.38 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.781 -1.099 . . . . 0.0 113.214 -176.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.611 ' HB2' HD13 ' A' ' 24' ' ' ILE . 25.3 ttm-85 -88.09 138.01 31.83 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.385 177.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -65.95 131.58 46.57 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.122 0.487 . . . . 0.0 110.502 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.469 HG23 ' HA ' ' A' ' 21' ' ' SER . 12.1 t -108.36 60.25 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.325 0.583 . . . . 0.0 110.052 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.518 -0.753 . . . . 0.0 111.032 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 N--CA 1.478 0.94 0 N-CA-C 110.804 -0.073 . . . . 0.0 110.804 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.704 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 16.5 t80 -62.69 -38.69 91.39 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 111.381 0.141 . . . . 0.0 111.381 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -56.55 -52.37 50.68 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.424 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.485 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 3.1 tm? -60.68 -43.01 98.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.027 0.442 . . . . 0.0 109.843 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 53.3 t -61.75 -46.41 89.72 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.382 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 62.7 ttt-85 -65.39 -44.03 88.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.778 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 4' ' ' LEU . 4.2 pp -66.26 -32.83 74.49 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.253 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -85.51 -2.37 58.07 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.609 0.242 . . . . 0.0 110.649 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 70.0 mtm180 61.91 42.89 9.77 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.488 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.71 147.1 19.21 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -81.88 134.11 35.38 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 117.211 0.506 . . . . 0.0 109.771 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.785 ' SG ' HG12 ' A' ' 31' ' ' VAL . 9.4 t -107.91 132.59 53.31 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -125.37 142.31 51.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.016 0.436 . . . . 0.0 111.805 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.557 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 15.1 ptp180 -70.2 126.2 28.97 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.19 129.22 4.34 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.757 ' HG2' ' HG3' ' A' ' 32' ' ' GLN . 73.5 mtt180 -60.75 114.78 3.21 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.983 0.42 . . . . 0.0 111.918 -178.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 21' ' ' SER . 3.7 m -72.03 150.53 43.9 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -154.93 56.83 0.67 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.021 -0.672 . . . . 0.0 111.736 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.889 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 36.2 t80 -166.39 -66.9 0.01 OUTLIER Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.144 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.889 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 94.3 Cg_endo -90.26 -20.84 0.98 Allowed 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.974 1.783 . . . . 0.0 112.267 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 38.3 m -154.27 148.41 25.83 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.493 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.543 HG12 HG21 ' A' ' 37' ' ' VAL . 36.6 pt -117.23 144.4 33.74 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 120.572 0.225 . . . . 0.0 110.916 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.771 ' HB3' ' HB3' ' A' ' 32' ' ' GLN . 11.5 Cg_exo -68.99 104.15 1.15 Allowed 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.675 2.25 . . . . 0.0 112.013 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.553 HD13 ' HD3' ' A' ' 35' ' ' ARG . 36.5 pt -88.6 -32.98 6.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.065 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -137.93 144.85 16.27 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.066 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 28' ' ' SER . 17.1 ttm105 -88.41 122.18 31.62 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.707 0.289 . . . . 0.0 111.563 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.704 ' HA ' ' HB2' ' A' ' 2' ' ' PHE . 26.9 m -88.89 -38.97 14.13 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.42 ' O ' ' HG3' ' A' ' 26' ' ' ARG . 17.1 t -154.59 -161.34 1.2 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.045 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 43.7 ttt-85 -65.14 -53.18 49.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.088 0.47 . . . . 0.0 111.051 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -98.47 -35.6 10.21 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.686 -178.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.785 HG12 ' SG ' ' A' ' 12' ' ' CYS . 1.8 t -71.12 116.64 13.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.138 -178.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.771 ' HB3' ' HB3' ' A' ' 23' ' ' PRO . 15.0 mm100 -116.38 139.99 49.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.808 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 47.9 t -85.3 93.97 8.82 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 23.2 m -84.3 109.65 17.97 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.683 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.553 ' HD3' HD13 ' A' ' 24' ' ' ILE . 46.6 ttp180 -76.26 138.55 40.65 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.265 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -56.5 125.51 22.4 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 123.438 0.461 . . . . 0.0 111.583 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.543 HG21 HG12 ' A' ' 22' ' ' ILE . 29.4 t -126.31 77.96 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.851 0.834 . . . . 0.0 109.23 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 14.3 t-105 . . . . . 0 C--O 1.251 1.153 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.226 179.945 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 36.1 t . . . . . 0 N--CA 1.479 0.975 0 CA-C-O 120.735 0.302 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.712 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 60.4 m-85 -89.68 -19.02 25.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.678 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -56.49 -26.75 52.71 Favored Glycine 0 C--N 1.336 0.531 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 42.0 tp -160.07 75.66 0.61 Allowed 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 10' ' ' GLY . 0.1 OUTLIER -58.49 142.47 48.73 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.676 -178.641 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.425 ' O ' ' HB2' ' A' ' 7' ' ' LEU . 69.8 mtt85 -41.65 -31.23 0.27 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -176.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 73.0 mt 72.25 -45.12 0.61 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.137 0.575 . . . . 0.0 110.636 -178.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -68.45 -41.74 79.79 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.2 ttt-85 -91.33 -65.44 1.01 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.801 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.765 ' HA2' ' HA ' ' A' ' 35' ' ' ARG . . . -123.96 123.53 5.22 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 178.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -109.04 131.23 55.27 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.016 0.436 . . . . 0.0 110.806 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.623 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -85.17 126.02 33.3 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.959 0.409 . . . . 0.0 110.545 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.475 ' O ' ' HA ' ' A' ' 31' ' ' VAL . . . -129.34 143.21 50.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.821 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.523 ' HA ' HG22 ' A' ' 31' ' ' VAL . 28.6 ttp-105 -62.62 126.95 29.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.046 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.15 -129.98 13.26 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.122 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -100.52 132.62 45.8 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.451 ' SG ' ' HB3' ' A' ' 13' ' ' ALA . 58.1 m -71.25 118.07 13.58 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.168 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -83.58 58.62 4.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.643 0.735 . . . . 0.0 109.949 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.584 ' CD1' ' HD2' ' A' ' 20' ' ' PRO . 37.3 t80 -167.94 138.58 2.26 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.809 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.584 ' HD2' ' CD1' ' A' ' 19' ' ' PHE . 10.0 Cg_endo -53.99 83.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 124.067 3.178 . . . . 0.0 112.96 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.85 ' HA ' HG12 ' A' ' 37' ' ' VAL . 57.4 m -158.62 121.39 3.71 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.101 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.1 pt -82.99 138.52 42.84 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-O 121.131 0.491 . . . . 0.0 111.558 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.769 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 46.6 Cg_endo -76.04 111.66 3.32 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.384 2.056 . . . . 0.0 112.196 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.405 HD13 ' HB2' ' A' ' 35' ' ' ARG . 16.8 pt -79.01 -24.06 12.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.512 0.672 . . . . 0.0 110.264 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.712 ' HA3' ' CE1' ' A' ' 2' ' ' PHE . . . -158.03 -165.82 16.2 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.111 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 32' ' ' GLN . 44.3 ttp180 -148.58 124.19 10.44 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.876 0.338 . . . . 0.0 110.123 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 40.2 m -74.66 -52.23 12.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.871 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.9 m -114.55 -147.98 0.42 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.413 ' O ' ' HD2' ' A' ' 26' ' ' ARG . 14.7 tpp180 -84.82 -46.03 11.75 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -95.69 -42.99 8.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.826 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.533 HG12 ' SG ' ' A' ' 12' ' ' CYS . 28.7 t -64.04 109.35 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.777 -178.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.623 ' O ' ' HA ' ' A' ' 12' ' ' CYS . 51.5 mt-30 -104.5 147.31 27.73 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.601 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 52.5 t -92.34 84.95 5.25 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.769 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 59.3 m -77.49 116.08 17.77 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.212 -178.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.765 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 59.3 ttp85 -80.19 135.42 36.27 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.73 178.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 18.1 tpp85 -60.65 125.48 23.87 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.228 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.85 HG12 ' HA ' ' A' ' 21' ' ' SER . 11.8 p -132.73 39.35 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 122.652 1.215 . . . . 0.0 108.721 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 2.3 t90 . . . . . 0 C--O 1.243 0.752 0 CA-C-N 114.495 -1.229 . . . . 0.0 108.943 179.791 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.473 0.706 0 N-CA-C 110.572 -0.158 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.43 ' CG ' ' HA ' ' A' ' 27' ' ' CYS . 88.3 m-85 58.69 26.55 14.73 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 122.982 0.513 . . . . 0.0 111.969 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.18 -42.49 3.48 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 80.1 mt -108.24 41.4 1.56 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.614 ' HA ' ' HG2' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -64.02 -29.49 70.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.592 -178.44 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 72.3 mtp85 -66.66 -47.81 71.33 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.425 HD12 ' N ' ' A' ' 8' ' ' ARG . 4.5 pp -77.81 -32.53 52.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.614 ' HG2' ' HA ' ' A' ' 5' ' ' CYS . 6.5 ptm85 -63.61 -50.62 68.67 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.159 -0.616 . . . . 0.0 109.504 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.556 ' HB2' ' O ' ' A' ' 8' ' ' ARG . 36.0 ttm180 163.51 97.16 0.0 OUTLIER 'General case' 0 C--O 1.235 0.306 0 O-C-N 124.01 0.819 . . . . 0.0 109.978 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.545 ' O ' ' HA ' ' A' ' 6' ' ' ARG . . . 127.74 -143.16 14.14 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.596 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.405 ' HE2' ' HG2' ' A' ' 36' ' ' ARG . 53.7 p90 -175.39 138.59 0.42 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.499 ' SG ' HG12 ' A' ' 31' ' ' VAL . 45.6 t -89.38 123.61 33.7 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.492 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -122.97 135.43 54.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.821 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.639 ' HA ' HG13 ' A' ' 31' ' ' VAL . 54.6 ttm-85 -75.53 133.2 41.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.026 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.24 -60.03 4.85 Favored Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.292 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.419 ' CZ ' ' HB2' ' A' ' 16' ' ' ARG . 2.3 ptm85 -173.79 173.19 3.35 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.7 m -112.29 -171.07 1.78 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.958 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -91.27 178.42 5.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.913 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.576 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 36.2 t80 -59.66 -52.85 71.01 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.576 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 10.1 Cg_exo -72.49 40.88 0.49 Allowed 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.39 2.06 . . . . 0.0 113.671 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.7 p -161.83 123.42 2.79 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.206 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.404 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 45.9 pt -102.84 141.67 22.97 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 120.79 0.328 . . . . 0.0 111.115 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 22' ' ' ILE . 18.9 Cg_exo -64.11 118.69 5.63 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.675 2.25 . . . . 0.0 111.714 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.515 HG12 ' O ' ' A' ' 33' ' ' CYS . 15.8 pt -101.85 -23.83 4.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.529 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 177.25 143.79 5.06 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.892 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.409 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 66.0 mtt85 -74.4 135.05 42.4 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.43 ' HA ' ' CG ' ' A' ' 2' ' ' PHE . 8.4 m -72.22 -34.53 68.41 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.1 m -141.15 -57.02 0.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.617 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.409 ' HA ' ' HD3' ' A' ' 26' ' ' ARG . 34.9 ttm105 -172.24 -66.47 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.01 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -76.6 -41.26 46.79 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.639 HG13 ' HA ' ' A' ' 14' ' ' ARG . 2.5 t -71.23 126.58 31.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.142 178.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -117.39 151.72 36.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.758 0.313 . . . . 0.0 111.514 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.515 ' O ' HG12 ' A' ' 24' ' ' ILE . 42.4 t -107.63 120.47 42.32 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 176.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.8 m -118.97 118.62 32.0 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.888 -0.725 . . . . 0.0 112.021 -177.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.437 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 28.3 ttm180 -70.91 130.71 42.33 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.932 178.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.554 ' HB2' ' CE3' ' A' ' 38' ' ' TRP . 25.6 mtp-105 -63.71 138.68 58.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.278 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 t -80.55 53.43 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.549 0.69 . . . . 0.0 110.243 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.554 ' CE3' ' HB2' ' A' ' 36' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.583 -0.723 . . . . 0.0 110.559 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.6 t . . . . . 0 N--CA 1.476 0.827 0 CA-C-O 120.879 0.371 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -68.73 -25.13 64.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.259 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -52.1 -43.13 55.99 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 116.392 -0.367 . . . . 0.0 113.791 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.437 ' O ' ' HB2' ' A' ' 8' ' ' ARG . 3.4 mm? -65.87 -48.08 72.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.017 0.436 . . . . 0.0 111.287 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -69.91 -32.78 71.27 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.583 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.557 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 62.4 ttt-85 -54.84 -37.67 66.46 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -178.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.545 HD22 HH11 ' A' ' 6' ' ' ARG . 1.9 pt? -151.23 -33.09 0.15 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 119.769 -0.772 . . . . 0.0 112.859 -178.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 4' ' ' LEU . 26.1 mmm180 -62.15 -28.39 69.62 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 121.233 -0.187 . . . . 0.0 111.169 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 41.6 mtm105 -141.66 35.41 1.62 Allowed 'General case' 0 C--O 1.233 0.198 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 7' ' ' LEU . . . 150.83 -144.52 11.89 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.057 -1.068 . . . . 0.0 112.969 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.557 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 22.8 p90 -159.62 148.65 17.93 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.517 ' SG ' ' HA ' ' A' ' 6' ' ' ARG . 62.7 m -87.97 142.06 28.09 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.083 0.468 . . . . 0.0 111.871 -178.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.458 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -134.6 133.34 40.07 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.593 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 57.3 ttt85 -82.78 116.32 22.08 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.98 -67.4 1.12 Allowed Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.561 -0.745 . . . . 0.0 113.919 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.65 134.42 54.74 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.607 0.241 . . . . 0.0 110.69 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.5 m -81.36 164.31 22.23 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 -69.07 167.6 15.67 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.62 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 41.6 t80 -50.88 -55.47 27.23 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.62 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 57.2 Cg_endo -88.57 51.98 1.8 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.169 1.912 . . . . 0.0 113.509 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.5 p -156.67 144.7 19.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.923 0.392 . . . . 0.0 111.629 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.575 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 25.8 pt -124.51 142.73 41.23 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.309 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.94 70.94 3.53 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 123.253 2.635 . . . . 0.0 113.153 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.542 HD13 ' HD3' ' A' ' 35' ' ' ARG . 40.7 pt -63.66 -35.36 72.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.9 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.403 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -139.69 -148.98 5.3 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.936 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.493 ' HA ' ' HA ' ' A' ' 32' ' ' GLN . 19.1 ttp-105 -155.26 136.43 13.9 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.97 0.385 . . . . 0.0 110.765 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.6 m -97.35 -35.02 10.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.896 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.6 t -138.77 -146.61 0.21 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -81.18 -52.66 7.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.072 0.463 . . . . 0.0 110.033 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -98.27 -33.24 11.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.672 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 14' ' ' ARG . 41.6 t -70.9 114.47 8.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.194 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 26' ' ' ARG . 55.0 mt-30 -96.35 161.51 13.9 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.398 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.6 t -94.76 100.77 12.62 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 176.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 22' ' ' ILE . 6.8 m -108.36 94.39 5.04 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.313 -177.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.542 ' HD3' HD13 ' A' ' 24' ' ' ILE . 29.9 ptt180 -69.58 144.75 52.95 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.881 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.426 ' C ' ' H ' ' A' ' 38' ' ' TRP . 57.6 ttt180 -69.69 129.77 40.53 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.4 m -75.89 37.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 122.545 0.338 . . . . 0.0 111.691 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.426 ' H ' ' C ' ' A' ' 36' ' ' ARG . 30.2 t-105 . . . . . 0 C--O 1.251 1.154 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.228 178.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 53.3 m . . . . . 0 N--CA 1.476 0.848 0 CA-C-O 120.892 0.377 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.646 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 4.9 m-30 -74.49 -21.16 59.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.945 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.17 39.75 31.15 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.455 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 30.4 tp 60.77 28.62 18.36 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.756 0.789 . . . . 0.0 109.918 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.62 ' HA ' ' HG3' ' A' ' 9' ' ' ARG . 4.0 t -97.78 -177.2 3.69 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.355 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 68.96 -37.16 0.36 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.812 0.845 . . . . 0.0 113.043 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.8 mt -53.47 -63.97 0.98 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.034 0.445 . . . . 0.0 110.683 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -137.79 29.12 2.61 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.657 ' HB3' HD11 ' A' ' 24' ' ' ILE . 29.6 mmm180 -108.46 -53.97 2.57 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.684 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.83 -144.28 5.19 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.049 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -133.55 142.24 48.09 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.005 0.431 . . . . 0.0 110.606 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.424 ' HB3' ' CG1' ' A' ' 31' ' ' VAL . 75.4 m -78.05 121.34 24.13 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.195 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.49 138.72 52.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.489 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -80.06 52.84 1.6 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.406 0.622 . . . . 0.0 110.415 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -174.83 148.54 9.75 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.394 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.61 ' HA ' ' HG3' ' A' ' 32' ' ' GLN . 89.2 mtm180 -75.41 87.73 2.59 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.06 0.457 . . . . 0.0 110.642 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.6 m -61.96 135.56 57.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.197 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -163.08 46.32 0.13 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.829 0.823 . . . . 0.0 109.996 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.825 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 31.8 t80 -172.84 -61.89 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.111 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.825 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 75.5 Cg_endo -91.79 8.69 2.99 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.042 1.828 . . . . 0.0 112.383 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.3 t 179.52 148.72 0.27 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 18.5 pt -106.68 137.87 19.6 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.165 0.507 . . . . 0.0 111.273 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.75 72.58 6.44 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 123.174 2.583 . . . . 0.0 112.319 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.657 HD11 ' HB3' ' A' ' 9' ' ' ARG . 40.3 pt -65.37 -23.22 32.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.435 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -146.13 -166.01 11.81 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.803 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 23.5 ttp-105 -142.97 123.79 14.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.825 0.345 . . . . 0.0 111.041 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.646 ' HA ' ' HA ' ' A' ' 2' ' ' PHE . 36.3 m -87.22 -40.57 14.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.49 0.662 . . . . 0.0 109.368 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.489 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 35.3 m -153.25 165.38 35.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.652 -1.158 . . . . 0.0 107.99 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.0 tpp180 -51.44 -48.08 62.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.712 0.233 . . . . 0.0 111.528 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -99.39 20.87 12.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.815 0.341 . . . . 0.0 111.582 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.489 ' HB ' ' HB2' ' A' ' 28' ' ' SER . 57.3 t -138.07 101.65 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.015 0.436 . . . . 0.0 110.586 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.61 ' HG3' ' HA ' ' A' ' 16' ' ' ARG . 15.0 mm100 -80.36 146.47 31.52 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.814 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 49.4 t -93.06 73.91 4.72 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 22' ' ' ILE . 7.7 m -70.75 120.23 16.05 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.43 -1.259 . . . . 0.0 113.184 -176.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.56 ' HD2' HG21 ' A' ' 24' ' ' ILE . 16.4 ttm180 -95.82 132.4 41.11 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.539 177.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -64.15 130.54 44.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.943 0.401 . . . . 0.0 110.89 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.63 52.37 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 1.6 t90 . . . . . 0 C--O 1.246 0.907 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.322 -178.735 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 45.1 m . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 120.595 0.236 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.44 ' CD2' ' HB3' ' A' ' 27' ' ' CYS . 2.5 m-85 -66.49 -38.29 86.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.096 0.474 . . . . 0.0 110.328 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -63.12 -30.34 77.18 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.805 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.4 mp -114.1 52.66 0.82 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.822 0.344 . . . . 0.0 110.213 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.497 ' C ' ' H ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -56.42 145.92 26.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.618 -179.628 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.595 ' HD2' HD12 ' A' ' 24' ' ' ILE . 47.6 ttt85 71.11 -19.19 0.25 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.435 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.497 ' H ' ' C ' ' A' ' 5' ' ' CYS . 69.6 mt 72.26 -28.62 0.19 Allowed 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.305 1.042 . . . . 0.0 113.108 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -78.47 53.59 1.31 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.285 0.564 . . . . 0.0 110.493 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 69.0 mtt85 60.76 45.5 9.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.036 -0.984 . . . . 0.0 112.002 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.12 154.81 16.35 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -145.93 139.73 26.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 118.097 0.948 . . . . 0.0 112.195 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.783 ' HB3' HG12 ' A' ' 31' ' ' VAL . 12.3 m -91.16 128.63 37.06 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.216 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.82 140.61 50.51 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.292 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.8 mtm-85 -72.77 142.7 48.11 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.414 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.58 -100.2 2.64 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.039 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -163.54 154.92 16.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.997 0.427 . . . . 0.0 111.484 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.25 129.67 33.99 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -162.56 57.03 0.22 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.203 0.525 . . . . 0.0 110.996 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.905 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 69.5 t80 -159.79 -63.01 0.02 OUTLIER Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.881 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.905 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 3.7 Cg_endo -84.92 -36.04 0.15 Allowed 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.136 1.891 . . . . 0.0 111.272 178.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.438 ' H ' ' HD2' ' A' ' 20' ' ' PRO . 22.6 m -139.27 144.15 38.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.294 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.468 HG12 HG21 ' A' ' 37' ' ' VAL . 38.5 pt -95.07 146.05 30.64 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.518 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -69.39 101.32 0.85 Allowed 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.49 2.127 . . . . 0.0 112.487 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.595 HD12 ' HD2' ' A' ' 6' ' ' ARG . 45.1 pt -84.23 -29.07 7.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.457 0.646 . . . . 0.0 110.054 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -166.68 -145.73 4.58 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.419 ' CB ' ' HA ' ' A' ' 32' ' ' GLN . 40.4 ptt180 -170.99 140.79 1.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 117.869 0.834 . . . . 0.0 112.273 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.44 ' HB3' ' CD2' ' A' ' 2' ' ' PHE . 87.8 m -81.11 -32.75 33.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.507 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.6 m -145.81 171.75 14.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.262 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -50.91 -51.48 51.52 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.35 0.406 . . . . 0.0 112.034 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -105.63 29.8 6.27 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.9 0.381 . . . . 0.0 110.93 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.783 HG12 ' HB3' ' A' ' 12' ' ' CYS . 31.9 t -136.59 80.51 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.419 ' HA ' ' CB ' ' A' ' 26' ' ' ARG . 85.5 mt-30 -71.67 142.83 49.87 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.183 -178.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.497 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 41.9 t -94.29 106.23 18.21 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 177.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 83.9 m -115.88 92.24 3.84 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.174 0.512 . . . . 0.0 110.575 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 73.7 ttt-85 -66.35 139.56 58.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.04 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -64.17 124.76 22.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.257 0.551 . . . . 0.0 110.596 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.468 HG21 HG12 ' A' ' 22' ' ' ILE . 16.9 t -114.87 65.96 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.513 0.673 . . . . 0.0 109.907 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 63.4 p-90 . . . . . 0 C--O 1.252 1.19 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.322 -179.603 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 17.3 p . . . . . 0 N--CA 1.479 0.987 0 CA-C-O 120.637 0.256 . . . . 0.0 111.468 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.448 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 5.1 p90 -88.94 -4.86 58.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.716 0.293 . . . . 0.0 111.419 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -60.34 -39.77 96.59 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.289 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 pp -88.72 38.75 0.89 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.01 0.433 . . . . 0.0 111.113 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.417 ' C ' ' H ' ' A' ' 7' ' ' LEU . 3.0 t -151.35 167.67 27.19 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.238 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 25.3 tpp180 70.24 -35.69 0.33 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.603 0.761 . . . . 0.0 112.22 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.417 ' H ' ' C ' ' A' ' 5' ' ' CYS . 59.5 mt -82.82 62.88 6.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.178 0.513 . . . . 0.0 110.978 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 43.8 mtm-85 72.72 -22.61 0.22 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.585 -1.188 . . . . 0.0 112.429 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.405 ' H ' ' C ' ' A' ' 7' ' ' LEU . 24.1 tpp180 -64.91 -31.34 72.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.358 0.599 . . . . 0.0 110.389 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.11 -147.03 9.69 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -155.43 138.14 15.2 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.163 0.506 . . . . 0.0 110.172 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.61 ' HB3' ' CG1' ' A' ' 31' ' ' VAL . 81.8 m -77.04 130.16 37.05 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.102 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -138.48 123.68 19.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.659 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.619 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 18.5 ptp180 -74.57 137.47 42.39 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.181 0.515 . . . . 0.0 110.892 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.14 -121.0 5.08 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 -161.31 112.2 1.73 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.507 0.67 . . . . 0.0 110.421 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.481 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 2.5 p -90.9 136.39 33.11 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.472 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -163.38 52.05 0.16 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.551 0.691 . . . . 0.0 110.123 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.939 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 47.0 t80 -167.05 -65.27 0.01 OUTLIER Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.142 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.939 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 2.9 Cg_endo -84.71 -23.73 2.55 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.136 1.891 . . . . 0.0 111.667 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.53 ' HA ' HG12 ' A' ' 37' ' ' VAL . 24.8 m -155.67 150.95 26.85 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.366 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.8 pt -110.3 143.58 28.36 Favored Pre-proline 0 C--N 1.323 -0.554 0 O-C-N 123.124 0.265 . . . . 0.0 110.821 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 17' ' ' CYS . 61.2 Cg_endo -75.22 78.26 3.0 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.862 2.375 . . . . 0.0 112.176 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.549 HD13 ' HD2' ' A' ' 35' ' ' ARG . 36.4 pt -62.37 -37.64 79.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.976 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.404 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -131.99 -160.56 9.77 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.853 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 28' ' ' SER . 37.5 ttm180 -140.28 119.7 13.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.852 0.358 . . . . 0.0 111.002 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 2' ' ' PHE . 56.2 m -83.56 -36.68 23.8 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.413 ' O ' ' HG3' ' A' ' 26' ' ' ARG . 47.4 m -159.9 172.66 17.21 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.165 -1.421 . . . . 0.0 107.165 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.9 tpp85 -56.07 -46.45 78.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 118.326 0.512 . . . . 0.0 111.097 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.512 ' CD2' ' HB2' ' A' ' 14' ' ' ARG . 8.6 t80 -87.61 -35.72 17.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.751 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.619 ' HA ' ' HA ' ' A' ' 14' ' ' ARG . 16.7 t -85.6 107.27 16.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.325 0.583 . . . . 0.0 111.916 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -85.95 153.73 21.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.96 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 37.6 t -97.16 85.9 3.82 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 20.5 m -82.44 117.63 22.62 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.642 -177.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.549 ' HD2' HD13 ' A' ' 24' ' ' ILE . 51.5 ttt85 -89.11 127.28 35.7 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.544 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -58.9 129.35 41.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.021 0.439 . . . . 0.0 111.017 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.53 HG12 ' HA ' ' A' ' 21' ' ' SER . 13.6 p -152.68 42.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 122.504 1.145 . . . . 0.0 109.601 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 4.6 t90 . . . . . 0 C--O 1.247 0.97 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.403 179.612 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.05 -34.95 89.84 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.564 -0.351 . . . . 0.0 113.062 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 92.0 mt -73.61 -2.38 22.73 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.6 t -137.58 -157.67 0.8 Allowed 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 6' ' ' ARG . 40.9 ttm180 56.01 30.2 15.75 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.802 0.81 . . . . 0.0 109.819 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.9 mt -74.86 -52.76 10.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.701 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 39.3 mtp85 -95.93 -55.38 3.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.383 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 45.3 ttt-85 -174.19 39.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.494 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.71 121.16 5.34 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.177 -1.011 . . . . 0.0 110.908 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.656 ' HE2' ' HG2' ' A' ' 36' ' ' ARG . 35.2 p90 -104.11 139.2 39.52 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.246 0.546 . . . . 0.0 110.746 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 61.1 m -76.12 126.4 30.92 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.646 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.489 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -123.76 136.75 54.61 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.093 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -70.1 120.44 15.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.247 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.84 -130.07 16.75 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.945 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 78.2 mtt-85 -76.8 146.96 37.5 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.899 0.38 . . . . 0.0 111.83 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 82.7 m -67.19 150.25 49.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.358 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.432 ' H ' ' HD2' ' A' ' 18' ' ' ARG . 1.1 mpt_? -68.49 163.51 23.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.241 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.753 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 30.4 t80 -46.86 -59.12 5.66 Favored Pre-proline 0 CA--C 1.543 0.674 0 O-C-N 123.648 0.592 . . . . 0.0 112.521 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.753 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 4.1 Cg_endo -86.53 46.87 1.61 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.36 2.04 . . . . 0.0 112.142 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.9 m -151.32 130.47 12.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.551 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.3 pt -104.65 139.16 19.83 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-O 120.983 0.42 . . . . 0.0 111.118 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.54 75.54 5.0 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 123.08 2.52 . . . . 0.0 112.798 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.9 pt -63.75 -30.13 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.103 0.478 . . . . 0.0 111.008 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -162.91 -172.99 31.08 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.6 mtm-85 -111.96 132.4 54.79 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.917 0.359 . . . . 0.0 110.507 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.503 ' HB3' HG12 ' A' ' 31' ' ' VAL . 35.0 t -77.77 -34.6 52.27 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.5 t -146.61 -141.85 0.12 Allowed 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.406 ' HA ' ' HD2' ' A' ' 29' ' ' ARG . 9.0 tpt180 -83.67 -57.52 3.19 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.638 -0.425 . . . . 0.0 109.973 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -93.29 -38.53 11.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.773 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.503 HG12 ' HB3' ' A' ' 27' ' ' CYS . 84.5 t -68.64 117.06 10.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.155 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -89.0 160.46 17.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.829 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 30.5 t -103.98 69.14 0.93 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.489 ' SG ' ' HB3' ' A' ' 13' ' ' ALA . 13.3 m -63.73 131.05 46.67 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.44 -1.255 . . . . 0.0 112.509 -177.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -107.68 138.55 43.71 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.264 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.656 ' HG2' ' HE2' ' A' ' 11' ' ' PHE . 22.5 mmt85 -62.02 150.24 38.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.993 0.425 . . . . 0.0 110.449 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.1 p -139.23 37.82 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 122.478 1.132 . . . . 0.0 109.57 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 12.3 m0 . . . . . 0 C--O 1.249 1.062 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.503 179.872 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.698 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 40.7 p90 . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 110.612 -0.144 . . . . 0.0 110.612 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -55.39 -49.6 63.63 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.538 -0.363 . . . . 0.0 113.19 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.28 -40.59 96.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.244 0.545 . . . . 0.0 110.19 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.608 ' SG ' ' HA3' ' A' ' 10' ' ' GLY . 47.7 t -62.96 -40.93 99.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.262 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.698 ' HG2' ' O ' ' A' ' 2' ' ' PHE . 20.9 mmt85 -59.91 -41.72 92.3 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.949 0.404 . . . . 0.0 110.565 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.3 mt -63.18 -34.82 78.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.18 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.2 ttm180 -86.64 10.69 14.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.04 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? 62.68 41.69 8.99 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.762 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.608 ' HA3' ' SG ' ' A' ' 5' ' ' CYS . . . -94.95 136.16 12.79 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 178.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -94.6 133.1 38.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.098 0.475 . . . . 0.0 110.862 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 85.4 m -78.45 108.84 12.11 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.836 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -103.44 128.59 50.57 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.967 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -72.28 111.88 7.87 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.0 0.428 . . . . 0.0 111.382 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.45 -58.86 3.72 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.76 -0.655 . . . . 0.0 113.659 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.5 mmm-85 -145.71 146.68 31.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.928 0.394 . . . . 0.0 111.663 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.7 m -76.25 125.68 29.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.993 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -90.45 45.88 1.3 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.712 0.768 . . . . 0.0 109.567 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -171.47 146.62 1.97 Allowed Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 114.35 -1.296 . . . . 0.0 107.908 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -63.24 60.44 0.17 Allowed 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.67 2.913 . . . . 0.0 113.944 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 57.8 m -127.02 129.73 48.62 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.7 pt -81.09 138.79 49.16 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 121.136 0.493 . . . . 0.0 111.691 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.64 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 65.8 Cg_endo -81.0 116.3 3.1 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.657 2.238 . . . . 0.0 111.427 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 25.5 pt -78.85 -30.31 14.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.988 0.423 . . . . 0.0 111.303 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -164.46 153.89 24.42 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -70.13 135.98 49.7 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.055 0.455 . . . . 0.0 110.975 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 34.9 t -80.96 -31.02 35.03 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.7 t -147.55 -140.44 0.1 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.315 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -86.44 -49.69 7.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.938 0.399 . . . . 0.0 110.298 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -103.15 -35.29 8.54 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 57.9 t -70.42 123.63 24.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.3 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -95.22 -177.56 4.16 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.481 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.5 t -139.92 107.73 5.67 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.64 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 0.7 OUTLIER -94.75 128.88 41.77 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.554 -176.266 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 61.7 ttt-85 -97.65 134.34 40.97 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.235 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.2 tpp85 -65.23 132.4 49.0 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.03 44.13 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 121.84 0.828 . . . . 0.0 111.32 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.931 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.126 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.434 ' HB3' ' HA ' ' A' ' 27' ' ' CYS . 15.8 p90 . . . . . 0 CA--C 1.526 0.035 0 CA-C-O 120.575 0.226 . . . . 0.0 111.57 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -60.29 -52.89 49.9 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.893 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.466 HD12 ' N ' ' A' ' 5' ' ' CYS . 4.0 pp -71.47 -35.02 70.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.723 0.296 . . . . 0.0 111.127 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.517 ' SG ' ' HA3' ' A' ' 10' ' ' GLY . 26.7 t -66.65 -32.78 74.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.104 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -57.85 -38.43 75.65 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.136 0.494 . . . . 0.0 110.26 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.7 mt -67.64 -37.62 82.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.089 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -76.91 -5.71 49.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.591 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 69.02 29.56 4.76 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.726 0.81 . . . . 0.0 112.171 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.517 ' HA3' ' SG ' ' A' ' 5' ' ' CYS . . . -76.19 137.93 21.93 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -96.41 142.08 28.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 117.471 0.635 . . . . 0.0 111.222 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 75.7 m -80.73 124.7 29.25 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.326 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.629 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . . . -130.83 111.78 12.43 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.28 0.562 . . . . 0.0 110.05 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.488 ' HG3' HG22 ' A' ' 31' ' ' VAL . 16.9 ttm180 -74.61 134.67 42.06 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.342 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.12 42.27 51.58 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.167 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 69.61 149.22 0.07 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.563 0.697 . . . . 0.0 111.595 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.629 ' SG ' ' HB3' ' A' ' 13' ' ' ALA . 3.2 m -90.11 -172.48 3.5 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.917 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 68.2 mtm-85 -80.48 -178.84 6.88 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.925 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.477 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 85.6 t80 -65.79 -55.34 23.41 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.477 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 72.2 Cg_endo -75.06 46.12 1.49 Allowed 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.179 1.92 . . . . 0.0 113.464 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.469 ' HA ' HG23 ' A' ' 37' ' ' VAL . 24.5 p -158.98 116.29 2.77 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.928 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.0 pt -96.02 138.49 21.65 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 120.92 0.391 . . . . 0.0 111.121 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 37.5 Cg_endo -74.91 77.71 3.03 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.843 2.362 . . . . 0.0 112.676 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.611 HD13 ' HB2' ' A' ' 35' ' ' ARG . 47.8 pt -62.94 -27.41 43.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.392 0.615 . . . . 0.0 110.27 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -156.28 -167.82 18.18 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.574 ' HD2' ' O ' ' A' ' 29' ' ' ARG . 83.7 mtm180 -141.33 135.57 30.66 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.434 ' HA ' ' HB3' ' A' ' 2' ' ' PHE . 47.7 m -68.2 -51.41 45.93 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.794 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.6 m -115.65 -62.94 1.52 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.934 0.397 . . . . 0.0 110.678 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.574 ' O ' ' HD2' ' A' ' 26' ' ' ARG . 8.1 tpp180 -172.83 -60.91 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.436 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -80.14 -40.32 27.63 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.488 HG22 ' HG3' ' A' ' 14' ' ' ARG . 61.3 t -70.16 114.73 8.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.282 178.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -77.06 154.48 33.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.324 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 12.8 t -122.3 69.46 0.96 Allowed 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 56.1 m -74.63 137.61 42.38 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.781 -1.099 . . . . 0.0 113.214 -176.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.611 ' HB2' HD13 ' A' ' 24' ' ' ILE . 25.3 ttm-85 -88.09 138.01 31.83 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.385 177.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -65.95 131.58 46.57 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.122 0.487 . . . . 0.0 110.502 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.469 HG23 ' HA ' ' A' ' 21' ' ' SER . 12.1 t -108.36 60.25 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.325 0.583 . . . . 0.0 110.052 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.518 -0.753 . . . . 0.0 111.032 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.704 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 16.5 t80 . . . . . 0 C--O 1.227 -0.093 0 N-CA-C 111.381 0.141 . . . . 0.0 111.381 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -56.55 -52.37 50.68 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.424 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.485 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 3.1 tm? -60.68 -43.01 98.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.027 0.442 . . . . 0.0 109.843 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 53.3 t -61.75 -46.41 89.72 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.382 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 62.7 ttt-85 -65.39 -44.03 88.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.778 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 4' ' ' LEU . 4.2 pp -66.26 -32.83 74.49 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.253 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -85.51 -2.37 58.07 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.609 0.242 . . . . 0.0 110.649 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 70.0 mtm180 61.91 42.89 9.77 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.488 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.71 147.1 19.21 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -81.88 134.11 35.38 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 117.211 0.506 . . . . 0.0 109.771 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.785 ' SG ' HG12 ' A' ' 31' ' ' VAL . 9.4 t -107.91 132.59 53.31 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -125.37 142.31 51.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.016 0.436 . . . . 0.0 111.805 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.557 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 15.1 ptp180 -70.2 126.2 28.97 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.19 129.22 4.34 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.757 ' HG2' ' HG3' ' A' ' 32' ' ' GLN . 73.5 mtt180 -60.75 114.78 3.21 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.983 0.42 . . . . 0.0 111.918 -178.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 21' ' ' SER . 3.7 m -72.03 150.53 43.9 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -154.93 56.83 0.67 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.021 -0.672 . . . . 0.0 111.736 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.889 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 36.2 t80 -166.39 -66.9 0.01 OUTLIER Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.144 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.889 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 94.3 Cg_endo -90.26 -20.84 0.98 Allowed 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.974 1.783 . . . . 0.0 112.267 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 38.3 m -154.27 148.41 25.83 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.493 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.543 HG12 HG21 ' A' ' 37' ' ' VAL . 36.6 pt -117.23 144.4 33.74 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 120.572 0.225 . . . . 0.0 110.916 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.771 ' HB3' ' HB3' ' A' ' 32' ' ' GLN . 11.5 Cg_exo -68.99 104.15 1.15 Allowed 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.675 2.25 . . . . 0.0 112.013 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.553 HD13 ' HD3' ' A' ' 35' ' ' ARG . 36.5 pt -88.6 -32.98 6.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.065 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -137.93 144.85 16.27 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.066 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 28' ' ' SER . 17.1 ttm105 -88.41 122.18 31.62 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.707 0.289 . . . . 0.0 111.563 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.704 ' HA ' ' HB2' ' A' ' 2' ' ' PHE . 26.9 m -88.89 -38.97 14.13 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.42 ' O ' ' HG3' ' A' ' 26' ' ' ARG . 17.1 t -154.59 -161.34 1.2 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.045 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 43.7 ttt-85 -65.14 -53.18 49.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.088 0.47 . . . . 0.0 111.051 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -98.47 -35.6 10.21 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.686 -178.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.785 HG12 ' SG ' ' A' ' 12' ' ' CYS . 1.8 t -71.12 116.64 13.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.138 -178.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.771 ' HB3' ' HB3' ' A' ' 23' ' ' PRO . 15.0 mm100 -116.38 139.99 49.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.808 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 47.9 t -85.3 93.97 8.82 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 23.2 m -84.3 109.65 17.97 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.683 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.553 ' HD3' HD13 ' A' ' 24' ' ' ILE . 46.6 ttp180 -76.26 138.55 40.65 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.265 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -56.5 125.51 22.4 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 123.438 0.461 . . . . 0.0 111.583 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.543 HG21 HG12 ' A' ' 22' ' ' ILE . 29.4 t -126.31 77.96 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.851 0.834 . . . . 0.0 109.23 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 14.3 t-105 . . . . . 0 C--O 1.251 1.153 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.226 179.945 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.712 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 60.4 m-85 . . . . . 0 N--CA 1.454 -0.225 0 CA-C-O 120.514 0.197 . . . . 0.0 110.678 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -56.49 -26.75 52.71 Favored Glycine 0 C--N 1.336 0.531 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 42.0 tp -160.07 75.66 0.61 Allowed 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 10' ' ' GLY . 0.1 OUTLIER -58.49 142.47 48.73 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.676 -178.641 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.425 ' O ' ' HB2' ' A' ' 7' ' ' LEU . 69.8 mtt85 -41.65 -31.23 0.27 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -176.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 73.0 mt 72.25 -45.12 0.61 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.137 0.575 . . . . 0.0 110.636 -178.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -68.45 -41.74 79.79 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.2 ttt-85 -91.33 -65.44 1.01 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.801 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.765 ' HA2' ' HA ' ' A' ' 35' ' ' ARG . . . -123.96 123.53 5.22 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 178.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -109.04 131.23 55.27 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.016 0.436 . . . . 0.0 110.806 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.623 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -85.17 126.02 33.3 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.959 0.409 . . . . 0.0 110.545 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.475 ' O ' ' HA ' ' A' ' 31' ' ' VAL . . . -129.34 143.21 50.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.821 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.523 ' HA ' HG22 ' A' ' 31' ' ' VAL . 28.6 ttp-105 -62.62 126.95 29.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.046 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.15 -129.98 13.26 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.122 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -100.52 132.62 45.8 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.451 ' SG ' ' HB3' ' A' ' 13' ' ' ALA . 58.1 m -71.25 118.07 13.58 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.168 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -83.58 58.62 4.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.643 0.735 . . . . 0.0 109.949 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.584 ' CD1' ' HD2' ' A' ' 20' ' ' PRO . 37.3 t80 -167.94 138.58 2.26 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.809 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.584 ' HD2' ' CD1' ' A' ' 19' ' ' PHE . 10.0 Cg_endo -53.99 83.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 124.067 3.178 . . . . 0.0 112.96 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.85 ' HA ' HG12 ' A' ' 37' ' ' VAL . 57.4 m -158.62 121.39 3.71 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.101 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.1 pt -82.99 138.52 42.84 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-O 121.131 0.491 . . . . 0.0 111.558 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.769 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 46.6 Cg_endo -76.04 111.66 3.32 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.384 2.056 . . . . 0.0 112.196 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.405 HD13 ' HB2' ' A' ' 35' ' ' ARG . 16.8 pt -79.01 -24.06 12.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.512 0.672 . . . . 0.0 110.264 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.712 ' HA3' ' CE1' ' A' ' 2' ' ' PHE . . . -158.03 -165.82 16.2 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.111 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 32' ' ' GLN . 44.3 ttp180 -148.58 124.19 10.44 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.876 0.338 . . . . 0.0 110.123 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 40.2 m -74.66 -52.23 12.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.871 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.9 m -114.55 -147.98 0.42 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.413 ' O ' ' HD2' ' A' ' 26' ' ' ARG . 14.7 tpp180 -84.82 -46.03 11.75 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -95.69 -42.99 8.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.826 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.533 HG12 ' SG ' ' A' ' 12' ' ' CYS . 28.7 t -64.04 109.35 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.777 -178.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.623 ' O ' ' HA ' ' A' ' 12' ' ' CYS . 51.5 mt-30 -104.5 147.31 27.73 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.601 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 52.5 t -92.34 84.95 5.25 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.769 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 59.3 m -77.49 116.08 17.77 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.212 -178.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.765 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 59.3 ttp85 -80.19 135.42 36.27 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.73 178.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 18.1 tpp85 -60.65 125.48 23.87 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.228 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.85 HG12 ' HA ' ' A' ' 21' ' ' SER . 11.8 p -132.73 39.35 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 122.652 1.215 . . . . 0.0 108.721 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 2.3 t90 . . . . . 0 C--O 1.243 0.752 0 CA-C-N 114.495 -1.229 . . . . 0.0 108.943 179.791 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.43 ' CG ' ' HA ' ' A' ' 27' ' ' CYS . 88.3 m-85 . . . . . 0 N--CA 1.466 0.349 0 CA-C-O 121.039 0.447 . . . . 0.0 111.969 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.18 -42.49 3.48 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 80.1 mt -108.24 41.4 1.56 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.614 ' HA ' ' HG2' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -64.02 -29.49 70.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.592 -178.44 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 72.3 mtp85 -66.66 -47.81 71.33 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.425 HD12 ' N ' ' A' ' 8' ' ' ARG . 4.5 pp -77.81 -32.53 52.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.614 ' HG2' ' HA ' ' A' ' 5' ' ' CYS . 6.5 ptm85 -63.61 -50.62 68.67 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.159 -0.616 . . . . 0.0 109.504 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.556 ' HB2' ' O ' ' A' ' 8' ' ' ARG . 36.0 ttm180 163.51 97.16 0.0 OUTLIER 'General case' 0 C--O 1.235 0.306 0 O-C-N 124.01 0.819 . . . . 0.0 109.978 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.545 ' O ' ' HA ' ' A' ' 6' ' ' ARG . . . 127.74 -143.16 14.14 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.596 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.405 ' HE2' ' HG2' ' A' ' 36' ' ' ARG . 53.7 p90 -175.39 138.59 0.42 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.499 ' SG ' HG12 ' A' ' 31' ' ' VAL . 45.6 t -89.38 123.61 33.7 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.492 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -122.97 135.43 54.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.821 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.639 ' HA ' HG13 ' A' ' 31' ' ' VAL . 54.6 ttm-85 -75.53 133.2 41.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.026 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.24 -60.03 4.85 Favored Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.292 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.419 ' CZ ' ' HB2' ' A' ' 16' ' ' ARG . 2.3 ptm85 -173.79 173.19 3.35 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.7 m -112.29 -171.07 1.78 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.958 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -91.27 178.42 5.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.913 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.576 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 36.2 t80 -59.66 -52.85 71.01 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.576 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 10.1 Cg_exo -72.49 40.88 0.49 Allowed 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.39 2.06 . . . . 0.0 113.671 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.7 p -161.83 123.42 2.79 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.206 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.404 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 45.9 pt -102.84 141.67 22.97 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 120.79 0.328 . . . . 0.0 111.115 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 22' ' ' ILE . 18.9 Cg_exo -64.11 118.69 5.63 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.675 2.25 . . . . 0.0 111.714 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.515 HG12 ' O ' ' A' ' 33' ' ' CYS . 15.8 pt -101.85 -23.83 4.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.529 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 177.25 143.79 5.06 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.892 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.409 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 66.0 mtt85 -74.4 135.05 42.4 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.43 ' HA ' ' CG ' ' A' ' 2' ' ' PHE . 8.4 m -72.22 -34.53 68.41 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.1 m -141.15 -57.02 0.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.617 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.409 ' HA ' ' HD3' ' A' ' 26' ' ' ARG . 34.9 ttm105 -172.24 -66.47 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.01 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -76.6 -41.26 46.79 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.639 HG13 ' HA ' ' A' ' 14' ' ' ARG . 2.5 t -71.23 126.58 31.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.142 178.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -117.39 151.72 36.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.758 0.313 . . . . 0.0 111.514 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.515 ' O ' HG12 ' A' ' 24' ' ' ILE . 42.4 t -107.63 120.47 42.32 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 176.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.8 m -118.97 118.62 32.0 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.888 -0.725 . . . . 0.0 112.021 -177.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.437 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 28.3 ttm180 -70.91 130.71 42.33 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.932 178.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.554 ' HB2' ' CE3' ' A' ' 38' ' ' TRP . 25.6 mtp-105 -63.71 138.68 58.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.278 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 t -80.55 53.43 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.549 0.69 . . . . 0.0 110.243 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.554 ' CE3' ' HB2' ' A' ' 36' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.583 -0.723 . . . . 0.0 110.559 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 37.3 p90 . . . . . 0 C--O 1.225 -0.228 0 CA-C-O 120.33 0.109 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -52.1 -43.13 55.99 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 116.392 -0.367 . . . . 0.0 113.791 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.437 ' O ' ' HB2' ' A' ' 8' ' ' ARG . 3.4 mm? -65.87 -48.08 72.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.017 0.436 . . . . 0.0 111.287 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -69.91 -32.78 71.27 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.583 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.557 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 62.4 ttt-85 -54.84 -37.67 66.46 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -178.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.545 HD22 HH11 ' A' ' 6' ' ' ARG . 1.9 pt? -151.23 -33.09 0.15 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 119.769 -0.772 . . . . 0.0 112.859 -178.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 4' ' ' LEU . 26.1 mmm180 -62.15 -28.39 69.62 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 121.233 -0.187 . . . . 0.0 111.169 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 41.6 mtm105 -141.66 35.41 1.62 Allowed 'General case' 0 C--O 1.233 0.198 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 7' ' ' LEU . . . 150.83 -144.52 11.89 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.057 -1.068 . . . . 0.0 112.969 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.557 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 22.8 p90 -159.62 148.65 17.93 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.517 ' SG ' ' HA ' ' A' ' 6' ' ' ARG . 62.7 m -87.97 142.06 28.09 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.083 0.468 . . . . 0.0 111.871 -178.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.458 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -134.6 133.34 40.07 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.593 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 57.3 ttt85 -82.78 116.32 22.08 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.98 -67.4 1.12 Allowed Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.561 -0.745 . . . . 0.0 113.919 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.65 134.42 54.74 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.607 0.241 . . . . 0.0 110.69 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.5 m -81.36 164.31 22.23 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 -69.07 167.6 15.67 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.62 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 41.6 t80 -50.88 -55.47 27.23 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.62 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 57.2 Cg_endo -88.57 51.98 1.8 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.169 1.912 . . . . 0.0 113.509 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.5 p -156.67 144.7 19.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.923 0.392 . . . . 0.0 111.629 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.575 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 25.8 pt -124.51 142.73 41.23 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.309 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.94 70.94 3.53 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 123.253 2.635 . . . . 0.0 113.153 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.542 HD13 ' HD3' ' A' ' 35' ' ' ARG . 40.7 pt -63.66 -35.36 72.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.9 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.403 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -139.69 -148.98 5.3 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.936 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.493 ' HA ' ' HA ' ' A' ' 32' ' ' GLN . 19.1 ttp-105 -155.26 136.43 13.9 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.97 0.385 . . . . 0.0 110.765 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.6 m -97.35 -35.02 10.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.896 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.6 t -138.77 -146.61 0.21 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -81.18 -52.66 7.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.072 0.463 . . . . 0.0 110.033 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -98.27 -33.24 11.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.672 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 14' ' ' ARG . 41.6 t -70.9 114.47 8.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.194 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 26' ' ' ARG . 55.0 mt-30 -96.35 161.51 13.9 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.398 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.6 t -94.76 100.77 12.62 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 176.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 22' ' ' ILE . 6.8 m -108.36 94.39 5.04 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.313 -177.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.542 ' HD3' HD13 ' A' ' 24' ' ' ILE . 29.9 ptt180 -69.58 144.75 52.95 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.881 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.426 ' C ' ' H ' ' A' ' 38' ' ' TRP . 57.6 ttt180 -69.69 129.77 40.53 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.4 m -75.89 37.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 122.545 0.338 . . . . 0.0 111.691 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.426 ' H ' ' C ' ' A' ' 36' ' ' ARG . 30.2 t-105 . . . . . 0 C--O 1.251 1.154 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.228 178.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.646 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 4.9 m-30 . . . . . 0 CA--C 1.522 -0.115 0 CA-C-O 121.055 0.455 . . . . 0.0 109.945 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.17 39.75 31.15 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.455 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 30.4 tp 60.77 28.62 18.36 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.756 0.789 . . . . 0.0 109.918 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.62 ' HA ' ' HG3' ' A' ' 9' ' ' ARG . 4.0 t -97.78 -177.2 3.69 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.355 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 68.96 -37.16 0.36 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.812 0.845 . . . . 0.0 113.043 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.8 mt -53.47 -63.97 0.98 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.034 0.445 . . . . 0.0 110.683 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -137.79 29.12 2.61 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.657 ' HB3' HD11 ' A' ' 24' ' ' ILE . 29.6 mmm180 -108.46 -53.97 2.57 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.684 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.83 -144.28 5.19 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.049 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -133.55 142.24 48.09 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.005 0.431 . . . . 0.0 110.606 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.424 ' HB3' ' CG1' ' A' ' 31' ' ' VAL . 75.4 m -78.05 121.34 24.13 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.195 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.49 138.72 52.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.489 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -80.06 52.84 1.6 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.406 0.622 . . . . 0.0 110.415 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -174.83 148.54 9.75 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.394 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.61 ' HA ' ' HG3' ' A' ' 32' ' ' GLN . 89.2 mtm180 -75.41 87.73 2.59 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.06 0.457 . . . . 0.0 110.642 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.6 m -61.96 135.56 57.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.197 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -163.08 46.32 0.13 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.829 0.823 . . . . 0.0 109.996 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.825 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 31.8 t80 -172.84 -61.89 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.111 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.825 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 75.5 Cg_endo -91.79 8.69 2.99 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.042 1.828 . . . . 0.0 112.383 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.3 t 179.52 148.72 0.27 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 18.5 pt -106.68 137.87 19.6 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.165 0.507 . . . . 0.0 111.273 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.75 72.58 6.44 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 123.174 2.583 . . . . 0.0 112.319 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.657 HD11 ' HB3' ' A' ' 9' ' ' ARG . 40.3 pt -65.37 -23.22 32.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.435 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -146.13 -166.01 11.81 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.803 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 23.5 ttp-105 -142.97 123.79 14.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.825 0.345 . . . . 0.0 111.041 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.646 ' HA ' ' HA ' ' A' ' 2' ' ' PHE . 36.3 m -87.22 -40.57 14.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.49 0.662 . . . . 0.0 109.368 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.489 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 35.3 m -153.25 165.38 35.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.652 -1.158 . . . . 0.0 107.99 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.0 tpp180 -51.44 -48.08 62.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.712 0.233 . . . . 0.0 111.528 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -99.39 20.87 12.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.815 0.341 . . . . 0.0 111.582 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.489 ' HB ' ' HB2' ' A' ' 28' ' ' SER . 57.3 t -138.07 101.65 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.015 0.436 . . . . 0.0 110.586 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.61 ' HG3' ' HA ' ' A' ' 16' ' ' ARG . 15.0 mm100 -80.36 146.47 31.52 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.814 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 49.4 t -93.06 73.91 4.72 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 22' ' ' ILE . 7.7 m -70.75 120.23 16.05 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.43 -1.259 . . . . 0.0 113.184 -176.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.56 ' HD2' HG21 ' A' ' 24' ' ' ILE . 16.4 ttm180 -95.82 132.4 41.11 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.539 177.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -64.15 130.54 44.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.943 0.401 . . . . 0.0 110.89 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.63 52.37 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 1.6 t90 . . . . . 0 C--O 1.246 0.907 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.322 -178.735 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.44 ' CD2' ' HB3' ' A' ' 27' ' ' CYS . 2.5 m-85 . . . . . 0 C--O 1.233 0.206 0 CA-C-O 121.096 0.474 . . . . 0.0 110.328 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -63.12 -30.34 77.18 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.805 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.4 mp -114.1 52.66 0.82 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.822 0.344 . . . . 0.0 110.213 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.497 ' C ' ' H ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -56.42 145.92 26.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.618 -179.628 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.595 ' HD2' HD12 ' A' ' 24' ' ' ILE . 47.6 ttt85 71.11 -19.19 0.25 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.435 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.497 ' H ' ' C ' ' A' ' 5' ' ' CYS . 69.6 mt 72.26 -28.62 0.19 Allowed 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.305 1.042 . . . . 0.0 113.108 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -78.47 53.59 1.31 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.285 0.564 . . . . 0.0 110.493 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 69.0 mtt85 60.76 45.5 9.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.036 -0.984 . . . . 0.0 112.002 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.12 154.81 16.35 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -145.93 139.73 26.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 118.097 0.948 . . . . 0.0 112.195 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.783 ' HB3' HG12 ' A' ' 31' ' ' VAL . 12.3 m -91.16 128.63 37.06 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.216 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.82 140.61 50.51 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.292 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.8 mtm-85 -72.77 142.7 48.11 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.414 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.58 -100.2 2.64 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.039 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -163.54 154.92 16.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.997 0.427 . . . . 0.0 111.484 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.25 129.67 33.99 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -162.56 57.03 0.22 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.203 0.525 . . . . 0.0 110.996 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.905 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 69.5 t80 -159.79 -63.01 0.02 OUTLIER Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.881 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.905 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 3.7 Cg_endo -84.92 -36.04 0.15 Allowed 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.136 1.891 . . . . 0.0 111.272 178.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.438 ' H ' ' HD2' ' A' ' 20' ' ' PRO . 22.6 m -139.27 144.15 38.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.294 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.468 HG12 HG21 ' A' ' 37' ' ' VAL . 38.5 pt -95.07 146.05 30.64 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.518 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -69.39 101.32 0.85 Allowed 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.49 2.127 . . . . 0.0 112.487 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.595 HD12 ' HD2' ' A' ' 6' ' ' ARG . 45.1 pt -84.23 -29.07 7.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.457 0.646 . . . . 0.0 110.054 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -166.68 -145.73 4.58 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.419 ' CB ' ' HA ' ' A' ' 32' ' ' GLN . 40.4 ptt180 -170.99 140.79 1.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 117.869 0.834 . . . . 0.0 112.273 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.44 ' HB3' ' CD2' ' A' ' 2' ' ' PHE . 87.8 m -81.11 -32.75 33.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.507 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.6 m -145.81 171.75 14.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.262 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -50.91 -51.48 51.52 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.35 0.406 . . . . 0.0 112.034 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -105.63 29.8 6.27 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.9 0.381 . . . . 0.0 110.93 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.783 HG12 ' HB3' ' A' ' 12' ' ' CYS . 31.9 t -136.59 80.51 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.419 ' HA ' ' CB ' ' A' ' 26' ' ' ARG . 25.6 mt-30 -71.67 142.83 49.87 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.183 -178.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.497 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 41.9 t -94.29 106.23 18.21 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 177.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 83.9 m -115.88 92.24 3.84 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.174 0.512 . . . . 0.0 110.575 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 73.7 ttt-85 -66.35 139.56 58.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.04 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -64.17 124.76 22.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.257 0.551 . . . . 0.0 110.596 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.468 HG21 HG12 ' A' ' 22' ' ' ILE . 16.9 t -114.87 65.96 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.513 0.673 . . . . 0.0 109.907 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 63.4 p-90 . . . . . 0 C--O 1.252 1.19 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.322 -179.603 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.448 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 5.1 p90 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.716 0.293 . . . . 0.0 111.419 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -60.34 -39.77 96.59 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.289 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 pp -88.72 38.75 0.89 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.01 0.433 . . . . 0.0 111.113 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.417 ' C ' ' H ' ' A' ' 7' ' ' LEU . 3.0 t -151.35 167.67 27.19 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.238 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 25.3 tpp180 70.24 -35.69 0.33 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.603 0.761 . . . . 0.0 112.22 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.417 ' H ' ' C ' ' A' ' 5' ' ' CYS . 59.5 mt -82.82 62.88 6.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.178 0.513 . . . . 0.0 110.978 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 43.8 mtm-85 72.72 -22.61 0.22 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.585 -1.188 . . . . 0.0 112.429 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.405 ' H ' ' C ' ' A' ' 7' ' ' LEU . 24.1 tpp180 -64.91 -31.34 72.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.358 0.599 . . . . 0.0 110.389 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.11 -147.03 9.69 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -155.43 138.14 15.2 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.163 0.506 . . . . 0.0 110.172 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.61 ' HB3' ' CG1' ' A' ' 31' ' ' VAL . 81.8 m -77.04 130.16 37.05 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.102 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -138.48 123.68 19.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.659 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.619 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 18.5 ptp180 -74.57 137.47 42.39 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.181 0.515 . . . . 0.0 110.892 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.14 -121.0 5.08 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 -161.31 112.2 1.73 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.507 0.67 . . . . 0.0 110.421 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.481 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 2.5 p -90.9 136.39 33.11 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.472 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -163.38 52.05 0.16 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.551 0.691 . . . . 0.0 110.123 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.939 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 47.0 t80 -167.05 -65.27 0.01 OUTLIER Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.142 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.939 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 2.9 Cg_endo -84.71 -23.73 2.55 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.136 1.891 . . . . 0.0 111.667 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.53 ' HA ' HG12 ' A' ' 37' ' ' VAL . 24.8 m -155.67 150.95 26.85 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.366 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.8 pt -110.3 143.58 28.36 Favored Pre-proline 0 C--N 1.323 -0.554 0 O-C-N 123.124 0.265 . . . . 0.0 110.821 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 17' ' ' CYS . 61.2 Cg_endo -75.22 78.26 3.0 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.862 2.375 . . . . 0.0 112.176 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.549 HD13 ' HD2' ' A' ' 35' ' ' ARG . 36.4 pt -62.37 -37.64 79.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.976 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.404 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -131.99 -160.56 9.77 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.853 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 28' ' ' SER . 37.5 ttm180 -140.28 119.7 13.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.852 0.358 . . . . 0.0 111.002 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 2' ' ' PHE . 56.2 m -83.56 -36.68 23.8 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.413 ' O ' ' HG3' ' A' ' 26' ' ' ARG . 47.4 m -159.9 172.66 17.21 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.165 -1.421 . . . . 0.0 107.165 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.9 tpp85 -56.07 -46.45 78.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 118.326 0.512 . . . . 0.0 111.097 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.512 ' CD2' ' HB2' ' A' ' 14' ' ' ARG . 8.6 t80 -87.61 -35.72 17.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.751 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.619 ' HA ' ' HA ' ' A' ' 14' ' ' ARG . 16.7 t -85.6 107.27 16.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.325 0.583 . . . . 0.0 111.916 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -85.95 153.73 21.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.96 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 37.6 t -97.16 85.9 3.82 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 20.5 m -82.44 117.63 22.62 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.642 -177.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.549 ' HD2' HD13 ' A' ' 24' ' ' ILE . 51.5 ttt85 -89.11 127.28 35.7 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.544 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -58.9 129.35 41.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.021 0.439 . . . . 0.0 111.017 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.53 HG12 ' HA ' ' A' ' 21' ' ' SER . 13.6 p -152.68 42.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 122.504 1.145 . . . . 0.0 109.601 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 4.6 t90 . . . . . 0 C--O 1.247 0.97 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.403 179.612 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.476 0.845 0 CA-C-O 120.408 0.147 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 72.67 -50.62 0.7 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.691 0.796 . . . . 0.0 111.72 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.05 -34.95 89.84 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.564 -0.351 . . . . 0.0 113.062 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 92.0 mt -73.61 -2.38 22.73 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.6 t -137.58 -157.67 0.8 Allowed 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 6' ' ' ARG . 40.9 ttm180 56.01 30.2 15.75 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.802 0.81 . . . . 0.0 109.819 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.9 mt -74.86 -52.76 10.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.701 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 39.3 mtp85 -95.93 -55.38 3.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.383 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 45.3 ttt-85 -174.19 39.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.494 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.71 121.16 5.34 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.177 -1.011 . . . . 0.0 110.908 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.656 ' HE2' ' HG2' ' A' ' 36' ' ' ARG . 35.2 p90 -104.11 139.2 39.52 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.246 0.546 . . . . 0.0 110.746 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 61.1 m -76.12 126.4 30.92 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.646 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.489 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -123.76 136.75 54.61 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.093 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -70.1 120.44 15.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.247 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.84 -130.07 16.75 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.945 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 78.2 mtt-85 -76.8 146.96 37.5 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.899 0.38 . . . . 0.0 111.83 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 82.7 m -67.19 150.25 49.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.358 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.432 ' H ' ' HD2' ' A' ' 18' ' ' ARG . 1.1 mpt_? -68.49 163.51 23.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.241 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.753 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 30.4 t80 -46.86 -59.12 5.66 Favored Pre-proline 0 CA--C 1.543 0.674 0 O-C-N 123.648 0.592 . . . . 0.0 112.521 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.753 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 4.1 Cg_endo -86.53 46.87 1.61 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.36 2.04 . . . . 0.0 112.142 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.9 m -151.32 130.47 12.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.551 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.3 pt -104.65 139.16 19.83 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-O 120.983 0.42 . . . . 0.0 111.118 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.54 75.54 5.0 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 123.08 2.52 . . . . 0.0 112.798 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.9 pt -63.75 -30.13 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.103 0.478 . . . . 0.0 111.008 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -162.91 -172.99 31.08 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.6 mtm-85 -111.96 132.4 54.79 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.917 0.359 . . . . 0.0 110.507 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.503 ' HB3' HG12 ' A' ' 31' ' ' VAL . 35.0 t -77.77 -34.6 52.27 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.5 t -146.61 -141.85 0.12 Allowed 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.406 ' HA ' ' HD2' ' A' ' 29' ' ' ARG . 9.0 tpt180 -83.67 -57.52 3.19 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.638 -0.425 . . . . 0.0 109.973 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -93.29 -38.53 11.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.773 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.503 HG12 ' HB3' ' A' ' 27' ' ' CYS . 84.5 t -68.64 117.06 10.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.155 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -89.0 160.46 17.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.829 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 30.5 t -103.98 69.14 0.93 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.489 ' SG ' ' HB3' ' A' ' 13' ' ' ALA . 13.3 m -63.73 131.05 46.67 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.44 -1.255 . . . . 0.0 112.509 -177.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -107.68 138.55 43.71 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.264 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.656 ' HG2' ' HE2' ' A' ' 11' ' ' PHE . 22.5 mmt85 -62.02 150.24 38.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.993 0.425 . . . . 0.0 110.449 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.1 p -139.23 37.82 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 122.478 1.132 . . . . 0.0 109.57 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 12.3 m0 . . . . . 0 C--O 1.249 1.062 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.503 179.872 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 41.9 t . . . . . 0 N--CA 1.478 0.962 0 CA-C-O 120.769 0.319 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.698 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 40.7 p90 -91.98 -37.17 13.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.612 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -55.39 -49.6 63.63 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.538 -0.363 . . . . 0.0 113.19 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.28 -40.59 96.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.244 0.545 . . . . 0.0 110.19 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.608 ' SG ' ' HA3' ' A' ' 10' ' ' GLY . 47.7 t -62.96 -40.93 99.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.262 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.698 ' HG2' ' O ' ' A' ' 2' ' ' PHE . 20.9 mmt85 -59.91 -41.72 92.3 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.949 0.404 . . . . 0.0 110.565 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.3 mt -63.18 -34.82 78.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.18 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.2 ttm180 -86.64 10.69 14.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.04 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? 62.68 41.69 8.99 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.762 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.608 ' HA3' ' SG ' ' A' ' 5' ' ' CYS . . . -94.95 136.16 12.79 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 178.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -94.6 133.1 38.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.098 0.475 . . . . 0.0 110.862 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 85.4 m -78.45 108.84 12.11 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.836 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -103.44 128.59 50.57 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.967 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -72.28 111.88 7.87 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.0 0.428 . . . . 0.0 111.382 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.45 -58.86 3.72 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.76 -0.655 . . . . 0.0 113.659 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.5 mmm-85 -145.71 146.68 31.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.928 0.394 . . . . 0.0 111.663 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.7 m -76.25 125.68 29.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.993 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -90.45 45.88 1.3 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.712 0.768 . . . . 0.0 109.567 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -171.47 146.62 1.97 Allowed Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 114.35 -1.296 . . . . 0.0 107.908 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -63.24 60.44 0.17 Allowed 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.67 2.913 . . . . 0.0 113.944 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 57.8 m -127.02 129.73 48.62 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.7 pt -81.09 138.79 49.16 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 121.136 0.493 . . . . 0.0 111.691 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.64 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 65.8 Cg_endo -81.0 116.3 3.1 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.657 2.238 . . . . 0.0 111.427 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 25.5 pt -78.85 -30.31 14.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.988 0.423 . . . . 0.0 111.303 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -164.46 153.89 24.42 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -70.13 135.98 49.7 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.055 0.455 . . . . 0.0 110.975 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 34.9 t -80.96 -31.02 35.03 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.7 t -147.55 -140.44 0.1 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.315 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -86.44 -49.69 7.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.938 0.399 . . . . 0.0 110.298 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -103.15 -35.29 8.54 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 57.9 t -70.42 123.63 24.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.3 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -95.22 -177.56 4.16 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.481 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.5 t -139.92 107.73 5.67 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.64 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 0.7 OUTLIER -94.75 128.88 41.77 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.554 -176.266 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 61.7 ttt-85 -97.65 134.34 40.97 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.235 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.2 tpp85 -65.23 132.4 49.0 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.03 44.13 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 121.84 0.828 . . . . 0.0 111.32 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.931 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.126 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.6 m . . . . . 0 N--CA 1.478 0.925 0 CA-C-O 121.178 0.513 . . . . 0.0 110.698 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.434 ' HB3' ' HA ' ' A' ' 27' ' ' CYS . 15.8 p90 -68.73 -24.39 64.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.57 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -60.29 -52.89 49.9 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.893 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.466 HD12 ' N ' ' A' ' 5' ' ' CYS . 4.0 pp -71.47 -35.02 70.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.723 0.296 . . . . 0.0 111.127 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.517 ' SG ' ' HA3' ' A' ' 10' ' ' GLY . 26.7 t -66.65 -32.78 74.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.104 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -57.85 -38.43 75.65 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.136 0.494 . . . . 0.0 110.26 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.7 mt -67.64 -37.62 82.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.089 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -76.91 -5.71 49.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.591 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 69.02 29.56 4.76 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.726 0.81 . . . . 0.0 112.171 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.517 ' HA3' ' SG ' ' A' ' 5' ' ' CYS . . . -76.19 137.93 21.93 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -96.41 142.08 28.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 117.471 0.635 . . . . 0.0 111.222 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 75.7 m -80.73 124.7 29.25 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.326 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.629 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . . . -130.83 111.78 12.43 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.28 0.562 . . . . 0.0 110.05 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.488 ' HG3' HG22 ' A' ' 31' ' ' VAL . 16.9 ttm180 -74.61 134.67 42.06 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.342 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.12 42.27 51.58 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.167 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 69.61 149.22 0.07 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.563 0.697 . . . . 0.0 111.595 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.629 ' SG ' ' HB3' ' A' ' 13' ' ' ALA . 3.2 m -90.11 -172.48 3.5 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.917 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 68.2 mtm-85 -80.48 -178.84 6.88 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.925 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.477 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 85.6 t80 -65.79 -55.34 23.41 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.477 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 72.2 Cg_endo -75.06 46.12 1.49 Allowed 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.179 1.92 . . . . 0.0 113.464 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.469 ' HA ' HG23 ' A' ' 37' ' ' VAL . 24.5 p -158.98 116.29 2.77 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.928 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.0 pt -96.02 138.49 21.65 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 120.92 0.391 . . . . 0.0 111.121 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 37.5 Cg_endo -74.91 77.71 3.03 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.843 2.362 . . . . 0.0 112.676 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.611 HD13 ' HB2' ' A' ' 35' ' ' ARG . 47.8 pt -62.94 -27.41 43.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.392 0.615 . . . . 0.0 110.27 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -156.28 -167.82 18.18 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.574 ' HD2' ' O ' ' A' ' 29' ' ' ARG . 83.7 mtm180 -141.33 135.57 30.66 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.434 ' HA ' ' HB3' ' A' ' 2' ' ' PHE . 47.7 m -68.2 -51.41 45.93 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.794 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.6 m -115.65 -62.94 1.52 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.934 0.397 . . . . 0.0 110.678 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.574 ' O ' ' HD2' ' A' ' 26' ' ' ARG . 8.1 tpp180 -172.83 -60.91 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.436 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -80.14 -40.32 27.63 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.488 HG22 ' HG3' ' A' ' 14' ' ' ARG . 61.3 t -70.16 114.73 8.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.282 178.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -77.06 154.48 33.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.324 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 12.8 t -122.3 69.46 0.96 Allowed 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 56.1 m -74.63 137.61 42.38 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.781 -1.099 . . . . 0.0 113.214 -176.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.611 ' HB2' HD13 ' A' ' 24' ' ' ILE . 25.3 ttm-85 -88.09 138.01 31.83 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.385 177.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -65.95 131.58 46.57 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.122 0.487 . . . . 0.0 110.502 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.469 HG23 ' HA ' ' A' ' 21' ' ' SER . 12.1 t -108.36 60.25 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.325 0.583 . . . . 0.0 110.052 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.518 -0.753 . . . . 0.0 111.032 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 N--CA 1.478 0.94 0 N-CA-C 110.804 -0.073 . . . . 0.0 110.804 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.704 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 16.5 t80 -62.69 -38.69 91.39 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 111.381 0.141 . . . . 0.0 111.381 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -56.55 -52.37 50.68 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.424 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.485 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 3.1 tm? -60.68 -43.01 98.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.027 0.442 . . . . 0.0 109.843 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 53.3 t -61.75 -46.41 89.72 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.382 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 62.7 ttt-85 -65.39 -44.03 88.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.778 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 4' ' ' LEU . 4.2 pp -66.26 -32.83 74.49 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.253 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -85.51 -2.37 58.07 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.609 0.242 . . . . 0.0 110.649 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 70.0 mtm180 61.91 42.89 9.77 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.488 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.71 147.1 19.21 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -81.88 134.11 35.38 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 117.211 0.506 . . . . 0.0 109.771 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.785 ' SG ' HG12 ' A' ' 31' ' ' VAL . 9.4 t -107.91 132.59 53.31 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -125.37 142.31 51.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.016 0.436 . . . . 0.0 111.805 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.557 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 15.1 ptp180 -70.2 126.2 28.97 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.19 129.22 4.34 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.757 ' HG2' ' HG3' ' A' ' 32' ' ' GLN . 73.5 mtt180 -60.75 114.78 3.21 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.983 0.42 . . . . 0.0 111.918 -178.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 21' ' ' SER . 3.7 m -72.03 150.53 43.9 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -154.93 56.83 0.67 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.021 -0.672 . . . . 0.0 111.736 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.889 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 36.2 t80 -166.39 -66.9 0.01 OUTLIER Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.144 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.889 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 94.3 Cg_endo -90.26 -20.84 0.98 Allowed 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.974 1.783 . . . . 0.0 112.267 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 38.3 m -154.27 148.41 25.83 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.493 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.543 HG12 HG21 ' A' ' 37' ' ' VAL . 36.6 pt -117.23 144.4 33.74 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 120.572 0.225 . . . . 0.0 110.916 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.771 ' HB3' ' HB3' ' A' ' 32' ' ' GLN . 11.5 Cg_exo -68.99 104.15 1.15 Allowed 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.675 2.25 . . . . 0.0 112.013 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.553 HD13 ' HD3' ' A' ' 35' ' ' ARG . 36.5 pt -88.6 -32.98 6.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.065 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -137.93 144.85 16.27 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.066 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 28' ' ' SER . 17.1 ttm105 -88.41 122.18 31.62 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.707 0.289 . . . . 0.0 111.563 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.704 ' HA ' ' HB2' ' A' ' 2' ' ' PHE . 26.9 m -88.89 -38.97 14.13 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.42 ' O ' ' HG3' ' A' ' 26' ' ' ARG . 17.1 t -154.59 -161.34 1.2 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.045 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 43.7 ttt-85 -65.14 -53.18 49.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.088 0.47 . . . . 0.0 111.051 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -98.47 -35.6 10.21 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.686 -178.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.785 HG12 ' SG ' ' A' ' 12' ' ' CYS . 1.8 t -71.12 116.64 13.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.138 -178.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.771 ' HB3' ' HB3' ' A' ' 23' ' ' PRO . 15.0 mm100 -116.38 139.99 49.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.808 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 47.9 t -85.3 93.97 8.82 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 23.2 m -84.3 109.65 17.97 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.683 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.553 ' HD3' HD13 ' A' ' 24' ' ' ILE . 46.6 ttp180 -76.26 138.55 40.65 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.265 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -56.5 125.51 22.4 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 123.438 0.461 . . . . 0.0 111.583 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.543 HG21 HG12 ' A' ' 22' ' ' ILE . 29.4 t -126.31 77.96 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.851 0.834 . . . . 0.0 109.23 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 14.3 t-105 . . . . . 0 C--O 1.251 1.153 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.226 179.945 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 36.1 t . . . . . 0 N--CA 1.479 0.975 0 CA-C-O 120.735 0.302 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.712 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 60.4 m-85 -89.68 -19.02 25.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.678 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -56.49 -26.75 52.71 Favored Glycine 0 C--N 1.336 0.531 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 42.0 tp -160.07 75.66 0.61 Allowed 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 10' ' ' GLY . 0.1 OUTLIER -58.49 142.47 48.73 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.676 -178.641 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.425 ' O ' ' HB2' ' A' ' 7' ' ' LEU . 69.8 mtt85 -41.65 -31.23 0.27 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -176.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 73.0 mt 72.25 -45.12 0.61 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.137 0.575 . . . . 0.0 110.636 -178.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -68.45 -41.74 79.79 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.2 ttt-85 -91.33 -65.44 1.01 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.801 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.765 ' HA2' ' HA ' ' A' ' 35' ' ' ARG . . . -123.96 123.53 5.22 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 178.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -109.04 131.23 55.27 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.016 0.436 . . . . 0.0 110.806 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.623 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -85.17 126.02 33.3 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.959 0.409 . . . . 0.0 110.545 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.475 ' O ' ' HA ' ' A' ' 31' ' ' VAL . . . -129.34 143.21 50.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.821 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.523 ' HA ' HG22 ' A' ' 31' ' ' VAL . 28.6 ttp-105 -62.62 126.95 29.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.046 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.15 -129.98 13.26 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.122 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -100.52 132.62 45.8 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.451 ' SG ' ' HB3' ' A' ' 13' ' ' ALA . 58.1 m -71.25 118.07 13.58 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.168 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -83.58 58.62 4.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.643 0.735 . . . . 0.0 109.949 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.584 ' CD1' ' HD2' ' A' ' 20' ' ' PRO . 37.3 t80 -167.94 138.58 2.26 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.809 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.584 ' HD2' ' CD1' ' A' ' 19' ' ' PHE . 10.0 Cg_endo -53.99 83.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 124.067 3.178 . . . . 0.0 112.96 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.85 ' HA ' HG12 ' A' ' 37' ' ' VAL . 57.4 m -158.62 121.39 3.71 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.101 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.1 pt -82.99 138.52 42.84 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-O 121.131 0.491 . . . . 0.0 111.558 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.769 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 46.6 Cg_endo -76.04 111.66 3.32 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.384 2.056 . . . . 0.0 112.196 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.405 HD13 ' HB2' ' A' ' 35' ' ' ARG . 16.8 pt -79.01 -24.06 12.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.512 0.672 . . . . 0.0 110.264 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.712 ' HA3' ' CE1' ' A' ' 2' ' ' PHE . . . -158.03 -165.82 16.2 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.111 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 32' ' ' GLN . 44.3 ttp180 -148.58 124.19 10.44 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.876 0.338 . . . . 0.0 110.123 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 40.2 m -74.66 -52.23 12.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.871 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.9 m -114.55 -147.98 0.42 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.413 ' O ' ' HD2' ' A' ' 26' ' ' ARG . 14.7 tpp180 -84.82 -46.03 11.75 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -95.69 -42.99 8.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.826 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.533 HG12 ' SG ' ' A' ' 12' ' ' CYS . 28.7 t -64.04 109.35 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.777 -178.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.623 ' O ' ' HA ' ' A' ' 12' ' ' CYS . 51.5 mt-30 -104.5 147.31 27.73 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.601 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 52.5 t -92.34 84.95 5.25 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.769 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 59.3 m -77.49 116.08 17.77 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.212 -178.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.765 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 59.3 ttp85 -80.19 135.42 36.27 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.73 178.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 18.1 tpp85 -60.65 125.48 23.87 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.228 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.85 HG12 ' HA ' ' A' ' 21' ' ' SER . 11.8 p -132.73 39.35 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 122.652 1.215 . . . . 0.0 108.721 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 2.3 t90 . . . . . 0 C--O 1.243 0.752 0 CA-C-N 114.495 -1.229 . . . . 0.0 108.943 179.791 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.473 0.706 0 N-CA-C 110.572 -0.158 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.43 ' CG ' ' HA ' ' A' ' 27' ' ' CYS . 88.3 m-85 58.69 26.55 14.73 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 122.982 0.513 . . . . 0.0 111.969 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.18 -42.49 3.48 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 80.1 mt -108.24 41.4 1.56 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.614 ' HA ' ' HG2' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -64.02 -29.49 70.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.592 -178.44 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 72.3 mtp85 -66.66 -47.81 71.33 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.425 HD12 ' N ' ' A' ' 8' ' ' ARG . 4.5 pp -77.81 -32.53 52.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.614 ' HG2' ' HA ' ' A' ' 5' ' ' CYS . 6.5 ptm85 -63.61 -50.62 68.67 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.159 -0.616 . . . . 0.0 109.504 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.556 ' HB2' ' O ' ' A' ' 8' ' ' ARG . 36.0 ttm180 163.51 97.16 0.0 OUTLIER 'General case' 0 C--O 1.235 0.306 0 O-C-N 124.01 0.819 . . . . 0.0 109.978 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.545 ' O ' ' HA ' ' A' ' 6' ' ' ARG . . . 127.74 -143.16 14.14 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.596 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.405 ' HE2' ' HG2' ' A' ' 36' ' ' ARG . 53.7 p90 -175.39 138.59 0.42 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.499 ' SG ' HG12 ' A' ' 31' ' ' VAL . 45.6 t -89.38 123.61 33.7 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.492 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -122.97 135.43 54.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.821 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.639 ' HA ' HG13 ' A' ' 31' ' ' VAL . 54.6 ttm-85 -75.53 133.2 41.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.026 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.24 -60.03 4.85 Favored Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.292 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.419 ' CZ ' ' HB2' ' A' ' 16' ' ' ARG . 2.3 ptm85 -173.79 173.19 3.35 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.7 m -112.29 -171.07 1.78 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.958 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -91.27 178.42 5.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.913 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.576 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 36.2 t80 -59.66 -52.85 71.01 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.576 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 10.1 Cg_exo -72.49 40.88 0.49 Allowed 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.39 2.06 . . . . 0.0 113.671 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.7 p -161.83 123.42 2.79 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.206 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.404 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 45.9 pt -102.84 141.67 22.97 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 120.79 0.328 . . . . 0.0 111.115 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 22' ' ' ILE . 18.9 Cg_exo -64.11 118.69 5.63 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.675 2.25 . . . . 0.0 111.714 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.515 HG12 ' O ' ' A' ' 33' ' ' CYS . 15.8 pt -101.85 -23.83 4.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.529 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 177.25 143.79 5.06 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.892 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.409 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 66.0 mtt85 -74.4 135.05 42.4 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.43 ' HA ' ' CG ' ' A' ' 2' ' ' PHE . 8.4 m -72.22 -34.53 68.41 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.1 m -141.15 -57.02 0.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.617 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.409 ' HA ' ' HD3' ' A' ' 26' ' ' ARG . 34.9 ttm105 -172.24 -66.47 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.01 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -76.6 -41.26 46.79 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.639 HG13 ' HA ' ' A' ' 14' ' ' ARG . 2.5 t -71.23 126.58 31.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.142 178.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -117.39 151.72 36.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.758 0.313 . . . . 0.0 111.514 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.515 ' O ' HG12 ' A' ' 24' ' ' ILE . 42.4 t -107.63 120.47 42.32 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 176.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.8 m -118.97 118.62 32.0 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.888 -0.725 . . . . 0.0 112.021 -177.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.437 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 28.3 ttm180 -70.91 130.71 42.33 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.932 178.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.554 ' HB2' ' CE3' ' A' ' 38' ' ' TRP . 25.6 mtp-105 -63.71 138.68 58.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.278 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 t -80.55 53.43 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.549 0.69 . . . . 0.0 110.243 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.554 ' CE3' ' HB2' ' A' ' 36' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.583 -0.723 . . . . 0.0 110.559 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.6 t . . . . . 0 N--CA 1.476 0.827 0 CA-C-O 120.879 0.371 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -68.73 -25.13 64.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.259 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -52.1 -43.13 55.99 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 116.392 -0.367 . . . . 0.0 113.791 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.437 ' O ' ' HB2' ' A' ' 8' ' ' ARG . 3.4 mm? -65.87 -48.08 72.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.017 0.436 . . . . 0.0 111.287 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -69.91 -32.78 71.27 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.583 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.557 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 62.4 ttt-85 -54.84 -37.67 66.46 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -178.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.545 HD22 HH11 ' A' ' 6' ' ' ARG . 1.9 pt? -151.23 -33.09 0.15 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 119.769 -0.772 . . . . 0.0 112.859 -178.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 4' ' ' LEU . 26.1 mmm180 -62.15 -28.39 69.62 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 121.233 -0.187 . . . . 0.0 111.169 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 41.6 mtm105 -141.66 35.41 1.62 Allowed 'General case' 0 C--O 1.233 0.198 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 7' ' ' LEU . . . 150.83 -144.52 11.89 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.057 -1.068 . . . . 0.0 112.969 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.557 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 22.8 p90 -159.62 148.65 17.93 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.517 ' SG ' ' HA ' ' A' ' 6' ' ' ARG . 62.7 m -87.97 142.06 28.09 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.083 0.468 . . . . 0.0 111.871 -178.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.458 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -134.6 133.34 40.07 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.593 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 57.3 ttt85 -82.78 116.32 22.08 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.98 -67.4 1.12 Allowed Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.561 -0.745 . . . . 0.0 113.919 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.65 134.42 54.74 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.607 0.241 . . . . 0.0 110.69 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.5 m -81.36 164.31 22.23 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 -69.07 167.6 15.67 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.62 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 41.6 t80 -50.88 -55.47 27.23 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.62 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 57.2 Cg_endo -88.57 51.98 1.8 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.169 1.912 . . . . 0.0 113.509 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.5 p -156.67 144.7 19.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.923 0.392 . . . . 0.0 111.629 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.575 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 25.8 pt -124.51 142.73 41.23 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.309 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.94 70.94 3.53 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 123.253 2.635 . . . . 0.0 113.153 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.542 HD13 ' HD3' ' A' ' 35' ' ' ARG . 40.7 pt -63.66 -35.36 72.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.9 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.403 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -139.69 -148.98 5.3 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.936 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.493 ' HA ' ' HA ' ' A' ' 32' ' ' GLN . 19.1 ttp-105 -155.26 136.43 13.9 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.97 0.385 . . . . 0.0 110.765 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.6 m -97.35 -35.02 10.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.896 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.6 t -138.77 -146.61 0.21 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -81.18 -52.66 7.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.072 0.463 . . . . 0.0 110.033 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -98.27 -33.24 11.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.672 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 14' ' ' ARG . 41.6 t -70.9 114.47 8.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.194 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 26' ' ' ARG . 55.0 mt-30 -96.35 161.51 13.9 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.398 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.6 t -94.76 100.77 12.62 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 176.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 22' ' ' ILE . 6.8 m -108.36 94.39 5.04 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.313 -177.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.542 ' HD3' HD13 ' A' ' 24' ' ' ILE . 29.9 ptt180 -69.58 144.75 52.95 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.881 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.426 ' C ' ' H ' ' A' ' 38' ' ' TRP . 57.6 ttt180 -69.69 129.77 40.53 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.4 m -75.89 37.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 122.545 0.338 . . . . 0.0 111.691 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.426 ' H ' ' C ' ' A' ' 36' ' ' ARG . 30.2 t-105 . . . . . 0 C--O 1.251 1.154 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.228 178.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 53.3 m . . . . . 0 N--CA 1.476 0.848 0 CA-C-O 120.892 0.377 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.646 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 4.9 m-30 -74.49 -21.16 59.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.945 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.17 39.75 31.15 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.455 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 30.4 tp 60.77 28.62 18.36 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.756 0.789 . . . . 0.0 109.918 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.62 ' HA ' ' HG3' ' A' ' 9' ' ' ARG . 4.0 t -97.78 -177.2 3.69 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.355 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 68.96 -37.16 0.36 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.812 0.845 . . . . 0.0 113.043 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.8 mt -53.47 -63.97 0.98 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.034 0.445 . . . . 0.0 110.683 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -137.79 29.12 2.61 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.657 ' HB3' HD11 ' A' ' 24' ' ' ILE . 29.6 mmm180 -108.46 -53.97 2.57 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.684 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.83 -144.28 5.19 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.049 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -133.55 142.24 48.09 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.005 0.431 . . . . 0.0 110.606 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.424 ' HB3' ' CG1' ' A' ' 31' ' ' VAL . 75.4 m -78.05 121.34 24.13 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.195 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.49 138.72 52.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.489 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -80.06 52.84 1.6 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.406 0.622 . . . . 0.0 110.415 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -174.83 148.54 9.75 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.394 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.61 ' HA ' ' HG3' ' A' ' 32' ' ' GLN . 89.2 mtm180 -75.41 87.73 2.59 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.06 0.457 . . . . 0.0 110.642 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.6 m -61.96 135.56 57.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.197 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -163.08 46.32 0.13 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.829 0.823 . . . . 0.0 109.996 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.825 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 31.8 t80 -172.84 -61.89 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.111 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.825 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 75.5 Cg_endo -91.79 8.69 2.99 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.042 1.828 . . . . 0.0 112.383 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.3 t 179.52 148.72 0.27 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 18.5 pt -106.68 137.87 19.6 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.165 0.507 . . . . 0.0 111.273 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.75 72.58 6.44 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 123.174 2.583 . . . . 0.0 112.319 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.657 HD11 ' HB3' ' A' ' 9' ' ' ARG . 40.3 pt -65.37 -23.22 32.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.435 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -146.13 -166.01 11.81 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.803 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 23.5 ttp-105 -142.97 123.79 14.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.825 0.345 . . . . 0.0 111.041 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.646 ' HA ' ' HA ' ' A' ' 2' ' ' PHE . 36.3 m -87.22 -40.57 14.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.49 0.662 . . . . 0.0 109.368 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.489 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 35.3 m -153.25 165.38 35.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.652 -1.158 . . . . 0.0 107.99 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.0 tpp180 -51.44 -48.08 62.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.712 0.233 . . . . 0.0 111.528 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -99.39 20.87 12.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.815 0.341 . . . . 0.0 111.582 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.489 ' HB ' ' HB2' ' A' ' 28' ' ' SER . 57.3 t -138.07 101.65 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.015 0.436 . . . . 0.0 110.586 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.61 ' HG3' ' HA ' ' A' ' 16' ' ' ARG . 15.0 mm100 -80.36 146.47 31.52 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.814 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 49.4 t -93.06 73.91 4.72 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 22' ' ' ILE . 7.7 m -70.75 120.23 16.05 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.43 -1.259 . . . . 0.0 113.184 -176.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.56 ' HD2' HG21 ' A' ' 24' ' ' ILE . 16.4 ttm180 -95.82 132.4 41.11 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.539 177.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -64.15 130.54 44.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.943 0.401 . . . . 0.0 110.89 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.63 52.37 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 1.6 t90 . . . . . 0 C--O 1.246 0.907 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.322 -178.735 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 45.1 m . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 120.595 0.236 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.44 ' CD2' ' HB3' ' A' ' 27' ' ' CYS . 2.5 m-85 -66.49 -38.29 86.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.096 0.474 . . . . 0.0 110.328 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -63.12 -30.34 77.18 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.805 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.4 mp -114.1 52.66 0.82 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.822 0.344 . . . . 0.0 110.213 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.497 ' C ' ' H ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -56.42 145.92 26.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.618 -179.628 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.595 ' HD2' HD12 ' A' ' 24' ' ' ILE . 47.6 ttt85 71.11 -19.19 0.25 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.435 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.497 ' H ' ' C ' ' A' ' 5' ' ' CYS . 69.6 mt 72.26 -28.62 0.19 Allowed 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.305 1.042 . . . . 0.0 113.108 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -78.47 53.59 1.31 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.285 0.564 . . . . 0.0 110.493 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 69.0 mtt85 60.76 45.5 9.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.036 -0.984 . . . . 0.0 112.002 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.12 154.81 16.35 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -145.93 139.73 26.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 118.097 0.948 . . . . 0.0 112.195 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.783 ' HB3' HG12 ' A' ' 31' ' ' VAL . 12.3 m -91.16 128.63 37.06 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.216 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.82 140.61 50.51 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.292 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.8 mtm-85 -72.77 142.7 48.11 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.414 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.58 -100.2 2.64 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.039 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -163.54 154.92 16.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.997 0.427 . . . . 0.0 111.484 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.25 129.67 33.99 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -162.56 57.03 0.22 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.203 0.525 . . . . 0.0 110.996 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.905 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 69.5 t80 -159.79 -63.01 0.02 OUTLIER Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.881 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.905 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 3.7 Cg_endo -84.92 -36.04 0.15 Allowed 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.136 1.891 . . . . 0.0 111.272 178.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.438 ' H ' ' HD2' ' A' ' 20' ' ' PRO . 22.6 m -139.27 144.15 38.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.294 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.468 HG12 HG21 ' A' ' 37' ' ' VAL . 38.5 pt -95.07 146.05 30.64 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.518 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -69.39 101.32 0.85 Allowed 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.49 2.127 . . . . 0.0 112.487 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.595 HD12 ' HD2' ' A' ' 6' ' ' ARG . 45.1 pt -84.23 -29.07 7.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.457 0.646 . . . . 0.0 110.054 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -166.68 -145.73 4.58 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.419 ' CB ' ' HA ' ' A' ' 32' ' ' GLN . 40.4 ptt180 -170.99 140.79 1.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 117.869 0.834 . . . . 0.0 112.273 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.44 ' HB3' ' CD2' ' A' ' 2' ' ' PHE . 87.8 m -81.11 -32.75 33.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.507 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.6 m -145.81 171.75 14.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.262 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -50.91 -51.48 51.52 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.35 0.406 . . . . 0.0 112.034 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -105.63 29.8 6.27 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.9 0.381 . . . . 0.0 110.93 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.783 HG12 ' HB3' ' A' ' 12' ' ' CYS . 31.9 t -136.59 80.51 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.419 ' HA ' ' CB ' ' A' ' 26' ' ' ARG . 25.6 mt-30 -71.67 142.83 49.87 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.183 -178.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.497 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 41.9 t -94.29 106.23 18.21 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 177.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 83.9 m -115.88 92.24 3.84 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.174 0.512 . . . . 0.0 110.575 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 73.7 ttt-85 -66.35 139.56 58.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.04 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -64.17 124.76 22.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.257 0.551 . . . . 0.0 110.596 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.468 HG21 HG12 ' A' ' 22' ' ' ILE . 16.9 t -114.87 65.96 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.513 0.673 . . . . 0.0 109.907 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 63.4 p-90 . . . . . 0 C--O 1.252 1.19 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.322 -179.603 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 17.3 p . . . . . 0 N--CA 1.479 0.987 0 CA-C-O 120.637 0.256 . . . . 0.0 111.468 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.448 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 5.1 p90 -88.94 -4.86 58.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.716 0.293 . . . . 0.0 111.419 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -60.34 -39.77 96.59 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.289 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 pp -88.72 38.75 0.89 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.01 0.433 . . . . 0.0 111.113 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.417 ' C ' ' H ' ' A' ' 7' ' ' LEU . 3.0 t -151.35 167.67 27.19 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.238 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 25.3 tpp180 70.24 -35.69 0.33 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.603 0.761 . . . . 0.0 112.22 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.417 ' H ' ' C ' ' A' ' 5' ' ' CYS . 59.5 mt -82.82 62.88 6.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.178 0.513 . . . . 0.0 110.978 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 43.8 mtm-85 72.72 -22.61 0.22 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.585 -1.188 . . . . 0.0 112.429 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.405 ' H ' ' C ' ' A' ' 7' ' ' LEU . 24.1 tpp180 -64.91 -31.34 72.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.358 0.599 . . . . 0.0 110.389 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.11 -147.03 9.69 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -155.43 138.14 15.2 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.163 0.506 . . . . 0.0 110.172 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.61 ' HB3' ' CG1' ' A' ' 31' ' ' VAL . 81.8 m -77.04 130.16 37.05 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.102 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -138.48 123.68 19.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.659 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.619 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 18.5 ptp180 -74.57 137.47 42.39 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.181 0.515 . . . . 0.0 110.892 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.14 -121.0 5.08 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 -161.31 112.2 1.73 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.507 0.67 . . . . 0.0 110.421 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.481 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 2.5 p -90.9 136.39 33.11 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.472 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -163.38 52.05 0.16 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.551 0.691 . . . . 0.0 110.123 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.939 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 47.0 t80 -167.05 -65.27 0.01 OUTLIER Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.142 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.939 ' HD3' ' HB3' ' A' ' 19' ' ' PHE . 2.9 Cg_endo -84.71 -23.73 2.55 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.136 1.891 . . . . 0.0 111.667 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.53 ' HA ' HG12 ' A' ' 37' ' ' VAL . 24.8 m -155.67 150.95 26.85 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.366 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.8 pt -110.3 143.58 28.36 Favored Pre-proline 0 C--N 1.323 -0.554 0 O-C-N 123.124 0.265 . . . . 0.0 110.821 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 17' ' ' CYS . 61.2 Cg_endo -75.22 78.26 3.0 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.862 2.375 . . . . 0.0 112.176 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.549 HD13 ' HD2' ' A' ' 35' ' ' ARG . 36.4 pt -62.37 -37.64 79.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.976 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.404 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -131.99 -160.56 9.77 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.853 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 28' ' ' SER . 37.5 ttm180 -140.28 119.7 13.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.852 0.358 . . . . 0.0 111.002 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 2' ' ' PHE . 56.2 m -83.56 -36.68 23.8 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.413 ' O ' ' HG3' ' A' ' 26' ' ' ARG . 47.4 m -159.9 172.66 17.21 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.165 -1.421 . . . . 0.0 107.165 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.9 tpp85 -56.07 -46.45 78.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 118.326 0.512 . . . . 0.0 111.097 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.512 ' CD2' ' HB2' ' A' ' 14' ' ' ARG . 8.6 t80 -87.61 -35.72 17.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.751 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.619 ' HA ' ' HA ' ' A' ' 14' ' ' ARG . 16.7 t -85.6 107.27 16.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.325 0.583 . . . . 0.0 111.916 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -85.95 153.73 21.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.96 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 37.6 t -97.16 85.9 3.82 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 20.5 m -82.44 117.63 22.62 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.642 -177.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.549 ' HD2' HD13 ' A' ' 24' ' ' ILE . 51.5 ttt85 -89.11 127.28 35.7 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.544 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -58.9 129.35 41.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.021 0.439 . . . . 0.0 111.017 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.53 HG12 ' HA ' ' A' ' 21' ' ' SER . 13.6 p -152.68 42.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 122.504 1.145 . . . . 0.0 109.601 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 4.6 t90 . . . . . 0 C--O 1.247 0.97 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.403 179.612 . . . . . . . . 0 0 . 1 stop_ save_